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AA amino acid 
AARS aminoacyl-tRNA-synthetase 
ACh acetylcholine 
ACP acyl carrier protein 
AMP / ATP adenosine 5’-monophosphate / adenosine 5′-triphosphate 
AMV avian myeloblastosis virus 
Anap 3-(6-acetylnaphthalen-2-ylamino)-2-aminopropanoic acid 
Azi p-azido-phenylalanine 
2-AR β2 adrenergic receptor 
B molecular brightness 
BC O6-benzylcytosine 
BCN / BCNK bicyclo[6.1.0]-nonyne / bicyclo[6.1.0]-nonyne lysine 
BG O6-benzylguanine 
BirA biotin ligase 
Bpa p-benzoyl-phenylalanine 
BSA bovine serum albumin 
Bst Bacillus stearothermophilus 
BstYam amber suppressor tRNA derived from the Bacillus stearothermophilus 
 tRNATyr 
Bt Bos taurus 
CMV cytomegalovirus 
CP / CPK 1,3-disubstituted cyclopropane / 1,3-disubstituted cyclopropane lysine 
CRF / CRF1R corticotropin releasing factor / corticotropin releasing factor receptor 
type 1 
CTD  C-terminal domain 
CuAAC copper-catalyzed azide alkyne cycloaddition 
Cy3 / Cy5 cyanine dye 3 / cyanine dye 3 





DEPC diethyl pyrocarbonate 
Dh Desulfitobacterium hafniense 
DHFR dihydrofolate reductase 
DMEM Dulbecco’s Modified Eagle’s Medium 
DMSO dimethyl sulfoxide 
DNA deoxyribonucleic acid 
Ec Escherichia coli 
EC50  half maximal effective concentration 
ECL enhanced chemiluminescence or extracellular loop 
Ec-Lam5 amber suppressor tRNA derived from the Escherichia coli tRNALeu 
EDTA ethylenediaminetetraacetic acid 
EF-Tu elongation factor thermo unstable 
EGFP epidermal growth factor receptor 
Em / Ex emission / excitation 
FACS fluorescence assisted cell sorting 
FAP fluorogen activating proteins 
FBS fetal bovine serum 
FCS fluorescence correlation spectroscopy 
Ffact p-2′-fluoroacetylphenylalanine 
FFS fluorescence fluctuation spectroscopy 
FKBP’ FK506 binding protein 12 
FlAsH fluorescein arsenical hairpin binder 
FP fluorescent protein 
FRET fluorescence resonance energy transfer 
GDP / GTP guanosine 5’-diphosphate / guanosine 5’-triphosphate 
  ABBREVIATIONS 
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GFP/EGFP green fluorescent protein / enhanced green fluorescent protein 
GLP-1 glucagon-like peptide-1 
GPCR G protein-coupled receptor 
HceG L-(7-hydroxycoumarin-4-yl)ethylglycine 
HDB HEPES dissociation buffer 
HDV hepatitis delta virus 
HEK human embryonic kidney 
HEPES 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
HH hammerhead 
HRP horseradish peroxidase 
ICL intracellular loop 
IR insulin receptor 
iRFP near-infrared fluorescent protein 
iv in vitro 
KD dissociation constant 
LBD ligand binding domain 
LBS lactate buffered saline  
LplA Lipoic acid ligase 
Lys(Boc) Nε-(tert-butyloxycarbonyl)-L-lysine 
Lys(Z) Nε-Carbobenzyloxy-L-lysine 
M2R muscarinic M2 receptor  
Ma Methanomethylophilus alvus 
Mb Methanosarcina barkeri 
Mm Methanosarcina mazei 
mRNA messenger ribonucleic acid  
MSD mean squared displacement 
mt mitochondrial 
  ABBREVIATIONS 
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MW molecular weight 
ncAA non-canonical amino acid 
ncAARS aminoacyl-tRNA synthetase for non-canonical amino acids 
NES nuclear export signal 
NMD nonsense mediated decay 
Nor norbornene 
NTD N-terminal domain 
OPD o-phenylenediamine dihydrochloride 
PAA polyacrylamide  
PAGE polyacrylamide gel electrophoresis 
PALM photoactivated localization microscopy 
p-BorF p-borono-L-phenylalanine 
PBS phosphate buffered saline 
PDB Protein data bank 
PDL poly-D-lysine 
PEI  polyethylenimine 
PFA paraformaldehyde 
PGK phosphoglycerate kinase 
PI protease inhibitor 
p-IF p-iodo-L-phenylalanine 
PMSF phenylmethylsulfonyl fluoride 
POI protein of interest 
Pol polymerase  
PPTase phosphopantetheinyl-transferases 
PRK N-propargyl-L-lysine 
Pu / R purine 
PVDF polyvinylidene difluoride 
  ABBREVIATIONS 
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Py / Y pyrimidine 
Pyl pyrrolysine 
PylRS pyrrolysyl-tRNA synthetase 
ReAsH resorufin arsenical hairpin binder 
RNA ribonucleic acid 
ROI region of interest  
RT room temperature or reverse transcription 
scFv single-chain variable antibody fragment 
SCO / SCOK strained cyclooctyne / strained cyclooctyne lysine 
SDS sodium dodecyl sulfate 
SiR silicon rhodamine 
sm single molecule 
SMS single molecule spectroscopy 
SrtA Sortase A 
SPAAC strain-promoted azide alkyne cycloaddition 
SpIDA spatial intensity distribution analysis  
SPIEDAC strain-promoted inverse Diels Alder cycloaddition 
SSC saline-sodium citrate buffer 
STED stimulated emission depletion 
STORM stochastic optical reconstruction microscopy 
T ribothymidine 
TAMRA 5-carboxytetramethylrhodamine 
TB temporal brightness  
TBS / TBS-T tris buffered saline / Tris-buffered saline supplemented with Tween 
TCO* / TCO*K trans-cyclooct-2-ene / trans-cyclooct-2-ene lysine 
TFA trifluoroacetic acid 
TIRF total internal reflection fluorescence  




Tris  tris(hydroxymethyl)aminomethane 
tRNA transfer ribonucleic acid 
TβRII transforming growth factor type II receptor 
Ucn1 urocortin 1 
UV ultraviolet 
wt wild type  
Ψ pseudouridine 
Nucleic acid notation and codes for amino acids were used according to IUPAC nomenclature. 
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The expansion of the genetic code for the site-specific incorporation of artificial moieties into 
proteins is a powerful tool for studying protein structure and function in vitro and in live cells. The 
technique utilizes engineered pairs of aminoacyl-tRNA synthetases and cognate suppressor tRNAs 
to incorporate non-canonical amino acids (ncAAs) with desired properties into the nascent 
polypeptide chain during the ribosomal biosynthesis. At the beginning of this work, the pyrrolysyl-
tRNA synthetase/tRNAPyl pair had emerged as the most versatile and widespread system for 
protein modification in mammalian cells, overall mediating the incorporation of more than 100 
different ncAAs. Among these is a group of pyrrolysine analogs bearing strained alkene and alkyne 
moieties that allow for rapid and efficient bioorthogonal click-chemistry. However, low 
incorporation yields of such large and sterically challenging ncAAs severely limited their 
applicability to relevant biological targets.  
In this thesis, novel tRNAPyl variants were generated that significantly boost the performance of 
the pyrrolysine system in mammalian cells, thus enabling efficient single-site and dual-site ncAA 
incorporation. These tRNAs are structurally more stable than tRNAPyl and feature higher 
intracellular concentrations. Interestingly, they bear partially distinct post-transcriptional 
modifications compared to the natural tRNAPyl, which likely improve their quality and 
compatibility with the eukaryotic translational machinery. By using these new tRNAs to 
incorporate last-generation ncAAs for bioorthogonal chemistry into G protein-coupled receptors 
(GPCRs), bioorthogonal GPCR labeling with bright and photostable organic fluorophores has been 
achieved on the surface of live human cells. Furthermore, a method based on fluorescence 
fluctuation microscopy was developed, which allows the accurate measure of the labeling yield at a 
single-cell level. The method was applied to identify sites for incorporation of trans-cyclooct-2-ene-
lysine (TCO*K) that give quantitative labeling. Quantitative labeling was achieved at more than 
one site of three tested GPCRs of both class A and B, thus enabling in principle investigations of 
GPCR distribution and oligomerization with high-end microscopy techniques (e.g. single molecule 
tracking) that require stoichiometric data analysis. Importantly, even sensitive loop regions could 
be labeled without losing receptor function. It could be shown that a GPCR labeled with a small 
fluorophore diffuses faster in the cell membrane than the same GPCR fused to a fluorescent protein. 
Finally, by using competitive dual-color labeling of a single GPCR site, a method was devised to 
estimate GPCR oligomerization without the need of a biological monomeric reference. 





Introducing new chemical or physical properties into proteins is an efficient tool to enhance their 
repertoire of functions, thereby opening up new ways for studying the dynamics and characteristics 
of these indispensable biomolecules. The most straightforward technique to add novel functions to 
a protein is to install non-canonical amino acids (ncAA) at a desired site. Over the last two decades, 
new technologies expanding the genetic code have emerged; these methods make use of specialized 
pairs of aminoacyl-tRNA-synthetases and cognate suppressor tRNAs, which mediate the 
incorporation of the desired ncAA in response to an in-frame stop codon during ribosomal 
translation of the target protein directly in the live cell. They are a much more powerful alternative 
than chemical methods for incorporating unnatural amino acids into polypeptides, which include 
solid-phase synthesis, native chemical ligation or in vitro translation. 
The specialized pairs need to be orthogonal in the context of the host organism’s endogenous 
translational pairs (AARS and tRNAs). At the same time, the aminoacylated suppressor tRNA must 
be able to interact with the components of the endogenous translational machinery, such as the 
elongation factor and the ribosome, in order to functionally introduce the ncAA into the nascent 
polypeptide chain. 
The pyrrolysyl-tRNA synthetase (PylRS) and tRNAPyl pair has been the most popular system for 
ncAA incorporation since first discovered in methanogenic archaea, where it facilitates the 
incorporation of the 22nd proteinogenic amino acid pyrrolysine in response to an amber stop codon. 
This system features great versatility and excellent orthogonality in both bacteria and eukaryotes 
due to a rare structure of the tRNAPyl, which is selectively recognized by a unique binding 
mechanism with its cognate PylRS. To date, well over a hundred ncAAs have been encoded using 
the pyrrolysine system or engineered variants derived from it, among them a novel group of ncAAs 
designed for bioorthogonal chemistry. These new ncAAs allow for selective labeling of proteins with 
small-molecule fluorophores directly in live cells and have become a critical application of the 
pyrrolysine system. 
While the pyrrolysine system works notoriously well in bacteria, the incorporation of ncAAs in 
mammalian cells produces only modest yields of the target protein. These low yields can prevent 
the applicability of the system with low abundant proteins and membrane proteins. The latter 
include targets of strikingly high pharmaceutical relevance like G protein-coupled receptors 
(GPCRs). Prior to this work, several efforts to improve the incorporation efficiency of the 
pyrrolysine system in mammalian cells had already been made. They mostly involved simple 
optimization of plasmid design or evolution of PylRS variants for optimized aminoacylation 
efficiency of a particular ncAA. Orthogonal suppressor tRNA still requires compatibility with the 
transcriptional, translational and processing machinery endogenous in the host organism and that 
provided the starting point for this work. We suspected that the atypically structured tRNAPyl may 
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impact the interaction with the complex biosynthetic machinery of mammalian cells. Hence, we 
expected tRNAPyl to be the ideal starting point for improving the pyrrolysine systems efficiency in 
eukaryotes. 
Chapter 1 summarizes the theoretical background of the methodology of genetic code expansion, 
including its use for site-specific labeling of proteins. Further, it provides a detailed insight into the 
working mechanisms of the pyrrolysine system and the molecular basis for several advantages over 
other established systems. Additionally, chapter 1 includes a comprehensive overview of available 
labeling methods and illustrates the advantages of ncAA mediated protein labeling over alternative 
approaches. It presents the aim of the overall work and an overview in the denouement. 
Results 
Chapter 2 describes the design and generation of tRNAPyl variants that significantly boost the 
performance of the pyrrolysine system in mammalian cells, thus enabling the incorporation of bulky 
ncAAs for bioorthogonal chemistry into challenging protein targets. Initially, small sets of tRNAPyl 
variants were designed with two different approaches and their suppression efficiency was screened 
using an EGFP-based fluorescence assay. The first approach was aimed at improving the 
recognition of tRNAPyl by mammalian endogenous components. For this purpose, single bases or 
base pairs of tRNAPyl were substituted with the corresponding nucleotides found in the conservation 
pattern of human tRNAs. Next, beneficial mutations were combined to produce even more efficient 
tRNAPyl variants. At the same time, additional tRNAPyl mutants were designed, which feature 
either intrinsic promoter elements typical for eukaryotic tRNAs or different combinations of bases 
connecting the acceptor-stem to the T-arm, a region which was shown to improve interactions with 
elongation factor EF-Tu in bacteria. The second design strategy makes use of structural similarities 
between the tRNAPyl and the mitochondrial tRNASer from Bos taurus. It was reasoned that the 
scaffold of a mammalian mitochondrial tRNA may yield chimeric tRNA well-suited for the 
mammalian cytosolic context. Based on existing knowledge of interactions between PylRS and 
tRNAPyl, different combinations of recognition motifs for PylRS were transplanted to the 
mitochondrial tRNASer. The best variants from each approach were selected and tested for their 
ability to encode a pool of different ncAAs. The focus was on ncAAs designed for bioorthogonal 
chemistry, which presents a major critical application of the pyrrolysine system nowadays. The 
new tRNAPyl variants yielded higher amber suppression ratios for all tested ncAAs compared to the 
reference tRNAPyl. Follow-up Northern Blot analysis of HEK293 cells expressing the different 
tRNAPyl variants revealed that these new tRNAPyl variants feature higher intracellular 
concentrations than wild type tRNAPyl. Structural analysis based on an in-line probing technique 
exposed no significant differences between the wild type tRNAPyl and the two new tRNAPyl, 
suggesting that their overall structure remains unaltered despite the variances in sequence. 
Interestingly, by applying reverse-transcription based methods, it was revealed that tRNAPyl is 
post-transcriptionally modified in mammalian cells and that the tRNAPyl and the engineered 
tRNAPyl bear partially distinct modifications. Next, one of the novel tRNAPyl was used to incorporate 
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a series of ncAAs into the corticotropin releasing factor type 1 receptor (CRF1R), a class B GPCR. 
Western Blot analysis, as well as fluorescence microscopy imaging, revealed that the novel tRNAM15 
gives significantly higher incorporation rates compared to the wild type tRNAPyl. The high efficiency 
of the engineered tRNA allowed incorporation of the ncAA for bioorthogonal chemistry trans-
cyclooct-2-ene lysine (TCO*) into the CRF1R, which was labeled via strain promoted inverse-
electron-demand Diels-Alder cycloaddition (SPIEDAC) with the small organic cyanine-based probe 
tetrazine-Cy3. The appendix of chapter 2 describes a similar rational design approach for 
generation of enhanced leucine suppressor tRNAs. Efforts were aimed at improving the leucine 
orthogonal system for use in mammalian cells, whose major application involves the incorporation 
of environmentally sensitive fluorescent ncAAs and photo-caged ncAAs for studies of protein 
dynamics. 
The novel pyrrolysine system made it feasible to incorporate ncAAs for bioorthogonal chemistry 
with high efficiency into a GPCR and allowed for attaching small, bright and photo-stable 
fluorophores, which are a main requirement for high-end microscopy techniques. Besides an 
efficient expression of the target protein, the labeling yields are a crucial aspect of all labeling 
techniques. Most strikingly, applications that involve stoichiometric analysis of data, such as single 
molecule tracking for oligomerization studies, require high to quantitative yield and the exact 
knowledge of the labeling ratio. However, the precise quantification of the labeling efficiency is 
often a challenge that should not be underestimated. Existing methods often resort to the indirect 
evaluation of fluorescence labeling yields. For instance, some methods assume quantitative labeling 
when the fluorescence observed upon labeling does not increase further with increasing 
concentrations of dyes. Others normalize fluorescence intensity of the label to signals obtained from 
immunostaining of the target. 
Chapter 3 describes a new approach to utilize fluorescence fluctuation spectroscopy (FFS) for a 
reliable and accurate assessment of labeling yields. This novel application of FFS allows extraction 
of the number of molecules of the target protein and the number of occupied labeling sites in 
selected areas of the cellular membrane. The technique is very precise and extracts data in a 
minimally invasive fashion. Initially, it was demonstrated that the previously achieved SPIEDAC-
labeling is not only applicable to class B GPCRs, but to class A GCPRs as well. A pool of solvent 
exposed positions in the extracellular and intracellular loops of three different GPCRs were selected 
on the bases of existing crystal structures, so that they should theoretically provide high rates of 
ncAA incorporation and good accessibility by the labeling dye. Next, the cell-surface expression of 
GPCR-EGFP fusion proteins bearing TCO* at the different sites was quantified. Data revealed that 
the incorporation rates of TCO* were highly position-dependent and that the overall achievable 
expression levels differ between the three receptors. At the same time, screening of TCO*-receptor-
EGFP variants was performed to identify positions that give the best labeling yields. Cells 
expressing TCO*-GPCR-EGFP were treated with cyanine-based membrane-impermeable dyes 
(Cy3-tetrazine, Cy5-tetrazine) or rhodamine-based membrane-permeable dyes (SiR-tetrazine or 
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TAMRA-tetrazine) in order to label extracellular and intracellular positions, respectively. For a 
first estimate of labeling efficiencies, dye-treated cells were visualized by wide-field fluorescence 
microscopy both in the green EGFP channel and red/far-red channels appropriate for the 
corresponding label. Based on these screening results, a subset of representative GPCR variants 
was selected for establishing this novel quantification method. Subsequently, fluorescence movies 
of the basolateral membrane from individual cells were recorded in separate channels for EGFP 
and the used dye on a confocal microscope. By analyzing the fluctuations of the fluorescence signal 
in a single pixel of a confocal image over time, it is possible to determine the average number of 
fluorescent objects diffusing in and out of the pixel and quantifying their brightness. Correlating 
the extracted numbers of red emitters (dye) to the quantity of green emitters (GPCR-EGFP) present 
in the basal membrane of different cells allows one to derive the labeling efficiency from linear 
regression. This method was applied to the previously selected class A and class B GPCR variants. 
It was shown that yields of the SPIEDAC-reaction were up to quantitative for all three receptors, 
which demonstrated the general applicability of the approach for labeling of GPCRs. Importantly, 
it was possible to quantitatively label positions in the sensitive loops of the receptors without losing 
receptor function. Further, this work compared the diffusion speeds of a GPCR labeled at a single 
residue by ncAA-labeling and the equivalent receptor fused to EGFP. The diffusion measurements 
revealed that receptors labeled with a small molecular dye move significantly faster. Overall, these 
faster moving, small-molecule labeled receptors are more likely to represent a natural state of the 
receptor and thereby demonstrate a major advantage of ncAA mediated labeling over conventional 
fusion of a fluorescent protein. Finally, one more application of the described FFS microscopy 
method illustrates that a labeling strategy including dual-color competitive labeling on a single 
ncAA site can be used to address the oligomerization state of a GPCR without previous 
identification of a monomeric reference. This approach was used to investigate the CRF1R and 
yielded an oligomeric fingerprint, which is in line with previous published estimates. 
Chapter 4, in detail, describes a protocol for the fluorescence-based evaluation of tRNA-synthetase 
pairs, which was applied in chapter 2 for screening the variants of the engineered tRNAPyl. This 
straightforward method was established throughout the compilation of this thesis to allow for a 
fast and highly reliable assessment of ncAA incorporation efficiencies. In addition, it describes two 
comprehensive protocols for ncAA applications to GPCR studies in live mammalian cells. These 
include a photo-crosslinking technique to investigate ligand-receptor interfaces and the step-by-
step procedure for site-specific bioorthogonal labeling of a GPCR, which was used in chapter 2 and 
chapter 3. Altogether, this section provides a high level of technical detail about the experimental 
procedures used in this work and focuses on a critical comparison of strengths and limitations 
compared to other available methods. 




Figure 1: Overview of this work. 
Conclusion 
This work fundamentally contributes to the general applicability of ncAAs for study of protein 
dynamics. The two tRNAPyl variants reported here increase several-fold the efficiency of the 
pyrrolysine orthogonal system in mammalian cells, which is the most popular tool for ncAA 
incorporation into proteins today. Employing the improved pyrrolysine system, quantitative 
SPIEDAC-mediated labeling of GPCRs could be achieved in live cells. Additionally, this work shows 
that improving the quality of an orthogonal pair is best achieved by adapting the suppressor RNA 
to the host organism. As a consequence, tRNAs offer a reasonable starting point for optimization of 
genetic code expansion techniques in general. Furthermore, the methods presented in this work, 
particularly the fluorescence-based assay for evaluation of ncAA incorporation efficiency and the 
fluorescence fluctuation microscopy approach for a direct assessment of labeling yields, 
independent of the used labeling strategy, constitute powerful tools to guarantee optimal conditions 
for follow-up studies of target proteins directly in the live cell. Finally, this work also demonstrates 
the diverse applicability of ncAA modification to study GPCRs. 
  





Durch die Ausstattung von Proteinen mit neuen chemischen und physikalischen Eigenschaften ist 
es möglich, deren Funktionsrepertoire zu erweitern, was wiederum neue Möglichkeiten eröffnet, 
die Eigenschaften und Dynamik dieser unverzichtbaren Biomoleküle zu untersuchen. Der Einbau 
nicht-kanonischer Aminosäuren (ncAAs) stellt hierbei die direkteste und zielführendste Methode 
dar, um eine gewünschte Funktion an beliebiger Stelle in das Protein zu integrieren. Im Laufe der 
letzten zwei Jahrzehnte haben sich hierfür neue Techniken zur Erweiterung des genetischen Codes 
etabliert. Diese Methoden verwenden spezialisierte Aminoacyl-tRNA-Synthetasen und zugehörige 
suppressor-tRNAs, welche den Einbau der gewünschten ncAA direkt in der lebenden Zelle als 
Antwort auf ein im Leserahmen befindliches Stopcodon während der ribosomalen Biosynthese des 
Zielproteins vermitteln. Sie stellen damit eine wesentlich wirksamere Alternative gegenüber 
bestehenden chemischen Verfahren, wie der Festphasensynthese, der nativen chemischen Ligation 
oder der in vitro Translation zum Einbau nichtnatürlicher Aminosäuren in Polypeptide dar.  
Dabei müssen diese spezialisierten Paare gegenüber den endogenen Translationspaaren des 
Wirtsorganismus (AARS und tRNAs) orthogonal sein. Gleichzeitig muss die beladene suppressor-
tRNA jedoch in der Lage sein, mit den Komponenten der endogenen Translationsmaschinerie, wie 
Elongationsfaktoren und dem Ribosom, zu interagieren, um den Einbau der ncAA in die 
entstehende Polypeptidkette zu gewährleisten. 
Seit seiner Entdeckung ist das Paar aus Pyrrolysyl-tRNA-Synthetase (PylRS) und tRNAPyl das 
beliebteste System für den Einbau von ncAAs. Dieses Paar wurde zuerst im Zusammenhang mit 
methanogenen Archaeen beschrieben, wo es den Einbau der 22. proteinogenen Aminosäure 
Pyrrolysine als Antwort auf ein TAG-Stopcodon ermöglichte. Das Pyrrolysin-System bietet eine 
enorme Vielseitigkeit und zudem eine ausgezeichnete Orthogonalität sowohl in Bakterien als auch 
in Eukaryonten. Zweiteres beruht auf der seltenen Struktur der tRNAPyl, welche durch einen 
einzigartigen Bindungsmechanismus von der PylRS erkannt wird. Auf Grund dieser 
entscheidenden Vorteile wurden bis heute weit über hundert verschiedene ncAAs mit Hilfe des 
Pyrrolysin-Systems oder daraus abgeleiteten Varianten codiert. Darunter findet sich auch eine 
neue Gruppe von ncAAs, welche spezifisch für bioorthogonale Chemie entwickelt wurden. Diese 
neuen ncAAs ermöglichen die selektive Markierung von Proteinen mit kleinen und stabilen 
Fluorophoren direkt in lebenden Zellen und stellen daher eine der entscheidenden Anwendungen 
des Pyrrolysin-Systems dar. 
Während das Pyrrolysin-System in Bakterien bekanntermaßen gut funktioniert, gelingt der 
Einbau von ncAAs in Säugetierzellen nur mit mäßigen Proteinausbeuten. Dies hat zur Folge, dass 
die Anwendbarkeit des Systems stark eingegrenzt wird. Besonders ins Gewicht fällt dies bei der 
Erforschung von Proteinen mit intrinsisch niedrigen Konzentrationen oder Membranproteinen. Zu 
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letzteren gehören auch die G-Protein-gekoppelten Rezeptoren (GPCRs), welche eine auffallend 
hohe pharmazeutische Relevanz besitzen und somit wichtige Untersuchungsziele darstellen. Vor 
Beginn dieser Arbeit wurden bereits verschiedene Anstrengungen unternommen, um die 
Einbaueffizienz des Pyrrolysin-Systems in Säugetierzellen zu verbessern. Dazu zählen meist 
einfache Optimierungen der Struktur von Plasmiden, auf denen sich die Gene für PylRS und 
tRNAPyl befinden oder die Entwicklung von PylRS-Varianten, welche eine effizientere 
Aminoacylierung von tRNAPyl mit einzelnen speziellen ncAAs ermöglichen. Diese Arbeit basiert 
darauf, dass eine orthogonale tRNA mit der im Wirtsorganismus vorliegenden Transkriptions-, 
Translations- und Verarbeitungs-Maschinerie kompatibel sein muss. Es wurde daher 
angenommen, dass die atypische Struktur der tRNAPyl die Interaktion mit der komplexen 
Biosynthesemaschinerie von Säugetierzellen mindern könnte, was tRNAPyl wiederum zum idealen 
Ausgangspunkt für eine Optimierung des Pyrrolysin-Systems in Eukaryoten macht. 
Kapitel 1 umfasst den theoretischen Hintergrund zur Methodik der Erweiterung des genetischen 
Codes, einschließlich der Verwendung für die positionsspezifische Fluoreszenzmarkierung von 
Proteinen. Darüber hinaus gibt dieses Kapitel einen detaillierten Einblick in die einzigartigen 
molekularen Funktionsmechanismen des Pyrrolysin-Systems, welche die Basis für dessen 
Überlegenheit gegenüber anderen etablierten Systemen bilden. Ferner beinhaltet Kapitel 1 einen 
umfassenden Überblick über verfügbare Markierungsmethoden und veranschaulicht die Vorteile 
der Proteinmarkierung mit Hilfe von ncAAs gegenüber alternativen Ansätzen. Im letzten Abschnitt 
dieses Kapitels wird das Ziel der Gesamtarbeit erläutert. 
Ergebnisse 
Kapitel 2 beschreibt den Entwurf und die Herstellung von tRNAPyl-Varianten, welche die 
Leistungsfähigkeit des Pyrrolysin-Systems in Säugetierzellen signifikant steigern. Dies 
ermöglichte einen effizienten Einbau sperriger ncAAs für die bioorthogonale Chemie in sonst 
herausfordernde Zielproteine. Zunächst wurden anhand zwei verschiedener Entwurfsansätze 
tRNAPyl-Varianten entwickelt und deren Effizienz zum Einbau von ncAAs mithilfe eines 
fluoreszenzbasierten EGFP-Assays bestimmt. Der erste Ansatz zielte darauf ab, die notwendigen 
Interaktionen von tRNAPyl mit eukaryotischen Proteinen zu verbessern. Daher wurden einzelne 
Basen oder Basenpaare von tRNAPyl ersetzt, so dass sie Nukleotiden entsprechen, welche im 
Konservierungsmuster menschlicher tRNAs vorkommen. Anschließend wurden vorteilhafte 
Mutationen kombiniert, um noch effizientere tRNAPyl-Varianten herzustellen. Zeitgleich wurden 
weitere solcher tRNAPyl-Mutanten entwickelt. Diese besaßen entweder intrinsische 
Promotorelemente, welche typisch für eukaryotische tRNAs sind oder verschiedene 
Basenkombinationen in der Region zwischen Akzeptorstamm und T-Arm, von denen bekannt ist, 
dass sie die Wechselwirkungen mit dem Elongationsfaktor EF-Tu in Bakterien verbessern. Die 
zweite Designstrategie nutzt die strukturelle Ähnlichkeit zwischen dem tRNAPyl und 
mitochondrialer Bos taurus tRNASer. Wir vermuteten, dass solch eine mitochondriale Säugetier-
tRNA eine gute Basis zur Entwicklung chimärer tRNAs darbietet, die orthogonal im zytosolischen 
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Kontext von Säugetieren sind. Basierend auf den vorhandenen Kenntnissen über 
Wechselwirkungen zwischen PylRS und tRNAPyl wurden verschiedene Kombinationen von 
Identifikationselementen für PylRS in die mitochondriale tRNASer transplantiert. Im nächsten 
Schritt wurde die jeweils beste tRNAPyl-Variante der beiden Ansätze ausgewählt und auf ihre 
Effizienz zum Einbau unterschiedlicher ncAAs getestet. Der Fokus lag hierbei auf ncAAs für 
bioorthogonale Chemie, welche heutzutage eine kritische und wichtige Anwendung des Pyrrolysin-
Systems darstellen. Im Vergleich zur Referenz-tRNAPyl erzielten die neuen tRNAPyl-Varianten 
höhere Einbauraten für alle getesteten ncAAs. Eine anschließende Expressionsanalyse der 
verschiedenen tRNAPyl in HEK293 Zellen mittels Northern-Blot-Strategien zeigte, dass diese neuen 
tRNAPyl-Varianten höhere intrazelluläre Konzentrationen als Wildtyp-tRNAPyl aufweisen. 
Untersuchungen der tRNA-Struktur, basierend auf der in-line probing-Methode, ergaben keine 
signifikanten Unterschiede zwischen der Wildtyp-tRNAPyl und den beiden neuen tRNAPyl, was 
darauf hindeutete, dass ihre zwei- und dreidimensionalen Strukturen trotz teils enormer 
Sequenzabweichungen unverändert blieben. Interessanterweise konnte mittels Anwendung von 
umgekehrter Transkriptionstechniken gezeigt werden, dass archaeale tRNAPyl in Säugetierzellen 
nach der Transkription modifiziert wird und dass Wildtyp-tRNAPyl und konstruierte tRNAPyl 
mitunter unterschiedliche Modifikationen aufweisen. Daraufhin wurde eine der neuen tRNAPyl 
verwendet, um eine Reihe von ncAAs in den corticotropin releasing factor Rezeptor 1 (CRF1R), 
einen GPCR der Klasse B, einzubauen. Detaillierte Untersuchungen mittels Western-Blot-Analyse 
und Fluoreszenzmikroskopie zeigten, dass die neue tRNAM15 im Vergleich zur Wildtyp-tRNAPyl 
signifikant höhere Einbauraten in ein solch anspruchsvolles Zielprotein lieferte. Diese neue 
tRNAM15 ermöglichte auch den effizienten Einbau von trans-cyclooct-2-ene-Lysin (TCO*), einer 
ncAA für bioorthogonale Chemie, in den CRF1-Rezeptor, welcher anschließend über eine strain 
promoted inverse-electron-demand Diels-Alder cycloaddition-Reaktion (SPIEDAC) mit einer 
kleinen Cyanin-Sonde fluoreszenzmarkiert werden konnte. Im Anhang von Kapitel 2 wird ein 
ähnlicher rationaler Designansatz zur Erzeugung von E. coli tRNALeu Varianten beschrieben. 
Dabei war es Ziel, das orthogonale Leucin-System für die Anwendung in Säugetierzellen zu 
verbessern. Die Hauptanwendungen des Leucin-Systems bilden heutzutage vor allem der Einbau 
von umgebungssensitiven fluoreszierenden ncAAs und photo-caged ncAAs für Untersuchungen von 
Proteindynamiken.  
Das neue Pyrrolysin-System ermöglichte es ncAAs für bioorthogonale Chemie mit hoher Effizienz 
in einen GPCR zu integrieren. Als Folge dessen konnte dieser modifizierte GPCR mit kleinen, 
hellen und lichtstabilen Fluorophoren markiert werden. Diese Eigenschaften stellen die 
Hauptanforderungen für fortgeschrittene Mikroskopie-Techniken dar. Neben einer effizienten 
Expression des Zielproteins sind jedoch auch die Ausbeuten der Markierungsreaktion von enormer 
Bedeutung. Dies fällt besonders ins Gewicht bei Anwendungen, die eine stöchiometrische Analyse 
von Daten beinhalten, wie beispielsweise das Verfolgen einzelner Moleküle während 
Oligomerisierungsstudien. Derartige Anwendungen bedürfen einer hohen bis quantitativen 
Markierungsausbeute oder setzen mindestens genaue Kenntnis über das Markierungsverhältnis 
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voraus. Die genaue Quantifizierung der Markierungseffizienz stellt jedoch oft eine nicht zu 
unterschätzende Herausforderung dar. Bestehende Verfahren greifen häufig auf die indirekte 
Bewertung der Markierungsrate zurück. Einige Methoden gehen beispielsweise dann von einer 
quantitativen Markierung aus, wenn die bei der Markierung beobachtete Fluoreszenz mit 
zunehmenden Farbstoffkonzentrationen nicht weiter steigt. Andere Ansätze normalisieren die 
Fluoreszenzintensität der Markierung auf Signale, die durch Immunfärbung des Zielproteins 
erhalten wurden. 
Kapitel 3 beschreibt eine neue Anwendung der Fluoreszenzfluktuationsspektroskopie (FFS), die 
eine zuverlässige und genaue Beurteilung der Markierungsausbeute ermöglicht. Diese neuartige 
Methode ermöglicht es die Anzahl der Moleküle des Zielproteins sowie die Anzahl der belegten 
Markierungsstellen aus einem ausgewählten Bereich der Zellmembran zu extrahieren und ist 
dabei hochpräzise und minimal invasiv. Im ersten Schritt wurde gezeigt, dass die SPIEDAC-
Markierungsmethode nicht nur auf Klasse B GPCRs anwendbar ist, sondern auch genutzt werden 
kann, um GPCRs der Klasse A zu markieren. Hierzu wurden auf Grundlage vorhandener 
Kristallstrukturen verschiedene Positionen in den extrazellulären und intrazellulären Schleifen 
von drei verschiedenen GPCRs ausgewählt. Die zu mutierenden Positionen wurden so ausgewählt, 
dass sie theoretisch hohe Einbauraten der ncAA ermöglichen und eine gute Zugänglichkeit durch 
den Markierungsfarbstoff bieten. Im ersten Schritt wurde TCO* an verschiedenen Positionen in 
GPCR-EGFP-Fusionsproteine eingebracht und deren Zelloberflächenexpression quantifiziert. Die 
Daten zeigten auf, dass die Inkorporationsraten von TCO* stark positionsabhängig sind und die 
insgesamt erreichbaren Expressionsniveaus zwischen den drei Rezeptoren stark unterschiedlich 
sind. Gleichzeitig wurden an den TCO*-GPCR-EGFP-Varianten fluoreszenzmikroskopische 
Untersuchungen durchgeführt, um Positionen zu identifizieren, welche die bestmöglichen 
Markierungsausbeuten erlauben. Für die Evaluierung extrazellulärer Positionen wurden die 
Zellen dazu mit Membran-undurchlässigen Farbstoffen auf Cyanin-Basis (Cy3-Tetrazin, Cy5-
Tetrazin) behandelt. Zur Evaluierung intrazellulärer Positionen wurden die Zellen mit Membran-
durchlässigen Rhodamin-Farbstoffen (SiR-Tetrazin oder TAMRA-Tetrazin) inkubiert. 
Anschließend wurden die farbstoffbehandelten Zellen mit Breitfeld-Fluoreszenzmikroskopie im 
grünen EGFP-Kanal und in den für die entsprechende Markierung geeigneten roten Kanälen 
untersucht. Basierend auf diesen Screening-Ergebnissen wurde eine Teilmenge repräsentativer 
GPCR-Varianten zur Etablierung der neuen Quantifizierungsmethode ausgewählt. Im nächsten 
Schritt wurden basolaterale Membranbereiche einzelner Zellen in separaten Kanälen für EGFP 
und den jeweils verwendeten Farbstoff über einen gewissen Zeitraum mit einem konfokalen 
Fluoreszenzmikroskop beobachtet und kurze Fluoreszenzfilme aufgenommen. Die Fluktuationen 
des Fluoreszenzsignals über einen bestimmten Zeitraum innerhalb eines Pixels des konfokalen 
Bildes erlaubt dabei die Quantifizierung der durchschnittlichen Anzahl fluoreszierender Objekte, 
welche sich in den Pixel hinein und heraus bewegen sowie die Bestimmung derer Helligkeit. 
Korreliert man die daraus extrahierte Anzahl an roten Emittern (Markierungsfarbstoff) mit der 
Menge an grünen Emittern (GPCR-EGFP) für mehrere Basalmembranen verschiedener Zellen, so 
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ist es möglich, die Markierungseffizienz mittels linearer Regression abzuleiten. Diese Methode 
wurde anschließend auf die zuvor ausgewählten GPCR-Varianten der Klassen A und B 
angewendet, wodurch gezeigt werden konnte, dass die SPIEDAC-Reaktion für alle drei Rezeptoren 
quantitative Ausbeuten ermöglicht. Dies verdeutlicht zum einen die allgemeine Anwendbarkeit der 
Reaktion für die Markierung von GPCRs und zum anderem ermöglichte SPIEDAC die quantitative 
Markierung in den empfindlichen Schleifen-Regionen von Rezeptoren ohne Verlust derer 
Funktionsfähigkeit. In dieser Arbeit wurde zudem der Einfluss der Markierungsstrategie auf 
Diffusionsgeschwindigkeiten eines GPCR durch die Membran verglichen. Hierzu wurden eine 
GPCR-Variante, welche nur mittels ncAA Mutagenese modifiziert wurde und ein 
Rezeptoräquivalent, das zusätzlich noch mit EGFP fusioniert war, verglichen. Die 
Diffusionsmessungen zeigten, dass sich Rezeptoren, die mit einem kleinen niedermolekularen 
Farbstoff markiert sind, signifikant schneller bewegen. Es ist davon auszugehen, dass diese 
minimal markierten Rezeptoren mit hoher Wahrscheinlichkeit einen natürlichen Zustand des 
Rezeptors widerspiegeln. Diese Ergebnisse zeigen somit einen bedeutenden Vorteil der ncAA-
vermittelten Markierung gegenüber der herkömmlichen Fusion mit einem fluoreszierenden 
Protein auf. Abschließend wurde eine weitere Anwendung des beschriebenen FFS-
Mikroskopieverfahrens veranschaulicht. Dabei wurde gezeigt, dass die Konkurrenz zweier 
Markierungsfarbstoffe um eine Reaktionsstelle zur Bestimmung des Oligomerisierungszustandes 
eines GPCR genutzt werden kann, ohne dass die vorherige Identifizierung einer monomeren 
Referenz notwendig ist. Dieser Ansatz wurde zur Untersuchung des CRF1R verwendet und lieferte 
einen oligomeren Fingerabdruck, welcher mit zuvor veröffentlichten Schätzungen übereinstimmt. 
Kapitel 4 umfasst ein ausführliches Protokoll zur fluoreszenzbasierten Bewertung von 
orthogonalen Paaren, das in Kapitel 2 zur Untersuchung der artifiziellen tRNAPyl Varianten 
angewendet wurde. Diese leicht zu handhabende Methode wurde im Rahmen dieser Dissertation 
etabliert, um eine schnelle und äußerst zuverlässige Beurteilung der Einbaueffizienz von ncAAs zu 
ermöglichen. Darüber hinaus werden zwei umfassende Protokolle für die Anwendung von ncAAs 
zur Studie von GPCRs in lebenden Säugetierzellen beschrieben. Dazu gehören eine UV-
lichtbasierte Quervernetzungsmethode, zur Untersuchung der Ligand-Rezeptor-
Interaktionsflächen und das schrittweise Verfahren zur positionsspezifischen bioorthogonalen 
Markierung eines GPCR, das in Kapitel 2 und Kapitel 3 verwendet wurde. Insgesamt enthält dieser 
Abschnitt ausführliche technische Details der verwendeten experimentellen Verfahren und 
konzentriert sich auf eine kritische Betrachtung derer Stärken und Grenzen im Vergleich zu 
anderen verfügbaren Methoden. 




Abbildung 1: Übersicht dieser Arbeit 
Fazit 
Diese Arbeit trägt grundlegend zur allgemeinen Anwendbarkeit von ncAAs für die Untersuchung 
von Proteindynamiken bei. Die beschriebenen tRNAPyl Varianten erhöhen die Effizienz des 
beliebten Pyrrolysin-Systems in Säugetierzellen um ein Vielfaches. Außerdem konnte mit Hilfe 
dieses verbesserten Systems erstmals eine quantitative SPIEDAC-vermittelte 
Fluoreszenzmarkierung von GPCRs in lebenden Zellen erreicht werden. Darüber hinaus zeigt diese 
Arbeit, dass die Verbesserung eines orthogonalen Paares am besten durch Anpassung der 
suppressor-tRNA an den Wirtsorganismus erreicht werden kann. Folglich bieten tRNAs einen 
vielversprechenden Ansatzpunkt für die Optimierung orthogonaler Systeme im Allgemeinen. 
Zudem bieten die in dieser Arbeit vorgestellten Methoden, insbesondere das Verfahren zur 
Bewertung von ncAA-Inkorporationsraten sowie der Mikroskopie-basierte Ansatz zur 
Quantifizierung von Markierungseffizienzen, nützliche Werkzeuge, um optimale Bedingungen für 
die Untersuchung von Zielproteinen direkt in lebenden Zellen zu gewährleisten. Nicht zuletzt 
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Proteins are the most abundant biomolecules within cells. They play essential roles in almost all 
biological processes, from DNA replication to maintaining cellular structure, and are indispensable 
for all living organisms. Proteins consist of amino acids, which are combined in long polyamide 
chains by the ribosome. With very few special exceptions, all organisms use the same 20 canonical 
amino acids. However, the vast variety of biological tasks performed by proteins often require 
chemical functions that exceed the capabilities of the canonical amino acid pool. The natural 
evolution of co-factors, nucleoproteins or posttranslational modifications (PTM) helped to overcome 
these limitations. In addition, some archaea and bacteria specialized to use a stop codon to 
genetically encode seleno-cysteine or pyrrolysine and incorporate them into specific proteins 
necessary for their survival, which makes them the 21st and 22nd proteinogenic amino acid, 
respectively. The same principle was adapted to insert artificial amino acids into proteins 
biosynthetically, which provides new invaluable tools to study biological processes in live cells. 
Translational incorporation of non-canonical amino acids (ncAA) into the growing peptide chain is 
enabled by highly specialized, orthogonal aminoacyl-tRNA-synthetase/tRNA pairs, which are 
imported into the host organism. Within the orthogonal systems for ncAA incorporation developed 
so far, those derived from the pair naturally incorporating pyrrolysine in Methanosarcinae 
(PylRS/tRNAPyl) have become the most widespread. However, while the pyrrolysine system works 
all too well in bacteria, its applicability in mammalian cells is often limited by low rates of ncAA 
incorporation, which hampers its application to challenging low-abundant biological targets, such 
as membrane proteins. This work presents new tRNAs, designed and selected via a rational 
approach, which significantly enhance the incorporation efficiency of pyrrolysine-like amino acids 
into proteins in mammalian cells. The utility of the new system is demonstrated by the 
incorporation of ncAA for bioorthogonal chemistry into G protein-coupled receptors (GPCRs), which 
was hardly practicable before. In this way, the receptors could be equipped with small organic 
fluorophores in a minimally invasive fashion, thus opening the way to the development of novel 
image-based methods to study GPCR distribution and dynamics in live cell settings.  
1.1. Expansion of the genetic code 
Introducing artificial moieties into proteins provides new means to understand their behavior. In 
particular, the incorporation of biochemical and biophysical probes at specific protein sites offers 
the possibility of investigating, with high spatial precision, aspects of protein structure and 
function, as well as protein-protein interactions. The most precise way to incorporate probes into 
designated protein sites is to install them onto the side chain of artificial non-canonical amino acids 
(ncAAs). Unnatural amino acids can be smoothly incorporated into polypeptide chains that are 
achievable by chemical synthesis (up to 50-80 residues) by solid-phase synthesis methods 1. NcAA 
incorporation into proteins can be achieved by native chemical ligation 2,3 and semi-synthetic 
approaches 4. The nature of these techniques, however, limits their use to in vitro studies or small 
proteins. In order to incorporate ncAAs into proteins of large size, or to incorporate unnatural 
moieties in live cells in general, requires exploiting the same synthetic machinery that naturally 
builds up the proteins of all living organisms. 
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1.1.1. Ribosomal biosynthesis of proteins 
During ribosomal translation, the information stored in the DNA is translated into proteins 
through a messenger RNA template (mRNA). The accurate transfer of data is achieved through the 
genetic code. The code defines which nucleotide triplet (codon) found in the transcribed mRNA 
specifies which amino acid is incorporated into the nascent polypeptide chain. Dedicated transfer 
RNAs (tRNAs) decode the mRNA codons and mediate the growth of the peptide chain at the 
ribosome. 
Protein biosynthesis is initialized when an mRNA molecule binds to the small subunit of the 
complex translational machinery referred to as ribosome. An initiator tRNA charged with N-formyl-
methionine base-pairs with the first AUG codon on the mRNA, which signals the start of the 
polypeptide chain. The mRNA binding and recruitment of aminoacylated tRNAfMet is guided by 
cytosolic proteins known as initiation factors. Next, the large ribosomal subunit associates and the 
initiation factors leave the initiation complex. This entire process of ribosome assembly is highly 
energy-dependent and driven through guanosine-triphosphate (GTP) hydrolysis by the initiation 
factors. Upon successful initiation, elongation of the peptide chain is achieved through successive 
covalent attachment of amino acids. Cytosolic proteins known as elongation factors bind to 
aminoacylated tRNAs and deliver them to the ribosome. In the ribosome, the amino acid is correctly 
positioned by the tRNA, which base-pairs with the corresponding codon on the mRNA. Peptide-
bond formation and transfer of the nascent peptide chain to the latest tRNA molecule in the active 
site of the ribosome is achieved through GTP hydrolysis by the elongation factors. At the same time, 
the ribosome moves along the mRNA to the next codon. This cycle continues until the ribosome 
reaches one of the three stop codons (UAA, UAG, UGA). Translational termination is achieved 
through proteins called releasing factors, which mimic tRNA structure and bind to the stop codon. 
These proteins then contribute to the hydrolysis of the terminal peptidyl-tRNA bond and facilitate 
the release of the polypeptide and terminal tRNA. Subsequently, the releasing factors induce the 
dissociation of the ribosome into its subunits, which are then recycled to begin a new cycle of 
translation. 
1.1.2. Aminoacylation of transfer RNAs 
In order to become available for incorporation into a polypeptide chain an amino acid must fulfill 
two requirements: The carboxyl group of the amino acids must be activated to allow later formation 
of a peptide bond, and a link between the genetic code and the cognate amino acid must be 
established. Both these requirements are met by covalently attaching the amino acid to a 
corresponding tRNA through an ATP-dependent reaction catalyzed by activating enzymes known 
as aminoacyl-tRNA synthetases (AARS). Attaching the right amino acid to the right tRNA is critical 
for maintaining an accurate reading of the genetic code during protein biosynthesis. In order to 
guarantee high amino acid fidelity, AARS have evolved to distinguish elements within each tRNA 
that serve as molecular determinants for specificity 5 and allow for compensating mistakes through 
a hydrolytic editing domain 6. 
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The cytosolic transfer RNAs of bacteria and eukaryotes consist of a small single strand of RNA, 
which is between 73 to 93 nucleotide residues long. All cytosolic tRNAs fold into similar secondary 
and tertiary structures (Figure 1.1). The hydrogen-bonding pattern in their two-dimensional 
secondary structure forms a typical cloverleaf form with four arms: the acceptor-arm, the D-arm, 
the anticodon-arm and the T-arm (Figure 1.1A). The anticodon-arm and the T-arm are connected 
by a small loop of variable length, which determines the tRNA type. Type I tRNAs have four or five 
nucleotides in this variable loop, whereas type II tRNAs have more than five nucleotides that 
sometimes form an additional arm (consisting of a stem and loop structure) 7. The acceptor-arm 
carries the esterified amino acid at the 3’-end of the tRNA and the anticodon-arm specifically 
interacts with the cognate codon on the mRNA, which makes these two arms critical for the adapter 
function of a tRNA during translation of the genetic code. The D-arm, which usually contains the 
unusual nucleotide dihydrouridine (D) and the T-arm, which almost universally contains a 
ribothymidine-pseudouridine-cysteine motive (TΨC), contribute essential interactions for proper 
tertiary L-shape folding of the tRNA by forming the so-called elbow region of the tRNA. 
 
Figure 1.1: Typical secondary and tertiary structures of transfer RNAs. A) The two-dimensional cloverleaf structure 
formed by secondary base-pairing. Large circles represent nucleotides that are always present. Additional nucleotides 
(represented by small circles) are often found in the D-loop and variable loop. The positions are numbered according to a 
universal conviction proposed by Sprinzl 8. B) Three-dimensional L-shape guided by tertiary interactions between 
nucleotides of the D-loop and T-loop (PDB id: 4TRA) 9. The individual arms were highlighted in the same colors as in panel A 
using PyMOL software.  
Since all canonical tRNAs have similar secondary and tertiary structures, AARS recognition 
strongly depends on embedded identity elements in the form of single nucleotides or base-pair 
variations (Figure 1.2A) 10–12. Some nucleotides are conserved among all tRNAs and therefore 
cannot be used for discrimination. Most elements important for AARS recognition were identified 
through mutation of the tRNA and observing changes in substrate specificity of the cognate AARS. 
Identity elements tend to appear in the anticodon- and acceptor-arm of the tRNA, regions that are 
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typical for direct interaction with the AARS 5. Most AARS rely on distal interactions with 
nucleotides of the tRNA anticodon for recognition. The only exceptions are LeuRS, SerRS, and 
AlaRS, which have many cognate isoacceptor tRNAs and cannot provide a unique anticodon 
recognition mechanism for the vast number of anticodon combinations 5,13,14. The most important 
single nucleotide for AARS recognition is the discriminator base at position 73. It is located at the 
3’-end of the acceptor-arm just before the conserved CCA end and is therefore in close proximity to 
the active site of the AARS, providing an ideal opportunity for specific protein–RNA 
interactions 5,15. Unique base pairs can also confer specificity, as for the beforementioned AlaRS, 
the unusual base pair G3:U70 in tRNAAla essentially contributes to substrate discrimination 12,16. 
In addition, subtle differences in tRNA folds also play an important role in dictating the specificity 
of interactions between tRNAs and their cognate synthetase. For instance, it was demonstrated 
that the specificity of a tRNA towards their corresponding AARS is affected by altering the tRNA 
core structure 14,17–23. These findings are supported by the crystal structures of AARS together with 
their tRNA. These studies also revealed that the structure of the elbow region between D-arm and 
T-arm can serve as an important recognition element 24–26. Aside from all these positive identity 
elements there exist anti-determinants, which prevent productive interactions between a tRNA 
and a noncognate AARS. Such a negative element was first discovered in E. coli tRNAIle. This tRNA 
is modified at position 34 with a lysidine, which efficiently prevents mis-aminoacylation by 
MetRS 27. Other examples found in yeast include tRNAAsp or tRNALeu, which rely on such 
determinants to avoid recognition by ArgRS and LeuRS, respectively 28–30. 
Upon recognition and correct binding of its cognate tRNA, the AARS carries out the ATP dependent 
aminoacylation of the tRNA. The amino acid resides in its binding pocket within the AARS with 
the amide facing towards the active site. Firstly, the amino acid is activated by the AARS through 
formation of an aminoacyl-AMP intermediate. Next, the aminoacyl-moiety is esterified to the tRNA. 
Based on the architecture of their catalytic domains and the presence of certain consensus 
sequences the family of AARSs can be divided into two major classes 34–36. The catalytic core of 
Class I AARS is defined by a typical Rossmann fold 31 of alternating α-helices and β-strands, which 
carries out the aminoacylation reaction. Two consensus sequences KMSKS (Lys-Met-Ser-Lys-
Ser) 37,38 and HIGH (His-Ile-Gly-His) 39 in the active site facilitate transfer of the amino acid to the 
tRNA 40–42. The catalytic core of class II AARS, on the other hand, is composed of seven antiparallel 
β-strands flanked by α-helices with three conserved sequence motifs 35,36,43. While class I AARS 
mostly act monomeric, class II AARS tend to form oligomers (predominantly dimers or tetramers). 
Motif 1 is located at the interface of the dimers and is postulated to facilitate communication 
between the active sites of the individual subunits 44. Motif 2 and Motif 3 comprise part of the active 
aminoacylation site 35,36,45. The dissimilar architectures of class I and class II AARS result in 
differences among tRNA binding and aminoacylation (Figure 1.2B). Class I AARS approach their 
cognate tRNA via the minor groove of the core structure 34. This causes the rearrangement of the 
tRNA 3′-terminus into a hairpin, which leads to aminoacylation of the terminal adenosine’s 2′-OH, 
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rather than the 3′-OH group. Class II AARS bind to the tRNA major groove and do not distort the 
3′ acceptor terminus, which leads to attachment of the amino acid to the 3’-OH. 
 
Figure 1.2: Recognition of tRNAs by their cognate AARSs. A) Identity elements on tRNA molecules. Characteristic 
residues common among tRNAs are written in the tRNA structure 31 (Pu = purine, Py = pyrimidine). Some positions are 
partially or strictly conserved in many tRNAs and therefore cannot be used to discriminate one from another (highlighted 
in red). Positions that are known recognition points for AARSs are highlighted in green 31. B) Differences in tRNA binding 
of class I and class II AARSs. Crystal structures of E. coli GlnRS (red; PDB id: 1QRT) 32 and C. cerevisiae AspRS (purple; 
PDB id: 1ASZ) 33 bound to their cognate tRNAs (lightblue). Green residues in the tRNA crystal structure present the 
positions of recognition elements highlighted in A. Panel B was compiled using PyMOL software. 
1.1.3. Generation of orthogonal pairs for ncAA incorporation 
In order to genetically incorporate ncAAs into proteins, it is necessary to add to the biosynthetic 
machinery of the host organism an AARS/tRNA pair dedicated to the artificial amino acid. Such 
pairs must fulfill a number of criteria, first and foremost the criterion of orthogonality (Figure 
1.3A). The aminoacyl-tRNA synthetase for the non-canonical amino acid (ncAARS) must accept 
only its designated substrate ncAA and not recognize any of the canonical amino acids. In addition, 
the ncAARS must transfer its substrate ncAA only to the cognate tRNA, while not interacting with 
any endogenous tRNAs. In turn, the tRNA should not be recognized by any of the endogenous 
AARSs and must be complementary to a unique codon. At the same time, the orthogonal tRNA 
must be compatible with endogenous factors related to tRNA transcription and processing. Finally, 
in order to participate in protein translation, the aminoacylated tRNA must be accepted by the 
elongation factor and the ribosome of the host organism (Figure 1.3B). 




Figure 1.3: Genetic code expansion. A) The artificial ncAARS/suppressor tRNA pair is designed to be orthogonal to the 
endogenous system of the host organism. B) The engineered ncAARS charges its cognate suppressor tRNA with the ncAA. 
The aminoacylated suppressor tRNA is bound by endogenous elongation factor (green) and transported to the ribosome 
(blue). Next, the ncAA is incorporated into the nascent polypeptide chain in response to a unique codon (light red). 
Most available orthogonal pairs for ncAA incorporation have been developed by importing 
heterologous AARS/tRNA pairs from one domain of life to another, so as to exploit the reduced 
cross-recognition of some interspecies AARS/tRNA pairs 46. In general, these imported, naturally-
orthogonal pairs originally recognize one of the 20 canonical amino acids. For instance, the pair 
that incorporates Tyrosine in the archaea M. jannaschii (MjTyrRS/tRNATyrGUA) neither crosstalks 
with the pair that incorporates Tyrosine, nor with any other AARS/tRNA pair in bacteria. However, 
this pair will still incorporate Tyrosine in response to the UAC codon when imported into E. coli. 
The first step to obtain a completely independent orthogonal pair is to change the anticodon of the 
tRNA into a CUA codon, complementary to the amber stop codon TAG, so as to obtain a so-called 
“suppressor tRNA”. The pair MjTyrRS/tRNATyrCUA will still incorporate Tyrosine in bacteria, but in 
response to the amber codon 47. To incorporate an ncAA, the substrate specificity of the orthogonal 
AARS must be changed. To develop specificity toward a desired ncAA, residues of the catalytic 
pocket that are involved in substrate binding undergo saturation mutagenesis. The desired 
ncAARS is then selected from such randomized AARS libraries by negative and positive selections 
(Figure 1.4). As a first step, E. coli is transformed with the randomized DNA library. The negative 
selection is a dead/alive selection. A toxic gene (usually barnase, a ribonuclease), bearing an in-
frame stop codon, is imported into the bacteria together with the AARS/tRNA pair. Clones 
expressing the toxic protein in the absence of ncAA bear an AARS that recognizes one of the 
canonical amino acids, and will die. The positive selection can be a dead/alive selection based on 
the amber suppression-dependent expression of a gene necessary for survival, such as antibiotic 
resistance. Modern protocols instead exploit the expression of a reporter protein, such as the green 
fluorescent protein (EGFP). When a stop codon is inserted in-frame into the EGFP gene, and a 
bacterial colony emits green fluorescence, it means that it contains a synthetase accepting the 
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ncAA, which is then incorporated into EGFP. AARS evolution is very well-established in 
bacteria 48,49. Although protocols have been developed to evolve ncAARS in yeast 50–52, the selection 
in yeast is not as efficient and successful as in bacteria. Currently, it is not possible to evolve 
ncAARS in mammalian cells. 
 
Figure 1.4: Evolution of an ncAARS in bacteria. Sequence of the gene encoding for an orthogonal AARS is randomized 
in positions that constitute the substrate binding pocket. The mutagenized plasmids are introduced into E. coli together 
with a plasmid that contains an engineered toxic gene. The toxic gene (e.g. barnase) includes a TAG codon in its sequence 
and can only be expressed in the absence of the ncAA when the ncAA variant accepts endogenous amino acids as substrate, 
which will lead to cell death. NcAARS plasmids from surviving cells are combined with a plasmid encoding for a fluorescent 
reporter including a TAG codon. The reporter is only expressed when the pre-selected ncAARS is specific towards the ncAA. 
1.1.4. Incorporation of ncAAs in mammalian cells 
As it is not possible to evolve orthogonal pairs for ncAA incorporation directly in mammalian cells, 
ncAARS/tRNA pairs for mammalian cell use must be evolved in other organisms and shuttled to 
mammalian hosts. As a consequence, pairs must be employed that are orthogonal both in 
mammalian cells and in the organism used for selection. However, the orthogonality of an 
ncAARS/tRNA pair is defined in respect to the set of AARS and tRNA present in the host organism, 
which can severely limit the availability of systems for use in mammalian cells. For instance, the 
famous MjTyrRS/tRNATyrCUA pair relies on a C1:G72 base pair for tRNA discrimination. E. coli 
TyrRS has evolved towards a G1:C72 pair and discriminates archeal Mj-tRNATyr, while eukaryotic 
TyrRS will aminoacylate Mj-tRNATyrCUA 53. 
For use in mammalian hosts there exist three major, well-established, orthogonal systems. Two of 
them are derived from AARS/tRNA pairs originally dedicated to the incorporation of either 
Tyrosine 51 or Leucine 54–57 in E. coli, which are orthogonal both in mammalian cells and in yeast. 
Not very many, but nonetheless very popular, ncAARSs have been evolved in yeast from the 
EcTyrRS. These include systems for incorporation of the photo-crosslinking ncAAs p-azido-
Phenylalanine (Azi) and p-benzoyl-Phenylalanine (Bpa) 51, as well as p-acetyl-Phenylalanine and 
the chemical crosslinking ncAA p-2′-fluoroacetylphenylalanine (Ffact) 58, which have been broadly 
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applied to study protein-peptide and protein-protein interactions 59. Orthogonal pairs derived from 
EcLeuRS have been used to encode, inter alia, photo-caged amino acids based on Ser, Cys and 2,3-
diaminopropionic acid, ncAAs bearing aliphatic chains 54–57,60 and small organic fluorophores 55,61.  
The third available system for ncAA mutagenesis in mammalian cells is the pyrrolysine (Pyl) 
system. The PylRS/tRNAPyl pair was first discovered in methanogenic archaea of the genus 
Methanosarcina, where it naturally incorporates Pyl into the active site of a methyl transferase in 
response to the amber codon 62. The pyrrolysine system has major advantages over the other two 
systems. In contrast to the orthogonal pairs based on the E. coli tyrosyl and leucyl system, where 
the anticodon of the tRNA is artificially mutated to CUA to make them suitable for amber 
suppression, the pyrrolysine system is the result of natural evolution for reassignment of the amber 
codon to pyrrolysine, whereby the tRNAPyl is a natural amber suppressor. This obviates drawbacks 
related to the mutation of the anticodon of the tRNA, which can affect the recognition by the cognate 
AARS and reduce the overall efficiency of the pair 63. In addition, the binding pocket of the PylRS 
is very malleable and can be evolved to accommodate a wide palette of ncAAs. Finally, a crucial 
advantage of the pyrrolysine system is that it is orthogonal both in bacteria and eukaryotes. This 
is particularly useful because, as mentioned above, the process of ncAARS evolution is much more 
robust and efficient in bacteria than in yeast 48,49. Because this pair is so easily and rapidly evolved, 
it has been used for genetic incorporation of more than 100 ncAAs into proteins expressed in 
bacteria and eukaryotes 52,64,65. Further, this system has been applied to expand the genetic code of 
whole organisms, including C. elegans 66, and D. melanogaster 67,68 and higher order organisms like 
M. musculus 69,70. 
1.2. The pyrrolysine orthogonal pair  
The tRNAPyl and PylRS exhibit a few unique features that distinguish them from the component of 
other orthogonal systems. The unique orthogonality both in bacteria and eukaryotes, which has led 
to the widespread use of this pair for expansion of the genetic code, is the result of a distinctive 
tertiary structure of tRNAPyl that is specifically recognized by its cognate PylRS. 
1.2.1. Structural features of tRNAPyl 
The sequence of tRNAPyl is highly conserved throughout archaea of the family Methanosacinaceae. 
Their secondary structure of tRNAPyl exhibits several unique traits (Figure 1.5A). All tRNAPyl 
feature a truncated D-loop and a short variable loop of only three nucleotides instead of commonly 
occurring lengths between 4 and 10 nucleotides in class I and class II tRNAs respectively. Further, 
they have a single nucleotide linker between the acceptor-stem and D-stem, as opposed to the 
dinucleotide present in canonical tRNAs and they possess an additional base-pair in the anticodon 
stem, yielding a total of 6 pairs. Importantly, tRNAPyl lack the TΨC and GG sequences in the T-loop 
and D-loop respectively, which are almost universally conserved throughout cytosolic tRNAs and 
play a central role for formation of proper L-shape tertiary structure. 
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At the same time as discovering the orthogonal pyrrolysine system in M. barkeri, investigation of 
available genomes revealed the presence of tRNAPyl and PylRS homologs in Desulfitobacterium 
hafniense, a gram-positive bacterium 71. Since then, the pyrrolysine encoding system has been 
found in 19 bacterial species including Firmicutes and delta-proteobacteria 72,73. While bacterial 
and archaeal tRNAPyl share little sequence homology, they do share the beforementioned structural 
features. Notably, these structural peculiarities are also features of a bovine mitochondrial seryl-
tRNA (Bt-tRNASer) from Bos Taurus, which again greatly differs in sequence from archaeal tRNAPyl. 
First elucidation of archaeal tRNAPyl tertiary structure was proposed from a series of RNA 
footprinting and ultraviolet melting experiments 74. Additionally, the tertiary structure of the alike 
Bt-tRNASer was already available from a combination of chemical probing, solution NMR and 
computer modeling 75,76 crystallography data obtained for bacterial Dh-tRNAPyl in complex with the 
catalytic domain of its cognate Dh-PylRS allowed first direct assessment of a tRNAPyl tertiary 
structure 77. All these data conclude that tRNAPyl adopts a typical L-shape tertiary structure, 
similar to that of canonical tRNAs, but with a compact core region (Figure 1.5). However, despite 
their compact structure, the acceptor and anticodon stems are positioned similarly to canonical 
tRNAs, allowing tRNAPyl to function normally during translation. 
 
Figure 1.5: The rare structure of tRNAPyl. Sequence and secondary structure of A) M. mazei tRNAPyl compared to the 
B) canonical tRNAPhe from C. cerevisiae. Nucleotides that form the tRNA core structure are highlighted in red. C) Crystal 
structures of D. hafniense tRNAPyl (PDB id: 2ZNJ) 77 and C. cerevisiae tRNAPhe (PDB id: 4TRA) 9. The one nucleotide long 
linker between the Acceptor-arm and the D-arm, together with the small D-loop and short variable loop in tRNAPyl has 
significant impact on the size of the tRNA core (red) in the three-dimensional L-shape. Panel C was prepared using PyMOL 
software. 
1.2.2. Interaction of tRNAPyl with PylRS 
In order to accommodate this compact tertiary structure of the tRNAPyl, the PylRS has co-evolved 
a specific, smaller binding site with respect to common AARS. The steric hindrance of canonical 
tRNAs prevents them from binding to PylRS, which explains the exceptional orthogonality of the 
pyrrolysine pair with respect to the translational pairs, both from bacteria and eukaryotes 77. 
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Sequence alignments indicated that archaeal and bacterial PylRS have a C-terminal catalytic 
domain similar to that of class II AARS and a N-terminal RNA binding domain that shares only 
little sequence homology with any know RNA binding domains 71,77,78. While for archaeal PylRS the 
N-terminal RNA binding domain and the C-terminal catalytic domain are connected by a linker, 
the two domains are coded by two separate genes in bacterial homologs. 
Detailed structure-activity relationship studies of the bacterial and archaeal tRNAPyl have revealed 
crucial identity elements for their recognition by their cognate PylRS 79,80. Described identity 
elements for Dh-tRNAPyl include the first two base pairs of the D-stem (G10:C25 and A11:U24) as 
well as the nucleotide connecting acceptor-stem and D-stem (G9). For Mb-tRNAPyl they identified 
a base pair in the T-stem (G51:C63) and the two nucleotides adjacent to the anticodon (U33 and 
A37) as major recognition elements. Mutual identity elements are the discriminator base (G73) and 
the first base pair of the acceptor-stem (G1:C72), which are highly conserved throughout all tRNAPyl 
from bacteria and archaea. Interestingly, mutation of the anticodon, which is a common and highly 
restrictive identity element for most tRNAs 5, does not influence the competency of tRNAPyl 
aminoacylation by its cognate PylRS. The lack of recognition at the anticodon makes it possible to 
use the tRNAPyl to respond to different codons. Indeed, variants of the tRNAPyl have been used to 
suppress ochre, opal and even quadruplet codons 62,81–85. 
In 2009, the crystal structure of the catalytic C-terminal domain (CTD) of the bacterial PylRS from 
D. hafniense (Dh-PylSc) in complex with its Dh-tRNAPyl has been solved, thus revealing how the 
tRNAPyl acceptor helix is directed to the catalytic core for acylation 77. Dh-PylSc forms a dimer and 
approaches the acceptor-stem of tRNAPyl from the side of the major groove, which is a typical feature 
among class II AARS 25,36,45. Recognition of tRNAPyl by the CTD takes place at the interface between 
the two dimer subunits (Figure 1.6A) and the structure of the binding surface allows for 
discrimination of tRNAs without a tight core structure. In total, 31 residues throughout the binding 
interface of the two subunits are involved in hydrogen bonding and stacking interactions with a 
total of 17 nucleotides from Dh-tRNAPyl, including the aforementioned identity elements. While the 
architecture and function of the bacterial and archaeal catalytic CTD are well understood 77,78,86,87, 
the structure of the N-terminal tRNA binding domain remained elusive for long, despite it being 
indispensable for in vivo activity of PylRS 88,89. This is due to the highly insoluble nature of the 
NTD, which makes it refractory to crystallization. Very recently, co-crystallization of the M. mazei 
PylRS N-terminal fragment together with Mm-tRNAPyl was achieved 90. This structure suggests 
that the N-terminal domain (NTD) forms extensive contacts with the tRNAPyl by fitting tightly into 
the concave surface comprised of the T-loop and short variable loop of tRNAPyl in the L-shape form 
(Figure 1.6B). Further, the N-terminal domain and the C-terminal domain bind on the opposite 
sides of the tRNAPyl molecule, suggesting that the full-length archaeal enzyme wraps around the 
tRNA molecule. Together, this cooperative binding mode and the tight fit of the NTD give a steric 
explanation for the exceptional orthogonality and high specificity of the PylRS towards tRNAPyl. 




Figure 1.6: Recognition of tRNAPyl by PylRS. Besides the recognition of specific identity elements on the tRNAPyl, PylRS 
uses steric discrimination to distinguish between its natural substrate tRNA and other tRNAs. A) Crystal structure of 
catalytic C-terminal domain of D. hafniense PylRS with its cognate Dh-tRNAPyl (PDB id: 2ZNJ) 77. PylRS functions as a 
dimer with the two subunits (green and beige) binding the tRNAPyl (blue and lightblue) from the major groove side. The 
tRNA binding domain of the CTD (highlighted in the box) tightly fits into the small tRNA core. B) Crystal structure of 
M. mazei PylRS N-terminal RNA binding domain in complex with Mm-tRNAPyl (PDB id: 5UD5) 90. The NTD binds the tRNA 
at the variable loop region. Close up views from the top (left box) and back (right box) show the tight binding of the NTD, 
which allows for steric discrimination of tRNAs with larger variable loop. The Figure was prepared using PyMOL software. 
1.2.3. Versatility of PylRS 
The crystal structure of M. mazei catalytic C-terminal domain revealed a deep hydrophobic binding 
pocket for pyrrolysine 91. The pyrrolysine side chain forms two key hydrogen bonds with the 
synthetase. One is between the side chain amide oxide and N346 of PylRS and the other one 
between the pyrroline nitrogen and Y384, which is part of a disordered flexible loop serving as a 
cap for binding of pyrrolysine to the active site. Other interactions of the side chain with the 
hydrophobic pocket mostly involve Van der Waals interactions. In order to maintain high 
translational fidelity, most AARSs have specifically evolved to recognize their exact substrate, and 
even subtle variations in the structure of the cognate amino acid will cause discrimination from the 
binding pocket or subsequent editing of mis-acylated tRNA. However, PylRS recognizes its 
substrate mostly by non-specific hydrophobic interactions, making it tolerant towards pyrrolysine 
analogs. This feature has been extensively explored and allowed for charging of tRNAPyl with a 
variety of ncAAs by wild type PylRS 64,91,92. Although the native PylRS displays high substrate 
versatility, its activity on certain ncAAs is sometimes very limited. The combination of random 
screening and structure-based mutation yielded a M. mazei PylRS variant with only two mutations 
(Y384F and Y306A) that exhibited higher aminoacylation efficiency and increased promiscuity 
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towards unnatural substrates bearing bulky side chains by removing steric hindrance in the 
binding pocket. Over the last decade, extensive efforts to identify PylRS mutants that improve 
efficiency or accept new substrates have been made. As a result more than 100 amino acids have 
been encoded including photo-caged amino acids, photo-activatable moieties, lysines bearing 
posttranslational modifications, phenylalanine or histidine derivatives and many others 65,93–105. 
Among these, there are also ncAAs that contain functional groups for bioorthogonal chemistry, 
which have been extensively used in this work and are described further below 106–110. 
Overall, the exceptional properties of orthogonality and versatility of the PylRS/tRNAPyl pair have 
made it the system of choice for ncAA mutagenesis both in bacteria and eukaryotes, so that the 
pyrrolysine system rapidly emerged as the most powerful tool for genetic code expansion available 
today. 
1.3. GPCRs - Important targets for ncAA mutagenesis 
G protein-coupled receptors (GPCRs) constitute a large protein superfamily of receptors that 
transduce extracellular signals into an intracellular response and thereby play key roles in the 
regulation of most physiological processes. Due to their important role in cellular signaling they 
represent valuable targets for pharmacological treatment. Drugs targeting GPCRs make up 
approximately 30% of all approved drugs on the market (as of 2018) 111. However, accurate 
knowledge about many molecular mechanisms involved in GPCR signaling still remains elusive 
due to general difficulties in structural characterization of these complex membrane proteins. 
NcAA mutagenesis offers enormous flexibility for study of protein dynamics in vitro and in vivo and 
indeed has proven to be a very powerful tool to investigate structural and functional aspects of 
GPCRs 112–115. However, GPCRs are not an easy target for ncAA mutagenesis. Low efficiency of 
ncAA incorporation often hampers the general applicability of ncAA tools to GPCR studies, which 
stresses the necessity to improve the overall efficiency of orthogonal systems. 
1.3.1. Structure and signaling of GPCRs 
All GPCRs share common structural features while they have divergent sequences with no 
significant homology. The widely conserved GPCR architecture is comprised of an extracellular 
N-terminal domain (NTD) followed by seven membrane-spanning α-helices, which are connected 
by three intracellular loops (ICLs) and three extracellular loops (ECLs), and finally an intracellular 
C-terminal tail (CTD) (Figure 1.7A). GPCRs arrange themselves into an anti-clockwise bundle 
forming a cavity within the plasma membrane that serves as a ligand binding domain and is often 
covered by the ECL2. For larger ligands, like peptides, the extracellular loops and NTD can also 
play key roles in the specific binding of the ligand. Based on their phylogeny, GPCRs can be grouped 
into five major classes (GRAFS system of classification) 116: The rhodopsin receptor family or 
class A, the secretin receptor family or class B, the glutamate receptor family or class C, the 
adhesion receptor family and the frizzled/taste receptor family, which differ in function, types of 
ligands and size of the NTD. 
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Different GPCRs can be activated by a diverse set of stimuli, including photons, mechanic pressure 
or binding of ligands, such as small molecules, nucleotides, peptides and many others. Their main 
course of signaling is facilitated trough a group of GTP-binding proteins referred to as G proteins 
(Figure 1.7C). G proteins are heterotrimeric complexes consisting of an α-, β- and γ-subunit 
anchored at the cellular membrane by lipid modifications of the α- and γ-subunits. In its inactive 
state, GDP is bound to the α-subunit (Gα) and all three subunits are associated. Extracellular 
stimulation of the receptor induces a conformational change of the entire GPCR molecule, including 
its intracellular surface. In this activated conformation, the GPCR acts as a guanine nucleotide 
exchange factor on Gα. GDP is released and GTP binds to activate the G protein 117. Next, the Gα 
dissociates from the βγ-dimer and both parts of the G protein initiate signaling cascades via binding 
to their respective effector proteins. G protein signaling is terminated by the intrinsic GTPase 
function of the Gα, catalyzing the hydrolysis of GTP to GDP. This causes the α-subunit to leave its 
effector and re-associate with the βγ-complex. The dormant trimer then awaits another round of 
activation. In order to trigger diverse responses upon activation of different GPCRs, a total of 16 
genes for Gα subunits have evolved, each specific for a different downstream pathway, and most 
GPCRs act mainly via one or two of the G proteins 118. When an active G protein has left the 
receptor, serine and threonine residues within the intracellular receptor domains are 
phosphorylated by G protein-coupled receptor kinases (GRKs). Phosphorylation of an active GPCR 
recruits arrestins. Binding of these regulatory proteins gives way to alternative and G protein 
independent ways of signaling and induces receptor desensitization 119. 
 
Figure 1.7: GPCR structure and signaling. A) Two-dimensional schematic of the conserved GPCR structure. 
B) Co-crystallization of a class A GPCR (grey) together with its G protein (α-subunit blue, β-subunit bright yellow and 
γ-subunit dark yellow) (PDB id: 3SN6) 203 . C) G protein signaling: Ligand binding induces a conformational change in the 
transmembrane domain of the GPCR, which induces GTP binding to the α-subunit of the associated G protein. The Gα and 
Gβγ divide, and each bind to their corresponding effector proteins, which in turn will start an intracellular response. Upon 
GTP hydrolysis, the Gα re-associates with Gβγ. 
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1.4. Illuminating biological processes  
Biological processes in living organisms, like the activation of GPCRs, are tightly coordinated in 
space and time and our understanding is often limited by the ability to observe their dynamics. 
Modern fluorescence microscopy allows us to investigate the spatiotemporal dynamics of 
fluorescent biomolecules directly in live cells at sub-second levels and resolutions below refraction 
limit. Equipping proteins with suitable fluorescent probes allows applying fluorescence microscopy 
to monitor their localization, trafficking, and conformational changes as well as interactions 
between proteins at high spatiotemporal resolution in living settings. Current methods to install 
fluorescent probes into proteins can be roughly summarized into four major groups of labeling 
approaches. 
1.4.1. Genetic fusion of fluorescent proteins  
The most straightforward technique is to genetically fuse a fluorescent protein (FP) in-frame to the 
protein of interest (POI). Fluorescent proteins cause minimal cytotoxicity and are very stable in 
intracellular environment, which allows their use in different sub-cellular compartments, tissues 
and even in living animals 120. The first characterized representative of fluorescent proteins was 
the green fluorescent protein (GFP) 121. GFP is approximately 240 amino acids long (∼27 kDa) and 
folds into a typical 11-β-sheet barrel 122. This barrel structure surrounds an internal distorted helix 
containing the chromophore, which derives from spontaneous posttranslational maturation of the 
tripeptide motive Ser65-Tyr66-Gly67. A wide variety of engineered GFP with different excitation 
and emission wavelengths, as well as improved brightness and photo-stability, have been generated 
by changing the hydrogen bonding network and π-stacking interactions between the chromophore 
and the amino acids of the barrel scaffold 123. Engineered GFP variants, together with other 
fluorescent proteins from different organisms, have revolutionized the ability to study proteins 
inside living cells and still find wide application 124. Most recent photo-activatable and photo-
switchable fluorescent proteins are suitable for super-resolution imaging techniques 125. However, 
all fluorescent proteins have a large molecular weight close to 30 kDa, which limits their application 
to either the N- or C-terminus of the POI and may perturb its structure, function or subcellular 
localization. For example, GFP fusion to β-tubulin in yeast was shown to interfere with tubulin 
assembly dynamics causing non-viable haploid cells 126. In addition, FPs are generally less photo-
stable and more prone to bleaching compared to organic dyes and feature suboptimal photo-physical 
properties for high-end imaging experiments. 
1.4.2. Protein tags – affinity binding and self-labeling 
In order to combine demands for high photo-stability of small molecular dyes and the outstanding 
target specificity of fluorescent proteins, labeling methods have been developed that are based on 
the high-affinity or covalent binding of a suitably functionalized organic dye to a genetically 
encoded protein tag fused to the POI.  
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Fluoromodules are complexes that are formed upon non-covalent binding of a specific dye to a 
single-chain variable antibody fragment (scFv) referred to as fluorogen activating proteins 
(FAP) 127. These functionalized protein tags (~25 kDa) were specifically designed to bind with high 
affinity (in the nanomolar range) fluorogenic dyes, which in turn will significantly increase in their 
fluorescence (Figure 1.8A). Recombinant fusion of these fluoromodules to a protein of interest 
allows for specific labeling of the target protein in vivo, as demonstrated on yeast surface-displayed 
proteins 127. Today a vast variety of such fluoromodules are available, spanning across blue to near-
infrared regions of the spectrum 127–129 and have been used for labeling of several membrane 
proteins in mammalian cells 130.  
Another approach for affinity-based specific labeling relies on fusing to the POI a ligand binding 
domains (LBD) of an enzyme. Such tags tightly bind synthetic analogs of native ligands bearing a 
fluorophore (Figure 1.8B). A prominent example of such a tag is the E. coli dihydrofolate reductase 
(eDHFR, ~18 kDa). The eDHFR binds the folate analogue trimethoprim (TMP) with nanomolar 
affinity (KD ~1 nM) 131, which is at least a 1000-fold higher affinity compared to the mammalian 
DHFR homologue (KD >1 µM) 132. Thus, proteins fused to eDHFR can be labeled with TMP-
fluorophore conjugates in mammalian cells, giving minimal off-target background. More recently, 
strategies for highly-specific covalent labeling of eDFHR-tags with TMP-fluorophore 
derivatives 133,134, including fluorogenic labels 135, have also been developed. A similar example of 
such a labeling strategy is the FKBP’-tag (~12 kDa), a variant of the eukaryotic FK506 binding 
protein 12 (FKBP12), which binds the synthetic ligand SLF’ with >1000-fold higher selectivity over 
wild type FKBP12 136, and can be used to label proteins in live mammalian cells with 
SLF’-fluorophore conjugates 137.  
An alternative approach is given by the self-labeling enzymes, which are designed to covalently 
attach a labeled probe (also referred to as suicide-substrate) to themselves (Figure 1.8C). The most 
prominent representative, the SNAP tag (~20 kDa), is a mutant of the enzyme O6-alkylguanine-
DNA alkyltransferase, which naturally repairs alkylated guanine in damaged DNA. The enzyme 
was engineered to accept O6-benzylguanine (BG) derivatives, which can be conjugated to 
fluorophores and desired probes 138,139. Another variant of this enzyme has been developed to 
selectively react with O6-benzylcytosine (BC) substrates, and is called CLIP-tag 140. SNAP- and 
CLIP-tag are orthogonal to each other and can be utilized to label proteins with fluorescent probes 
of different colors simultaneously in the same cell. Importantly, a wide variety of fluorophore 
substrates for SNAP and CLIP are commercially available, so that the tags are very popular and 
find large application, especially in combination with super-resolution imaging techniques 141,142. 
The recent development of fast-labeling SNAP variants and fluorogenic substrates, which limit the 
background and obviate the need of washing out unbound dyes, have further increased the potential 
of these tags 143,144. Another well-established self-labeling tag is the Halo-tag, which is derived from 
a bacterial haloalkane dehalogenase and was designed to trap the covalent ester intermediate 
between the alkyl residue of the alkyl halide and the enzyme 145. 
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Protein tags are an excellent choice for protein labeling in live cells due to the high labeling 
specificity and the modular nature of their substrates that yields an enormous diversity. While self-
labeling enzyme tags have the advantage of fast and covalent binding for a permanent labeling of 
the POI, protein tags based on high-affinity binding allow for replacement of photo-bleached dyes 
by fresh probes, which can be advantageous for applications involving long-time exposure. 
However, protein tags often have sizes similar to those of fluorescent proteins and can equally 
perturb structure and function of the POI. 
 
Figure 1.8: Labeling strategies using protein tags. A) A single-chain variable antibody fragment (scFv) specific for a 
fluorogenic dye is genetically fused to the POI. Dye is turned on upon binding to the scFv. B) A ligand binding protein tag 
is attached to the POI via genetic fusion and reversibly binds a synthetic ligand-analog with a significantly higher affinity 
than endogenous homologs, allowing for specific labeling with minimal background. C) The engineered enzyme-tag 
recognizes its specific substrate-analog and covalently attaches it to itself. The tag loses catalytic activity in the process. 
1.4.3. Peptide tags 
To overcome the limitations of large protein tags, various smaller peptide tags have been developed, 
which can be introduced into the POIs sequence with less perturbation of its structure and function. 
Their size between 0.6 and 6 kDa and the variety of available labeling chemistries (reviewed in 146) 
make them an attractive choice for protein labeling. Peptide tags can be broadly classified into two 
groups based on the means in which the probe is attached. 
The first group comprises of peptide tags that are modified by naturally occurring enzymes (Figure 
1.9A). The enzyme is ad hoc engineered so as to accept substrates that bear the desired label. In 
this way, the label is attached to the peptide tag at a specific site by an accurate enzymatic reaction. 
In general, these enzymes are of bacterial origin, so as to be orthogonal in mammalian context. 
Some prominent examples include the phosphopantetheinyl-transferases (PPTases) from E. coli 
and B. subtilis, which transfer fluorophores conjugated to CoA-derivatives to either small carrier 
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proteins (8-10 kDa) 147,148 or small engineered sequences of 8-12 residues in length 149,150. The biotin 
ligase (BirA) from E. coli attaches biotin or biotin isosteres containing a keto group to a 15-mer 
peptide hairpin substrate, which can be labeled successively with fluorescent probes via either 
streptavidin-dye conjugates or hydrazide and aminooxy probes, respectively 151. Likewise, 
engineered versions of E. coli Lipoic acid ligase (LplA) 152–154 and the S. aureus 
Sortase A (SrtA) 155-157 have also been employed to specifically label short peptide sequences 
appended to POIs. As useful as these tags are, they use substrates that are accessible only to 
specialized labs and not all of them are applicable for intracellular labeling; for instance the 
CoA-dye substrates of the PPTases would interfere with intracellular processes involving CoA, 
whereas biotin labeling would suffer from very high background of endogenous biotinylated 
proteins. 
The second group are so-called “self-labeling” peptide tags. Such tags will either bind small 
molecule probes with very high affinity or guide the covalent transfer of a probe to itself through 
chemical labeling. The most important self-labeling motif was designed by the same Roger Tsien 
who discovered GFP. Its core consists of a 6-mer sequence bearing two pairs of Cysteine residues 
spaced by two amino acids (CCXXCC) 158. The sequence forms a hairpin, so that it preferentially 
accommodates Proline and Glycine at its center (CCPGCC) 159. This motif tightly binds biarsenical 
dyes, such as the fluorescein derivative FlAsH-EDT2 (Figure 1.9B). The highly fluorogenic 
character of this probe, which is cell permeable, makes of this system a great choice for 
investigation of intracellular proteins. Further development of FlAsH analogs with other useful 
properties, such as red or blue excitation and emission wavelengths, localizability by electron 
microscopy, membrane impermeability and a non-fluorescent targeting moiety that can be tethered 
to a wide variety of fluorophores, have further increased the impact of the tetracysteine tag and it 
has been widely applied to study numerous biological systems 160–165. However, in practice this 
labeling technology is impaired by nonspecific labeling of thiol-rich biomolecules in the cell and the 
general cytotoxicity related to biarsenical dyes 166. Efforts to address these issues include the 
development of improved 12-mer biarsenical binding motifs with higher affinity toward the 
substrates 167, as well as other self-labeling systems like the bisboronic RhoBo-tetraserine 
motive 168, or the larger hydrazide-reactive (HyRe) tag 169, SpyTag 170 or E3 tag 171,172. The latter 
uses peptide-peptide interactions between the E3 and K3 peptides for covalent transfer of a 
fluorescent probe (Figure 1.9C). For this purpose, a cysteine residue is added to the N-terminus of 
the E3 peptide, which is fused to the POI and the fluorophore is conjugated to the N-terminus of 
the K3 probe via a thioester link. The two peptides form a parallel coiled-coil structure, which 
brings the N-terminal moieties into close proximity. This allows for spontaneous chemical transfer 
of the dye to the E3 peptide. 




Figure 1.9: Protein labeling using peptide tags. A) The common scheme of enzyme-mediated labeling of a peptide tag, 
which shows the covalent transfer of a substrate-analog to the acceptor peptide. B) Reaction of peptide tag self-labeling 
through metal chelation. The prototypical FlAsh-EDT2 probe binds to the tetracysteine-tag encoded within the sequence of 
the POI with high affinity. The fluorogenic FlAsH-probe is turned on upon self-labeling. C) Self-labeling strategies based 
on peptide-peptide (or peptide-protein) interactions. The functional peptide tag fused to the POI specifically binds a 
fluorophore-labeled donor peptide. The close proximity of the functional moieties allow for spontaneous chemical transfer of 
the fluorophore to the peptide-tag. 
1.4.4. Single-residue labeling via ncAAs  
Although peptide tags are significantly smaller than fluorescent proteins and protein tags, they are 
still hardly applicable in sensitive regions of the POIs, such as for instance binding domains or 
small loops exerting catalytic or structural functions. Lately, the expanded genetic code technology 
has made it possible to incorporate fluorescent probes by modifying one single amino acid in the 
POI sequence, thus minimizing the interference with protein structure and function. 
Fluorophores can be directly incorporated into a protein chain in the form of an ncAA bearing the 
fluorescent moiety in the side chain. NcAAs bearing groups based on dansyl, prodan and coumarin 
fluorophores have been genetically encoded both in prokaryotes and eukaryotes. These ncAAs 
include L-(7-hydroxycoumarin-4-yl)ethylglycine (HceG) 173,174, the environmentally sensitive 
3-(6-acetylnaphthalen-2-ylamino)-2-aminopropanoic acid (Anap) 56,175 and 2-amino-3-(5-(dimethyl-
amino)-naphthalene-1-sulfonamide)propanoic acid (Dansylalanine) 55,61. Unfortunately, the 
ribosome does not accept indefinitely large ncAAs, so only small fluorophores can be incorporated 
into proteins directly. These fluorophores are excited at relatively short wavelengths, which gives 
significant intracellular background, and are overall not suitable for high-end imaging applications. 
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In order to decorate proteins with large organic fluorophores, and in general with labels that are 
not genetically encoded, a two-step procedure is necessary. In the first place, an ncAA equipped 
with a suitable chemical handle is incorporated into the POI. Next, the desired probe is chemically 
conjugated to the ncAA post-translationally. The chemistry involved in this procedure must be 
bioorthogonal, i.e. the two reacting groups should be highly selective for each other and may not 
cross-react with functional groups naturally present in the proteins and in the physiological milieu. 
This implies that the reactants need to be metabolically and thermodynamically stable under 
physiological conditions (aqueous solutions, temperature, pH) and non-toxic to the host organism. 
Due to the enormous potential of bioorthogonal reactions for installing into proteins biocompatible 
probes of virtually any kind, an enormous effort has been invested into developing bioorthogonal 
chemistries and suitable ncAAs (thoroughly reviewed in 176). The most popular systems include 
ncAAs bearing carbonyl groups, such as m- and p-acetylphenylalanine or p-benzoylphenylalanine, 
which react with hydroxylamine and hydrazide compounds to form stable oxime and hydrazone 
linkages 177–179, ncAAs bearing either haloarenes or boronic acids for palladium catalyzed Suzuki 
coupling, such as p-Iodo-L-phenylalanine (p-IF) and p-Borono-L-phenylalanine (p-BorF) 180,181 and 
ncAAs bearing azide or alkyne groups for copper-catalyzed azide alkyne cycloaddition (CuAAC, the 
classic “click-chemistry”) 182,183, catalyst-free strain-promoted azide alkyne cycloaddition 
(SPAAC) 184,185 and Staudinger ligation (azides only) 186. While all these reactions have been 
successfully used to install fluorophores and other labels onto isolated proteins in vitro, their use 
in live cells is quite limited: Ketones and aldehydes are poorly orthogonal in live a cell context, 
azides can be reduced to amines in the cell milieu, Staudinger ligation has sluggish kinetics, 
whereas the copper catalyst of the CuAAC, which is in fact the most rapid, robust and selective 
chemistry, is cytotoxic 182. Examples of protein labeling on the surface of live cells via SPAAC have 
been shown with ncAAs bearing strained cyclooctyne anchors by azide-fluorophores in complex and 
live biological systems, including mammalian cells and animals 187–190. 
The real breakthrough in bioorthogonal chemistry on ncAAs has happened with the development 
of ncAAs for strain-promoted inverse electron-demand Diels-Alder cycloadditions (SPIEDAC) 
(Figure 1.10A). These amino acids bear electron-rich dienophiles (e.g. strained alkenes and 
alkynes), which react with electron-poor dienes (e.g. tetrazines). The reaction is very rapid and 
selective under cellular conditions, going to completion in a few minutes with very limited 
background. Other dipolar cycloaddition reactions have been implemented for ncAA mediated 
labeling (reviewed in 191) but compared to SPIEDAC, these reactions feature slower kinetics, often 
involve less stable reactants in vivo, and are usually limited to in vitro applications. NcAAs for 
SPIEDAC bearing norbornene (NorK) 108, bicyclo[6.1.0]-nonyne (BCNK) 192,193, trans-cyclooctenes 
(TCOK) 192,194, and 1,3-disubstituted cyclopropenes (CPK) 68,110, have been encoded by engineered 
PylRS/tRNACUA pairs in E. coli and mammalian cells. These ncAAs allow for highly efficient and 
specific in vivo labeling with tetrazine-dyes. Importantly, green- and red-emitting fluorophores 
show electronic interactions with tetrazines that have absorption-maxima at 500-525 nm. This 
makes tetrazine conjugates with BODIPY-FL, Fluorescein, VT680 or SiR fluorogenic, which is an 
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important characteristic especially for intracellular labeling 191. Further, tetrazine and methyl-
tetrazine moieties have different reactivity towards different strained alkenes and alkynes, which 
allows for selective dual-color labeling of two SPIEDAC-ncAAs in the same system 195 (Figure 
1.10B). The large spectrum of commercially available reactants for strain-promoted cycloaddition 
reactions, the superior reaction kinetics compared to other bioorthogonal chemistries and the 
missing requirement for any catalyst, makes this labeling strategy the most powerful available 
today. 
 
Figure 1.10: Single-residue labeling of proteins via bioorthogonal chemistry. A) Simple reaction schemes of the 
two most popular bioorthogonal labeling reactions. The ncAA with either a strained alkene or alkyne moiety is incorporated 
into the POI during ribosomal biosynthesis. The exposed bioorthogonal handles allow for specific labeling using azides or 
tetrazines. B) [modified from Chen and Wu 191] Different reactivities of strained alkenes and alkynes towards tetrazines 
and methyl-tetrazines allow for simultaneous dual-color labeling. 
1.4.5. Study of proteins via chemo-selective labeling of UAAs 
The development of super-resolution fluorescence microscopy has revolutionized biological imaging 
and its founders were awarded with the Nobel Prize in Chemistry in 2014. These functional super-
resolution techniques, such as stimulated emission depletion (STED) 196, photoactivated 
localization microscopy (PALM) 197 or stochastic optical reconstruction microscopy (STORM) 198 
allow capturing images at resolutions below the diffraction limit of light and opened new avenues 
for the study of biological processes in the live cell. The performance of these techniques is highly 
dependent on the size of the fluorescent entity and its photochemical properties. The installation 
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of small, bright and photo-stable fluorescent probes onto genetically encoded ncAAs offers the 
highest possible spatial resolution at the protein level, because the fluorophore can be installed 
onto a single residue in the protein chain at virtually any position. Furthermore, this approach 
offers utmost flexibility in the choice of fluorophore due to the two-step labeling procedure. Super-
resolution microscopy has been performed on membrane receptors such as the insulin receptor (IR) 
or epidermal growth factor receptor (EGFR) labeled via SPIEDAC on genetically encoded 
ncAAs 106,199, as well as on intracellular structural proteins like vimentin and actin 199. The modular 
nature of ncAA-mediated labeling is also particularly beneficial for single-molecule spectroscopy 
(SMS). Using bioorthogonal reactions to attach a small-molecule dye to an ncAA allows for control 
over the labeling ratio between target protein and fluorescent dye. This offers great advantages for 
imaging at the single protein level and has been proven useful for the study of dimerization 
stoichiometry and kinetics of transforming growth factor type II receptors (TβRII) 200. 
The fact that fluorophores attached to ncAAs are the smallest possible label, opens special 
perspectives for their application. In the first place, it has already been demonstrated that 
environmentally sensitive fluorophores attached as an ncAA or onto an ncAA can serve as precise 
sensors of changes to the protein structure 55,56,173,175. In addition, ncAA mutagenesis lends itself to 
the generation of small size FRET sensors able to report about movements of protein domains 
relative to each other. A major bottleneck for a facile and general application of FRET studies comes 
from the necessity to label biological samples with high spatial precision and suitable fluorescent 
dyes. NcAA mutagenesis allows for simultaneous incorporation of the same ncAA at multiple sites, 
simply by adding additional stop codons to the gene of the protein target, which allows for a high 
degree of freedom when choosing the mutation sites but at the cost of protein yields. This approach 
has been used for the generation of a single-molecule FRET (smFRET) sensor to study domain 
movement of a highly intrinsically-distorted protein by installing two ncAAs with bioorthogonal 
handles followed by simultaneous dual-labeling with a mixture of FRET donors and acceptors 201. 
This demonstrates the high value of ncAA-labeling for investigation of conformational changes 
within a protein. 
Simultaneous incorporation of two or more distinct ncAAs into the same protein, or interacting 
proteins, allows for even higher versatility when studying protein dynamics. The major prerequisite 
for doing so is mutually orthogonal pairs, each responding to a specific blank codon. Since PylRS 
does not rely on anticodon recognition for aminoacylation specificity, the tRNAPyl has been 
reprogrammed to suppress ochre (UAA), opal (UGA) and even quadruplet codons, which allows for 
combining the Pyl system with other available orthogonal pairs that are restricted to amber 
codons 62,83,84. Later, these approaches were used to introduce functional FRET pairs into proteins 
via incorporation of two different ncAAs, each one equipped with a bioorthogonal handle for 
mutually orthogonal labeling reactions 81,82,85. However, the number of ncAAs for bioorthogonal 
reactions that can be introduced with orthogonal pairs other than the Pyl system is limited. In 
addition, the functional moieties of these available ncAAs often limit them to labeling reactions 
with slow kinetics. Recently, mutually orthogonal PylRS/tRNAPyl pairs for simultaneous 
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incorporation of different ncAAs were described 202. Orthogonality between these PylRS/tRNAPyl 
pairs from Methanosacina mazei and Methanomethylophilus alvus is achieved via mutation of the 
variable loop of tRNAPyl and takes advantage of the different binding modes of Mm-PylRS and 
Ma-PylRS to their tRNAPyl. Since PylRS can be easily evolved for different substrates and tRNAPyl 
allows reprogramming to other codons, this discovery will allow for a broad spectrum of ncAA 
combinations and thereby improve the applicability of multi-site ncAA mutagenesis for study of 
protein dynamics in general. 
1.5. Scope of the thesis 
1.5.1. Aim 
As the first reports about the Pyl system appeared in the literature in the late 2000s, quickly it 
became clear that this would be the most relevant system for incorporating non-canonical amino 
acids in mammalian cells. The orthogonality of the PylRS/tRNAPyl, both in bacteria and mammalian 
cells, and the exceptional malleability of the amino acid pocket of the PylRS were obvious 
advantages compared to the leucyl and the tyrosyl systems from E. coli that had been used to 
incorporate ncAA in eukaryotes until then. At the beginning of this PhD work in 2014, the number 
of ncAAs that had been genetically encoded using the PylRS already exceeded the one hundred 
mark. Among those was a group of ncAAs harboring strained alkene and alkyne moieties for rapid 
bioorthogonal chemistry in live cells. Such ncAAs had an enormous potential for the development 
of minimal-sized fluorescent sensors to monitor structural dynamics of proteins in live cell settings, 
especially membrane receptors. Although the Pyl system was giving high protein yields in bacterial 
hosts, the ncAA incorporation efficiency of several Pyl-like ncAAs in mammalian cells was 
suboptimal and hampered their application to low abundant proteins and integral membrane 
proteins, which are intrinsically a challenging target for ncAA mutagenesis.  
The aim of this work was to improve the Pyl system in order to make it generally applicable to 
eukaryotic membrane proteins, in particular G protein-coupled receptors (GPCRs), which are one 
of the most important therapeutic targets in current biomedicine. While works from other groups 
were focusing on the development of improved plasmid systems for high expression of the 
PylRS/tRNAPyl pair in the host organism, we suspected that the deeper reason for the modest 
efficiency of the Pyl system in eukaryotes may have been the poor quality of the tRNAPyl, which has 
a number of peculiar features and may be poorly compatible in the eukaryotic context. Therefore, 
this work was focused on engineering a new tRNA to be paired to the PylRS to boost the efficiency 
of the ncAA incorporation system. The enhanced Pyl system could then be employed to incorporate 
ncAAs for bioorthogonal chemistry into GPCRs. The ultimate goal was to achieve rapid and 
quantitative GPCR labeling at a single residue with organic fluorophores in live cells, so as to 
enable studies of GPCR trafficking and dynamics, via high-end fluorescence microscopy methods. 
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1.5.2. Overview of the work 
First, the performance of the pyrrolysine system in mammalian cells was indeed significantly 
increased by engineering a novel tRNA, as described in chapter 2. Rational design approaches were 
applied for adapting the archaeal tRNAPyl to mammalian cells. A set of artificial tRNA variants was 
screened using an ad hoc established fluorescence-based assay with a fluorescent protein reporter 
bearing a stop codon. Two engineered tRNAPyl were identified that improved the incorporation rate 
of several different ncAAs compared to wild type tRNAPyl. A detailed analysis of the characteristics 
of the tRNAs showed that these variants featured a canonical hinge between D- and T-loop, showed 
higher intracellular concentrations and bore partially distinct post-transcriptional modifications. 
Using these engineered tRNAs, efficient ncAA incorporation into a G protein-coupled receptor was 
achieved and even allowed for simultaneous incorporation of two ncAAs at two different GPCR 
sites. Further, by incorporating ncAAs for bioorthogonal SPIEDAC-labeling into a GPCR, the 
receptor could be equipped with an organic fluorophore on the surface of the live cell. Importantly, 
the labeled receptor remained functional, as it physiologically internalized when stimulated with 
an agonist.  
Imaging methods requiring stoichiometric data analysis, such as oligomerization studies, need the 
protein of interest to be labeled quantitatively. A new method to quantify labeling yields of 
membrane receptors at a single-cell level is described in Chapter 3. This technique is based on 
fluorescence fluctuation microscopy and allows to extract and compare the number of occupied 
labeling sites and the amount of target protein present in areas of the cellular basal membrane of 
live cells and in a minimally invasive fashion. Quantitative single-residue labeling of the 
extracellular loops of three different GPCR with tetrazine-dyes was demonstrated without loss of 
receptor functionality. This is a very important aspect, as current labeling methods are more 
invasive than single-residue ncAA labeling and are not applicable to sensitive internal domains, 
such as the loops. Moreover, it could be shown that a receptor labeled on a single residue diffuses 
faster than the same GPCR fused to a fluorescent protein. Further, by performing competitive 
labeling with two dyes for one single site within the receptor, a strategy is presented to estimate 
the oligomerization state of a GPCR without the need of a biological monomeric reference. 
Chapter 4 describes in detail the fluorescence-assay developed to perform the tRNA screening 
described in Chapter 2 and includes a detailed procedure for bioorthogonal labeling of GPCRs, 
together with a photo-crosslinking technique to study ligand-GPCR interfaces. This chapter 
provides high levels of technical detail about the experimental procedures used in this work and 
focuses on a critical comparison of strengths and limitations of ncAA tools compared to other 
available methods. 
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The pyrrolysyl-tRNA synthetase/tRNAPyl pair is the most versatile and widespread system for the 
incorporation of non-canonical amino acids (ncAAs) into proteins in mammalian cells. However, low 
yields of ncAA incorporation severely limit its applicability to relevant biological targets. Here, we 
generate two tRNAPyl variants that significantly boost the performance of the pyrrolysine system. 
Compared to the original tRNAPyl, the engineered tRNAs feature a canonical hinge between D- and 
T-loop, show higher intracellular concentrations and bear partially distinct post-transcriptional 
modifications. Using the new tRNAs, we demonstrate efficient ncAA incorporation into a G protein-
coupled receptor (GPCR) and simultaneous ncAA incorporation at two GPCR sites. Moreover, by 
incorporating last-generation ncAAs for bioorthogonal chemistry, we achieve GPCR labeling with 
small organic fluorophores on the live cell and visualize stimulus-induced GPCR internalization. 
Such a robust system for incorporation of single or multiple ncAAs will facilitate the application of 
a wide pool of chemical tools for structural and functional studies of challenging biological targets 
in live mammalian cells. 
2.2. Introduction 
Genetic code expansion is the most powerful method to introduce artificial moieties into proteins 
site-specifically in live cells. Non-canonical amino acids (ncAAs) are incorporated in response to an 
in-frame amber stop codon (UAG) by a suppressor tRNA (tRNACUA), which is charged with the ncAA 
by an engineered amino-acyl-tRNA-synthetase (AARS). Most of the AARS/tRNA pairs evolved for 
ncAA mutagenesis in mammalian cells are derived from the archaeal pair that naturally 
incorporates pyrrolysine (Pyl) in Methanosarcina species (PylRS/tRNAPyl). Over a hundred ncAAs 
have been encoded using the Pyl system, including all ncAAs for ultrafast bioorthogonal 
chemistry 1, photo-caged and photo-switchable ncAAs, small fluorophores and photo-crosslinkers, 
among others (reviewed in 2). However, the Pyl system gives modest protein yields in mammalian 
cells, which hampers its general applicability. 
While non-canonical AARS/tRNA pairs must not cross talk with the endogenous translational pairs 
(criterion of orthogonality), the tRNA must be compatible with the endogenous transcription and 
processing machinery. In mammalian cells, transcription of prokaryotic tRNAs that lack A-box and 
B-box internal promoter sequences 3, as in the case of tRNAPyl, is achieved by placing the tRNA 
gene under control of RNA Pol III external promoters, such as the H1 4 or U6 promoter 5. 
Alternatively, some prokaryotic sequences have been engineered so as to have functional A and B-
boxes 6. In the tRNA expression cassette, the gene lacks the universal CCA-end and is flanked by 
a T-rich 3’-trailer. In the cell, the trailer is enzymatically cleaved from primary transcripts and the 
3’-CCA is added by the CCA-adding enzyme 7, 8. In addition, multiple tRNA nucleotides are modified 
at specific positions, which includes isomerization of uridine to pseudouridine (U), dehydrations 
and methylations 9. Once the mature tRNA is acylated by the cognate AARS, the AA-tRNA is bound 
by the elongation factor, which protects it from hydrolysis and delivers it to the ribosome, where it 
participates to protein synthesis 10. 
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The archaeal tRNAPyl features a secondary structure that significantly diverges from that of 
canonical tRNAs 11 (Figure 2.1) and is shared in mammals only by the mitochondrial tRNASerUGA 12. 
We suspected that such peculiar tRNA may be poorly compatible with the endogenous translational 
machinery and may possibly be unstable in the mammalian cytosol. In fact, it has been shown that 
stabilizing the U29a:G41b pair in tRNAPyl by the U29aC mutation (tRNAPyl*) slightly improves 
ncAA incorporation rates in 293T cells 13. Experiments in E. coli showed that the suppression 
efficiency by tRNAPyl is enhanced not only by the U29aC mutation 14, but also by improving the 
recognition with the endogenous elongation factor EF-Tu 15, as observed for other suppressor 
tRNAs 16. 
 
Figure 2.1: Cloverleaf structures of tRNAs. A) M. mazei tRNAPyl. Compared to canonical tRNAs, tRNAPyl misses 
nucleotides represented by small circles and features a longer anticodon stem (six base pairs instead of five). To conserve 
the canonical numbering 28, 29, position 29:41 is counted twice as a/b. Dashed lines indicate tertiary interactions inferred 
from the crystal structure of D. hafniense tRNAPyl 11. B) Canonical human tRNA with tertiary interactions indicated as 
dashed lines 26, 27, 28. Positions that are 100% conserved as a purine (R) or a pyrimidine (Y), and single nucleotides (A,U,G,C) 
that are >90% conserved are indicated. Nucleotides corresponding to the consensus internal promoter sequences (A-box, 
TRGCNNAGY for positions 8–16 and G18G19; B-box, GGTTCGANTCC for positions 52–62) are highlighted by bold circles. 
C) Stabilized B. taurus mt-tRNASerCUA amber suppressor 29. D) tRNAM15. Gray shades indicate mutations from wild type 
tRNAPyl. E) tRNAC15. Gray shading indicates nucleotides imported from tRNAPyl. 
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In this work, we aimed at generating more efficient tRNAPyl variants for ncAA incorporation in 
mammalian cells. Since directed tRNA evolution using large libraries is not feasible in mammalian 
systems, we focused on screening small sets of rationally designed tRNAs. We selected two novel 
tRNAs that improve ncAA incorporation by several folds. Using the new system, we demonstrate 
efficient ncAA incorporation into a G protein-coupled receptor (GPCR) and simultaneous ncAA 
incorporation at two GPCR sites. Moreover, we demonstrate ultrafast GPCR labelling with a bright 
small organic fluorophore on the surface of live mammalian cells. Finally, by combining our novel 
tRNAs with a recently reported PylRS variant, we present the most efficient pyrrolysine system 
currently available for general application in mammalian cells. 
2.3. Materials and Methods 
2.3.1. General Molecular Biology 
Escherichia coli strain DH5α was used for general cloning. All PCRs were performed using Phusion 
High Fidelity DNA-Polymerase. Point mutations were introduced using the QuikChange® method 
(Stratagene, La Jolla, CA) adapted for Phusion polymerase. Oligonucleotides were purchased from 
Microsynth (Balgach, CH) and Biomers (Ulm, DE). All constructs were verified by DNA sequencing 
(Sequencing Laboratories Göttingen). Lys(Boc) and Lys(Z) were purchased from Bachem and 
Novabiochem (Merk), respectively, the other ncAAs from SiChem (Bremen, DE). ncAA stocks were 
prepared in NaOH at 0.1-0.5 M as described previously 17 right before the experiments. 
All tRNAPyl and PylRS expression cassettes were cloned into a modified pcDNA3.1 vector that we 
called pNEU (Supplementary Figure S2.1A). MbPylRSF and the monomeric U6-tRNAPyl* expression 
cassette (Supplementary Figure S2.1A) were amplified from pAcBac1.tR4-MbPyl (P.G. Schultz, 
Addgene Plasmid #50832). The codon-optimized gene of MbPylRSF was custom synthesized by 
GeneArt (ThermoFisher Scientific). The NES motif was build de novo using overlapping primers 
and fused to the MbPylRS via PCR. tRNA variants were mostly generated de novo using 
overlapping primers and joined to the U6 promoter via overlapping PCR. Tandem cassettes were 
generated as described previously 18. DNA sequences are reported in the supplementary data. The 
reporter plasmid for the fluorescence assay (Supplementary Figure S2.1B) has been described 
previously 17. The pIRE4-Azi plasmid (Supplementary Figure S2.1C) bears a humanized gene 
encoding the E2AziRS 19 (custom synthesized by GeneArt, ThermoFisher Scientific) under control 
of the PGK promoter and, right downstream, four tandem repeats of the expression cassette for 
Bacillus stearothermophilus tyrosyl amber suppressor tRNA (BstYam) under control of the U6 
promoter. The pcDNA3.1-CRF1R-FLAG and pcDNA3.1-CRF1R(xxxTAG)-FLAG plasmids were 
previously built by I.C. at The Salk Institute for Biological Studies (La Jolla, CA) in the laboratory 
of Lei Wang 18. 
2.3.2. Cell Culture 
HEK293 and 293T cells were maintained in Dulbecco’s Modified Eagle’s Medium (DMEM; high 
glucose, 4mM glutamine, pyruvate), supplemented with 10% (v/v) of fetal bovine serum (FBS 
superior; Biochrom) and 100 units/ml of Penicillin and 100 µg/ml Streptomycin at 37°C in a 5% CO2 
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atmosphere. Unless otherwise stated, ncAAs were added to the growth medium 1 h prior 
transfection at a final concentration of 500 μM. 
2.3.3. Fluorescence Assay 
As previously described 17, ~half million HEK293 cells were seeded per well of 6-well plates in 2 ml 
complete growth medium. The day after, cells were transfected with 1 μg of the reporter plasmid 
and 1 μg of the tRNA/AARS plasmid using Polyethylenimine 25kD (PEI; Polysciences). Two days 
after transfection, total green and red fluorescence of cell lysates was quantified using a plate 
reader (FLUOstar Omega, equipped with Ex485-12/Em520 and Ex584/Em620-10 filter sets). 
Suppression efficiency was calculated as the ratio between the fluorescence of the sample and the 
fluorescence obtained for wild type EGFP expression. All values were normalized to mCherry 
fluorescence. 
2.3.4. Isolation of total RNA and total small RNA from HEK293 cells 
1.5 x 106 HEK293 cells were seeded in 6 cm dishes. The day after, cells were transfected with 3 μg 
DNA plasmid encoding for the tRNA/AARS pair using PEI. 48h later, total RNA was isolated under 
acidic conditions using TRIzol® (Invitrogen) according to the manufacturer protocol. RNA pellets 
were dissolved in 10 mM sodium acetate (pH 5.0). Large RNAs were precipitated with 10 M lithium 
chloride in 1:1 ratio (v/v) and separated by centrifugation at 14000 x g and 4°C for 10 min. Small 
RNAs (<200 nt) were precipitated from the supernatant with ethanol 20 and dissolved in RNase-
free water. 
2.3.5. Semi-denaturing urea-PAGE and Northern Blotting 
Northern Blot analysis was performed as described by Köhrer et al., 2008 21 with minor variations 
for mini-gel format. Total tRNA samples (10 μg) were added of 2x sample buffer (0.1 M sodium 
acetate (pH 5.0), 8 M urea, 0.05% Bromophenol blue and 0.05% Xylene cyanol), heated to 65°C for 
5 min and loaded on freshly prepared semi-denaturing polyacrylamide gels (19:1 
acrylamide/bisacrylamide) containing 7 M urea and 0.1 M sodium acetate (pH 5.0). The gel was run 
at 5W (100V and 50mA) in 0.1 M sodium acetate, pH 5.0 for 3-4 h until the Xylene cyanol reached 
the front. RNA was transferred onto BrightStar™-Plus Nylon Membrane (ThermoFisher Scientific) 
at 2mA/cm² in a semi-dry apparatus (Bio-Rad) for 35 min using transfer buffer (40 mM Tris-HCl, 
pH 8.0, 2 mM Na2EDTA). The membrane was irradiated at 254 nm UV light for 50 sec (120 mJ/cm² 
total) and pre-hybridized for 14-20 h at 42°C in 6x saline-sodium citrate buffer (SSC) containing 
10x Denhardt’s solution and 0.5% SDS. 5’-Biotin-labeled DNA oligonucleotides complementary to 
tRNAPyl* and tRNAM15 (CGGAAACCCCGGGAATCxAACCCGGCTGAACGGA, x = deoxyribose 
spacer), tRNAC15 (CGGGAGAGGGGGGAATCGAACCCCCCTGTGTTGA), and ribosomal 5.8S RNA 
(CGCAAGTGCGTTCGAAGTGTCGATGATCAATGTG) were used as probes (100 pM) in the 
presence of a 100x excess (10 nM) of unlabeled “unfolder”-probes (tRNAPyl 
TCCGTTCGATCTACATGATCAGGTTTCC; tRNAM15 TCCGTTCGGTCTCCCTGACCAGGTTTCC; 
tRNAC15 TCAACACGGCCACCTTGGCCACTCTCCC). Membranes were hybridized for 12-24 h at 
42°C in 6x SSC containing 0.1% SDS, washed at room temperature with 6x SSC (2x 10 min), 
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followed by washes at 4x and 2x SSC and incubated with streptavidin-horseradish peroxidase 
conjugate (1:10000 in TBS + 0.1% Tween) for 1 h at room temperature. Membranes were washed 
with TBS + 0.1% Tween (3x 10 min) and soaked in homemade ECL reagent (0.1 M Tris-HCl pH 8.6, 
22 % luminol, 10 % p-coumaric acid, 10 % DMSO, 0.0001 % H2O2). After 1 min delay, signals were 
collected for 5 min in the dark (Gbox, Syngene). Intensities of bands were quantified using Image 
Studio software (LI-COR Biosciences, Ver5.2). 
2.3.6. Denaturing urea-PAGE 
10 μg of total tRNA were added of 3x denaturing sample buffer (10 mM Tris-HCl, pH 7.6, 80% 
formamide (v/v), 0.25% Bromophenol blue and 0.25% Xylene cyanol) and incubated for 5 min at 
65°C. Samples were loaded on freshly prepared denaturing polyacrylamide gels (19:1 
acrylamide/bisacrylamide) containing 8 M urea and 1xTBE (89 mM Tris, 89 mM boric acid, 2 mM 
EDTA, pH 8.0). Electrophoresis was run at 100 V for 3 h in 1xTBE running buffer. 
2.3.7. In vitro tRNA transcription 
tRNA standards for Northern Blot analysis and tRNA samples for structural probing were 
transcribed from DNA constructs including 3’ and 5’ self-cleaving ribozymes 22 (Supplementary 
Figure S2.1D) using homemade T7 RNA polymerase (3 h, 37°C), followed by ribozyme cycling. 
Products were resolved on a denaturing urea-PAA gel (10%), tRNA bands were visualized via UV-
shadowing and excised. tRNAs were extracted overnight in RNase-free water at 4°C, precipitated 
with ethanol and 3’-dephosphorylated using T4 Polynucleotide Kinase (NEB) at 37◦C for 4 h in 3’-
dephosphorylation buffer (100 mM Imidazole, 10 mM MgCl2, 10 mM β-mercaptoethanol, 20 µg/ml 
BSA, 100 µM ATP, pH 6.0). 
2.3.8. In-line probing of tRNA secondary structure 
In vitro tRNA was labeled at the 5’-end with [γ-32P]-ATP (Hartmann Analytic) using T4 
Polynucleotide Kinase (NEB). The reaction mixture was resolved on a 10% denaturing urea-
polyacrylamide gel, the labeled tRNA was eluted from the corresponding band overnight at 4°C in 
DEPC-treated water, precipitated with ethanol, and recovered in RNase-free water. In-line probing 
was performed as described 23. Labeled tRNA (~105 cpm) was denatured at 65°C for 5 min, refolded 
at RT for 5 min, and incubated in in-line reaction buffer (50 mM Tris/HCl, pH 8.5, 20 mM MgCl2 
and 0.1 M KCl) for 40 h at 25°C in a 10 μl volume. In parallel, a “no-reaction” control sample was 
incubated in RNase-free water. Reactions were quenched by adding an equal volume of 2x colorless 
loading dye (10 M urea and 1.5 mM EDTA). A third tRNA sample was digested in a reaction volume 
of 10 μl with 250 mUnits RNase T1 in RNase T1 buffer (10 mM Tris/HCl, pH 7.5, 30 mM NaCl and 
0.5 mM EDTA) added of 2 μg E. coli total tRNA for 2-4 min at 37°C. The reaction was stopped on 
ice before adding colorless loading dye. Partial alkaline digestion of a fourth tRNA sample in 
NaHCO3 (100 mM, pH 9.75, 90°C, 2 min) provided the hydrolysis ladder. Samples were 
immediately resolved on a 10% denaturing polyacrylamide gel. Signals were detected with storage 
phosphor screens and analyzed with a Typhoon 9410 Phosphor imager (GE Healthcare). 
CHAPTER 2 2.3 Materials and Methods 
68 
 
2.3.9. Detection of post-transcriptional modifications via reverse transcription 
(RT) based methods 
Reverse transcription (RT) methods were applied to detect the presence of pseudouridine (Ψ), 
dihydrouridine (D) and 2’-O-methylations according to Motorin et al., 2007 24 and Wintermeyer et 
al., 1979 25. To detect pseudouridine 24 (Supplementary Figure S2.6), two 4 µg aliquots of the same 
total small tRNA sample were differently treated. One aliquot (sample Ψ) was added to 30 µl of 1-
cyclohexyl-(2-morpholinoethyl)carbodiimide metho-p-toluene sulfonate (CMCT) solution (50 mM 
Bicine, pH 8.0, 7 M urea, 4 mM EDTA and 330 mM CMCT) and incubated at 37 °C for 20 min. The 
RNA was precipitated with ethanol, dissolved in 50 mM Na2CO3 (aq) and incubated at 37 °C for 
3 h. The second aliquot (control C) was treated exactly as sample Ψ, but omitting CMCT in the first 
buffer. The RNA was precipitated with ethanol and resuspended in nuclease-free water. 10 pmol of 
pre-treated in vitro transcribed tRNA or 1 µg total small tRNA in a volume of 10 µl were mixed 
with 20 pmol 5’-32P-labeled RT-primer (TGGCGGAAACCCCG for both tRNAPyl* and tRNAM15, 
TGGCGGGAGAGGGG for tRNAC15), incubated at 65 °C for 5 min and cooled on ice. 5 units Avian 
Myeloblastosis Virus (AMV) Reverse Transcriptase (NEB) in AMV reaction buffer containing 
dNTPs to 1 mM were added. Reverse transcription was performed for 30 min at 42°C. Products 
were precipitated with ethanol, resuspended in 10 µl 2x colorless loading dye and resolved on 15% 
denaturing PAA gels. Sequencing ladders were generated via RT reactions, each containing an 
additional ddNTP in a ratio of 20:1 (ddNTP:dNTP). Radioactive signals were detected with storage 
phosphor screens and analyzed with a Typhoon 9410 Phosphor imager (GE Healthcare). 
2.3.10. Western Blot analysis of corticotropin-releasing factor 1 type receptor 
variants 
The day before transfection, 4.5 x 105 293T cells were seeded per well of 6-well culture plates in 
2 ml complete medium. For amber suppression, cells were transfected with equal amounts of the 
plasmid encoding for the orthogonal pair and pcDNA3.1-CRF1R(xxxTAG)-FLAG for a total of 2 μg 
DNA. For simultaneous suppression of amber and opal codons, cells were transfected with equal 
amounts of the two plasmid encoding for the orthogonal pairs (MbPylRSAF/tRNAPylUCA in pNEU, 
EcAziRS/tRNATyrCUA in pIRE4) and a third plasmid encoding for the CRF1R(xxxTGA, yyyTAG)-
FLAG mutant in pcDNA3.1, for a total of 2.1 μg DNA. PEI was used as transfection reagent (3 μg 
PEI/1 μg DNA). Two days after transfection, whole cells lysates (15-50 µg) were resolved by SDS-
PAGE, transferred to PVDF membranes and analyzed via Western Blot using both an αFLAG-HRP 
conjugate and αACTB antibody. ECL detection followed as described above. 
2.3.11. Fluorescence microscopy 
Microscopy experiments were performed in 4-well IBIDI plates coated with poly-D-lysine 
hydrobromide (BD bioscience). 1.0 x 105 cells were seeded per well in 600 µl FluoroBrite® (Gibco) 
growth medium, supplemented with 10% (v/v) FBS, 100 units/ml Penicillin and 100 µg/ml 
Streptomycin. The following day, cells were co-transfected with the pCRF1R(xxxTAG)-EGFP 
plasmid and the plasmid encoding for the tRNA/AARS pair (1:1 w/w) for total of 0.4 μg DNA per 
well. 14-20 h later, CRF1RTCO*K was labeled with 1.5 μM Tetrazine-Cy3 in complete growth medium 
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for 5 min at 37°C 26. Cells were washed twice in growth medium for 5 min. Genomic DNA was 
stained using Hoechst 33342 according to manufacturer's recommendations. Fluorescence was 
detected on inverted fluorescence microscopes (Axio observer; Zeiss) equipped with Ex: BP470/40 
Em: BP525/50 or Em: LP515 filters for green fluorescence (EGFP), Ex: BP565/30 Em: BP620/60 
filters for red fluorescence (Cy3) and Ex: G365 Em: BP445/50 filters for blue/cyan fluorescence 
(Hoechst 33342). 
2.4. Results 
2.4.1. Screening of rationally designed tRNAPyl variants for improved efficiency 
in mammalian cells 
We designed two sets of tRNAPyl variants. The first set (M series) was based on the scaffold of 
Methanosarcina mazei tRNAPyl (Supplementary Table S2.1) and was aimed at improving the 
recognition of tRNAPyl by mammalian endogenous components. It included 11 tRNAPyl mutants in 
which single bases or base pairs were substituted with the corresponding nucleotides found in the 
conservation pattern of human tRNAs 27, 28, 29 (Figure 2.1B). In the D-stem, base pair U11:A24 was 
either inverted to A11:U24 or mutated to G:C to fit the human purine-pyrimidine conservation 
muster. In the D-loop, the pyrimidine U15 was mutated to the conserved purine position (A/G). In 
the anticodon stem, C32 was substituted with the alternative pyrimidine U32. In the variable loop, 
we mutated G48 to A. In the T-loop, A56 was mutated to the conserved human counterpart C, and 
G57 to the alternative purine A. As A56 is engaged in a tertiary Watson-Crick pair by U19 in the 
D-loop (Figure 2.1A), we explored also the mutation U19G, both combined to A56C and on its own. 
(Supplementary Table S2.1). 
The second set (C series) relied on the structural similarity between the tRNAPyl and the mt-
tRNASerUGA. In E. coli, chimera tRNAs built by introducing identity elements for PylRS into a 
stabilized CUA anticodon variant of bovine mt-tRNASerUGA (Figure 2.1C) are acylated by the PylRS 
and function as orthogonal amber suppressors 30. We expected mt-tRNASer/Pyl chimeras to be 
orthogonal in mammalian cells, as the cytosolic translational machinery is quite distinct from the 
mitochondrial one 31-33. On the other hand, we envisioned that the scaffold of a mammalian 
mitochondrial tRNA may provide tRNAs compatible with the mammalian context. Based on the 
known PylRS-tRNAPyl interaction pattern 11, we transplanted different combinations of recognition 
motifs for PylRS into Bos taurus mt-tRNASerCUA. These included the discriminator base G73, pairs 
G1:C72 and G2:C71 in the acceptor-stem, U8 at the junction between acceptor-stem and D-stem, 
pairs G10:C25 and C13:G22 in the D-stem, pair A31:U39 in the anticodon stem, C44, A45 and G48 
in the variable loop, pairs C50:G64 and G51:C63 in the T-stem. We generated a set of 12 chimeric 
tRNAs, which included the two tRNASer/Pyl chimeras described in the literature 30 (Supplementary 
Table S2.1). 
We built bicistronic plasmids combining each tRNA with the PylRS from Methanosarcina barkeri, 
which bears the mutation Y349F for enhanced activity (PylRSF) 34 (Supplementary Figure S2.1). 
Efficiency and orthogonality of the tRNAs were tested in HEK293 cells using the amber suppressor 
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reporter EGFPY183TAG in a fluorescence assay 17. All tRNAs were orthogonal and gave no amber 
suppression in the absence of ncAA (Supplementary Table S2.2). In the presence of the PylRS 
substrate Lys(Boc) (Figure 2.2A), four engineered tRNAs in the M series and five in the C series 
yielded higher amber suppression compared to the tRNAPyl*, whereas the other tRNAs showed 
either lower efficiency or no amber suppression at all (Figure 2.2B). In the M series, the best tRNA 
was obtained by mutating the tertiary Watson-Crick pair U19:A56 between D-loop and T-loop to 
G19:C56. Further beneficial mutations were found in the D-stem (A11:U24 to G:C or C:G) and D-
loop (U15G). However, the most efficient tRNAs were found in the C-series, with Chimera 11 and 
Chimera 12 yielding a 2,5-fold increase in suppression efficiency compared to tRNAPyl*. In general, 
chimeras bearing the highest number of bases from tRNAPyl were the most efficient. Interestingly, 
the most efficient tRNAs of both series, Mutant 11 and the two chimeras, bear a canonical B-box in 
the T-arm. 
We also considered the scaffold of Desulfitobacterium hafniense tRNAPyl 11, 35. However, neither wild 
type DhtRNAPyl, nor a GC stabilized variant of it (Supplementary Table S2.1) performed better 
than the MmtRNAPyl* (Supplementary Figure S2.2). 
We then discarded tRNAs less efficient than tRNAPyl* and generated further tRNAs for a second 
round of screening (Supplementary Table S2.1). In the M series, we combined beneficial mutations 
found in the first round (Mutants 12-15). In addition, we attempted to reconstruct a complete A-
box motif in the D-arm (Mutants 16-17). Finally, we explored different combinations of bases in the 
region connecting the acceptor-stem to the T-arm (Mutants 18-21), as mutations in this region have 
been shown to improve interactions with EF-Tu in bacteria 15. In the C series, we also reconstructed 
stepwise the A-box motif in the D-Arm (Chimeras 13-15). As mutations in the tRNA may differently 
affect incorporation of different ncAAs 15, 36, we tested now the incorporation of two sterically 
distinct ncAAs, Lys(Boc) and Lys(Z) (Figure 2.2A). Lys(Z) is recognized by the PylRSAF, which bears 
the F271A mutation deep inside the AA binding pocket to accept bulky substrates 34. We observed 
different trends with the two ncAAs in the two tRNA series. In general, with exception of the tRNA 
variants mutated in the region of elongation factor recognition (M18-M21), mutant tRNAs based 
on tRNAPyl (M series) showed parallel improvements with the two ncAAs, whereas all chimeras 
performed better with Lys(Boc) (Figure 2.2C). 
For further experiments, tRNAM15 was selected from the M series because it gave the best overall 
performance considering both Lys(Boc) and Lys(Z), whereas tRNAC15 was selected from the C 
series, as the best tRNA for Lys(Boc) incorporation. To maximize suppression yields, we combined 
four tandem repeats of the tRNA expression cassette. We then tested the two tRNAs for 
incorporation of several ncAAs by either PylRSF or PylRSAF 37, 38, 39, 40. Compared to tRNAPyl*, both 
tRNAM15 and tRNAC15 gave higher amber suppression yields with all ncAAs tested, with tRNAM15 
outperforming tRNAC15 (Figure 2.2D). 




Figure 2.2: Selection of enhanced tRNAPyl variants for ncAA incorporation. A) ncAAs used in this study. 
B-D) Amber codon suppression in EGFPY183TAG by tRNAPyl* and engineered tRNA variants. Bars represent the fluorescence 
of the probe relative to the fluorescence intensity of wild type EGFP expression. All values were normalized to mCherry 
fluorescence. Data represent the average ± SD of biological triplicates. All tRNA sequences are reported in Supplementary 
Table S2.1. B) First round of screening. Mutant and chimera tRNAs (1 copy) were combined with MbPylRSF (natural gene 
with archaeal codon usage) for the incorporation of Lys(Boc). C) Second round of screening. tRNA variants (1 copy) were 
combined with either MbPylRSF or MbPylRSAF (genes optimized for human codon usage) for incorporation of Lys(Boc) or 
Lys(Z) respectively. D) Incorporation efficiency of different ncAAs by tRNAPyl*, tRNAM15, tRNAC15, using constructs bearing 
either one (1x) or four (4x) copies of the tRNA expression cassette. 
2.4.2. Characterization of the engineered tRNAs 
The intracellular concentration and the amino acylation rate of tRNAPyl*, tRNAM15 and tRNAC15 
was examined via Northern Blot analysis 41 (Figure 2.3). We used either one or four tRNA 
expression cassettes, in the presence and absence of either Lys(Boc) or Lys(Z). As compared to the 
in vitro loading control, tRNAC15 showed the highest intracellular concentration, followed by 
tRNAM15 and tRNAPyl* (Figure 2.3 and Supplementary Figure S2.3). In general, we detected more 
tRNA when the ncAA was present. The overall amounts of all tRNAs increased when increasing 
the number of tRNA expression cassettes. tRNAC15 showed the smallest increase, possibly 
explaining why this tRNA is the most efficient tRNA for Lys(Boc) incorporation when using one 
copy of the tRNA expression cassette but is equivalent to tRNAM15 when using four copies 
(Figure 2.2D). The acylation rate did not correlate either with the tRNA amount nor with the ncAA 
identity and was around 50% for all tRNAs, both with Lys(Boc) and Lys(Z) 
(Supplementary Table S2.3). 




Figure 2.3: Northern Blots. Total RNA from HEK293 cells expressing the indicated tRNA were isolated under acidic 
conditions to preserve the AA-tRNA ester linkage 41, resolved on 12.5% acidic urea-PAA gels and electroblotted. A) tRNAPyl* 
and tRNAM15 were detected using the same 5’-biotinylated oligonucleotide probe (in gray), whereas tRNAC15 was detected 
with a different oligonucleotide targeted to the same tRNA region. B-C) # indicates RNA probes extracted from non-
transfected cells; iv indicates in vitro transcripts (25 ng); B) cells co-expressed MbPylRSF, C) cells co-expressed MbPylRSAF. 
The results are representative of at least 3 independent experiments. 
Notably, although all tRNAs run at the same height in fully denaturing gels, both in vivo and in 
vitro transcripts of tRNAM15 and tRNAC15 tRNAs run slightly faster than tRNAPyl* in semi-
denaturing gels (Supplementary Figure S2.4), which suggests that they remain partially folded. No 
major differences were identified by analyzing the secondary loops/stems structure of the three 
tRNAs with in-line probing 23, 42 (Supplementary Figure S2.5), so that the higher stability of 
tRNAM15 and tRNAC15 is likely explained by more favorable tertiary interactions. 
Using reverse transcription (RT)-based methods, we also investigated the occurrence of post-
transcriptional modifications. While we did not find evidences for the presence of dihydrouridine 
and 2’-O-methylations, our RT results suggest the presence of the almost universally conserved 
Ψ55 in the T-loop of both tRNAPyl* and tRNAM15, as well as the additional presence of Ψ39 in 
tRNAM15 (Supplementary Figure S2.6). Ψ39 is conserved in canonical tRNAs, where it stabilizes 
interactions at the base of the anticodon stem by providing an additional locus for hydrogen bonding 
to A31 43, 44. On the contrary, RT-methods did not provide clear indication for the presence of 
pseudouridine in tRNAC15. 
2.4.3. Testing tRNAM15 for ncAA incorporation into CRF1R 
The MbPylRSAF/tRNAM15 pair was applied to incorporate a series of ncAAs into a demanding 
protein target, the class B GPCR corticotropin releasing factor type 1 receptor (CRF1R) (Figure 
2.4A). We focused on ncAAs designed for bioorthogonal chemistry, which are a critical application 
of the Pyl system nowadays. We tested amber suppression both at position 95 in the N-terminal 
domain (NTD) and position 254 further downstream in extracellular loop 2 (ECL2), which was 
particularly challenging in previous experiments 18, 45. At both positions, tRNAM15 yielded higher 
incorporation of all ncAAs tested in respect to tRNAPyl*, yielding detectable protein amounts in 
Western Blot also when no signal was detectable using tRNAPyl*. 
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As the PylRS does not recognize the anticodon of its tRNA, pyrrolysine tRNAs can be reassigned to 
ochre, opal and even four-base codons 46-49. Anticodon variants of tRNAM15 functioned as efficient 
ochre and opal suppressors, with the opal variant giving higher yield than the ochre variant (Figure 
2.4B). Different from what reported for E. coli 50, we did not observe appreciable near-cognate read 
through of any of the stop codons. By combining the MbPylRSAF/tRNAM15UCA pair with the amber-
suppressing EcAziRS/tRNATyrCUA pair, we simultaneously incorporated two different ncAAs into 
the CRF1R. Based on densitometric analysis of Western Blot signals, the yield of double stop codon 
suppression is about 25% respect to the single suppression (Figure 2.4C). 
 
Figure 2.4: Single and multiple ncAA incorporation into a GPCR. ncAAs were incorporated into the CRF1R bearing 
FLAG at the C-terminus. A) Amber suppression by the indicated tRNAs combined to either MbPylRSF or MbPylRSAF. 
# indicates non-transfected cells. B) Amber (TAG), opal (TGA) or ochre (TAA) suppression by tRNAM15CUA, tRNAM15UCA, 
tRNAM15UUA, respectively, measured by fluorescence assay as described above. Data represent the average ± SD of biological 
triplicates. C) Opal and amber suppression by the MbPylRSAF/tRNAM15UCA pair combined with the EcAziRS/tRNATyrCUA pair. 
In A and C * indicates half amount and one fourth amount loaded, respectively. 
We also performed labeling and imaging experiments on CRF1R bearing TCO*K (Figure 2.2A) at 
position 95NTD. The receptor was fused to EGFP to evaluate its expression and localization at the 
cell membrane. Both the number of fluorescent cells and the intensity of EGFP fluorescence 
increased when using tRNAM15 instead of tRNAPyl* (Supplementary Figure S2.7). CRF1R95TCO*K was 
selectively labeled via strain promoted inverse-electron-demand Diels-Alder cycloaddition 
(SPIEDAC) 40 upon a short treatment with Cy3-tetrazine, with the fluorescence of the label 
localizing with EGFP fluorescence (Figure 2.5A). The Cy3-labeled receptor was still functional and 
internalized upon a short treatment with the natural CRF1R agonist Urocortin1 (Figure 2.5B). 




Figure 2.5: GPCR labeling via SPIEDAC on live cells. Representative images in the green, red and blue channel. 
A) Cells expressing CRF1R95TCO*K-EGFP were treated with Cy3-tetrazine (1.5 M) for 5 min. Only cells expressing the 
receptor (green) showed Cy3 labeling (red). B) Cy3-CRF1R95TCO*K-EGFP was activated with Urocortin1 (200 nM) and imaged 
after 15 min. Intracellular vesicles correspond to the internalized receptor. Scale bar: 10 μm. 
2.4.4. The optimal pyrrolysine system for ncAA incorporation in mammalian 
cells 
Recently, Nikic et al. discovered that the wild type PylRS accumulates in the nucleus of mammalian 
cells, so that the suppression efficiency of the Pyl system is enhanced by adding to the PylRS a 
strong N-terminal nuclear export signal (NES) 51. We combined tRNAPyl*, tRNAM15 and tRNAC15 
with the PylRS bearing the published NES and evaluated the suppression efficiency via 
fluorescence assay (Supplementary Figure S2.8). At optimal conditions for ncAA incorporation 
(0.5 mM ncAA, four copies of tRNA expression cassette), adding the NES was beneficial in the case 
of tRNAPyl*, but did not improve amber suppression by either tRNAM15 or tRNAC15. However, when 
working either with limiting ncAA concentration (50 M) or a single copy of tRNA expression 
cassette, a general improvement via the NES was observed. Therefore, the combination of the NES-
PylRS with the tRNAM15 should guarantee the best performance of the Pyl system for demanding 
applications. 
2.5. Discussion 
We reported here the generation of two enhanced orthogonal tRNAs, tRNAM15 and tRNAC15, for the 
Pyl orthogonal system, which is the most popular tool for ncAA incorporation into proteins 
expressed in mammalian cells. The engineered tRNAs feature a 2-5 fold higher intracellular 
concentration compared to tRNAPyl*, although all tRNA genes are expressed using the same 
external promoter in identical expression cassettes. Increasing tRNA amounts is known to increase 
suppression efficiency in mammalian hosts 13,43,50. Our results demonstrate (Figure 2.3) that higher 
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tRNA concentrations can be better achieved by improving the quality of the tRNA, rather than by 
increasing the number of tRNA expression cassettes in the expression system as it has been done 
so far 13,33. 
Comparison of electrophoretic mobility suggests that the engineered tRNAs are intrinsically more 
stable than the tRNAPyl*. This is possibly due to stronger tertiary interactions, as both tRNAM15 
and tRNAC15 have the tertiary Watson-Crick pair U19:A56 mutated to the more stable pair G19:C56 
between D- and T-loop, as it occurs in canonical tRNAs. Literature data 13,14 and the results on Dh-
tRNAPyl (Supplementary Figure S2.2) clearly show that tRNA efficiency increases by GC stabilizing 
tRNA arms. Our engineered tRNAs suggest that the presence of a canonical hinge is likewise 
important for tRNA efficiency. Interestingly, some recently discovered non-methanosarcinal 
tRNAPyl species may feature a canonical hinge 51,52. 
Higher structural stability is likely one factor contributing to the higher intracellular levels of 
engineered tRNAs respect to tRNAPyl*. For instance, it is known that tRNA concentrations are 
strongly affected by the stability surveillance of the CCA-adding enzyme 53. However, steady state 
tRNA levels are regulated by complex tRNA turnover mechanisms 54. It is possible that the 
engineered tRNAs interact with endogenous proteins differently from the tRNAPyl, which may have 
a protective effect, but elucidating this question will require further investigations. 
Interaction of tRNAPyl variants with the mammalian elongation factor may involve the junction 
between the acceptor-stem and the T-arm. tRNAs mutated in this region (Mutants 18–21) show 
higher suppression efficiency when charged with Lys(Boc) rather than with Lys(Z). These mutants, 
like all the chimeras, bear a G7:C66 pair at the root of the acceptor-stem, whereas mutants 1–17, 
which show parallel trends with the two ncAAs, feature the inverted combination C7:G66. 
Mutations in the same tRNA region have been shown to improve interaction of archaeal suppressor 
tRNAs with the bacterial elongation factor EF-Tu 15,16. It is also well known that the affinity of AA-
tRNAs for EF-Tu depends on the esterified amino acids 55,56. Overall, our results support the notion 
that suppressor tRNAs should be optimized for each ncAA 15,16. 
Orthogonal tRNAs used in mammalian cells are usually derived from prokaryotes to avoid cross 
talk with the endogenous translational pairs. Here, our tRNAC15 demonstrates that an engineered 
mitochondrial tRNA can well function as orthogonal suppressor tRNAs in the cell cytosol, in line 
with the prokaryotic origin of mitochondria 30,31. Notably, tRNAC15 yielded the highest incorporation 
efficiency of ncAAs accepted by the PylRSF when using one copy of the tRNA cassette, which may 
be advantageous when working with viral vectors that do not tolerate the presence of repeated 
sequences. 
ncAAs for ultrafast bioorthogonal chemistry encoded by the PylRS 1 (TCO*K, SCOK, BCNK, Figure 
2.2A) offer the unique possibility of installing biophysical probes, such as last-generation 
fluorophores for single molecule microscopy, at specific protein sites directly in the live cell. Using 
our tRNAM15, we have demonstrated for the first time ncAA incorporation by the Pyl system into a 
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GPCR, a notoriously more challenging object than model systems like the green fluorescent protein 
and cytosolic proteins. We achieved rapid fluorescent GPCR labeling via SPIEDAC chemistry on 
the live cell and we could follow in real time the physiological intracellular fate of the labeled 
receptor upon stimulation. Our work opens the way to a number of in cell fluorescence experiments 
with GPCRs, whereas so far site-specific GPCR labeling with small fluorophores had been achieved 
only on isolated receptors in vitro 57. Moreover, we could incorporate two distinct ncAAs into the 
receptor, thus moving a crucial step toward the development of small intramolecular FRET sensors 
for in cell studies. Finally, by pairing our engineered tRNAM15 with the NES-PylRS, we obtained 
the most robust version of the Pyl system available to date to incorporate ncAAs even under sub-
optimal conditions. We anticipate that this system will find general application for ncAA 
incorporation into biologically relevant substrates in mammalian cells and facilitate employing 
ncAA tools to study molecular mechanisms of biological processes in the cellular context. 
2.6. Acknowledgment 
We thank Sonja Bonin for experimental support. 
2.7. References 
1. Lang, K. and Chin, J.W. Cellular incorporation of unnatural amino acids and bioorthogonal 
labeling of proteins. Chem. Rev., 114, 4764–4806 (2014). 
2. Wan, W., Tharp, J.M. and Liu, W.R. Pyrrolysyl-tRNA synthetase: an ordinary enzyme but an 
outstanding genetic code expansion tool. Biochim. Biophys. Acta, 1844, 1059–1070 (2014). 
3. Galli, G., Hofstetter, H. and Birnstiel, M.L. Two conserved sequence blocks within eukaryotic 
tRNA genes are major promoter elements. Nature, 294, 626–631 (1981). 
4. Wang, W.Y., Takimoto, J.K., Louie, G.V., Baiga, T.J., Noel, J.P., Lee, K.F., Slesinger, P.A. and 
Wang, L. Genetically encoding unnatural amino acids for cellular and neuronal studies. Nat. 
Neurosci., 10, 1063–1072 (2007). 
5. Mukai, T., Kobayashi, T., Hino, N., Yanagisawa, T., Sakamoto, K. and Yokoyama, S. Adding l-
lysine derivatives to the genetic code of mammalian cells with engineered pyrrolysyl-tRNA 
synthetases. Biochem. Biophys. Res. Commun., 371, 818–822 (2008). 
6. Drabkin, H.J., Park, H.J. and RajBhandary, U.L. Amber suppression in mammalian cells 
dependent upon expression of an Escherichia coli aminoacyl-tRNA synthetase gene. Mol. Cell. 
Biol., 16, 907–913 (1996). 
7. Xiong, Y. and Steitz, T.A. A story with a good ending: tRNA 3’-end maturation by CCA-adding 
enzymes. Curr. Opin. Struct. Biol., 16, 12–17 (2006). 
8. Betat, H., Rammelt, C. and Mörl, M. tRNA nucleotidyltransferases: ancient catalysts with an 
unusual mechanism of polymerization. Cell. Mol. Life Sci., 67, 1447–1463 (2010).  
9. Phizicky, E.M. and Alfonzo, J.D. Do all modifications benefit all tRNAs? FEBS Lett., 584, 265–
271 (2010). 
CHAPTER 2 2.7 References 
77 
 
10. Alberts, B., Johnson, A., Lewis, J., Morgan, D., Raff, M., Roberts, K. and Walter, P. Molecular 
Biology of the Cell. 6th edn. Garland Science, pp. 333–362 (2015). 
11. Nozawa, K., O’Donoghue, P., Gundllapalli, S., Araiso, Y., Ishitani, R., Umehara, T., Söll, D. and 
Nureki, O. Pyrrolysyl-tRNA synthetase-tRNA(Pyl) structure reveals the molecular basis of 
orthogonality. Nature, 457, 1163–1167 (2009). 
12. Watanabe, Y., Kawai, G., Yokogawa, T., Hayashi, N., Kumazawa, Y., Ueda, T., Nishikawa, K., 
Hirao, I., Miura, K. and Watanabe, K. Higher-order structure of bovine mitochondrial 
tRNA(SerUGA): chemical modification and computer modeling. Nucleic. Acids. Res., 22, 5378–
5384 (1994). 
13. Schmied, W.H., Elsasser, S.J., Uttamapinant, C. and Chin, J.W. Efficient multisite unnatural 
amino acid incorporation in mammalian cells via optimized pyrrolysyl tRNA synthetase/tRNA 
expression and engineered eRF1. J. Am. Chem. Soc., 136, 15577–15583 (2014). 
14. Chatterjee, A., Sun, S.B., Furman, J.L., Xiao, H. and Schultz, P.G. A versatile platform for 
single- and multiple-unnatural amino acid mutagenesis in Escherichia coli. Biochemistry, 52, 
1828–1837 (2013). 
15. Fan, C., Xiong, H., Reynolds, N.M. and Söll, D. Rationally evolving tRNAPyl for efficient 
incorporation of noncanonical amino acids. Nucleic. Acids. Res., 43, e156 (2015). 
16. Guo, J., Melancon, C.E. 3rd, Lee, H.S., Groff, D. and Schultz, P.G. Evolution of amber 
suppressor tRNAs for efficient bacterial production of proteins containing nonnatural amino 
acids. Angew. Chem. Int. Ed. Engl., 48, 9148–9151 (2009). 
17. Serfling, R. and Coin, I. Incorporation of unnatural amino acids into proteins expressed in 
mammalian cells. Methods Enzymol., 580, 89–107 (2016).  
18. Coin, I., Katritch, V., Sun, T., Xiang, Z., Siu, F.Y., Beyermann, M., Stevens, R.C. and Wang, L. 
Genetically encoded chemical probes in cells reveal the binding path of urocortin-I to CRF class 
B GPCR. Cell, 155, 1258–1269 (2013). 
19. Takimoto, J.K., Adams, K.L., Xiang, Z. and Wang, L. Improving orthogonal tRNA-synthetase 
recognition for efficient unnatural amino acid incorporation and application in mammalian 
cells. Mol Biosyst, 5, 931–934 (2009). 
20. Kohrer, C. and Rajbhandary, U.L. The many applications of acid urea polyacrylamide gel 
electrophoresis to studies of tRNAs and aminoacyl-tRNA synthetases. Methods, 44, 129–138. 
21. Mörl, M., Lizano, E., Willkomm, D.K. and Hartmann, R.K. (2008) Handbook of RNA 
Biochemistry. Wiley-VCH Verlag GmbH, pp. 22–35 (2008). 
22. Regulski, E.E. and Breaker, R.R. In-line probing analysis of riboswitches. Methods Mol. Biol., 
419, 53–67 (2008). 
23. Motorin, Y., Muller, S., Behm-Ansmant, I. and Branlant, C. Identification of modified residues 
in RNAs by reverse transcription-based methods. Methods Enzymol., 425, 21–53 (2007). 
24. Wintermeyer, W., Schleich, H.G. and Zachau, H.G. Incorporation of amines or hydrazines into 
tRNA replacing wybutine or dihydrouracil. Methods Enzymol., 59, 110–121 (1979). 
CHAPTER 2 2.7 References 
78 
 
25. Nikic, I., Kang, J.H., Girona, G.E., Aramburu, I.V. and Lemke, E.A. Labeling proteins on live 
mammalian cells using click chemistry. Nat. Protoc., 10, 780–791 (2015). 
26. Juhling, F., Mörl, M., Hartmann, R.K., Sprinzl, M., Stadler, P.F. and Putz, J. tRNAdb 2009: 
compilation of tRNA sequences and tRNA genes. Nucleic Acids Res., 37, D159–D162 (2009). 
27. Dirheimer, G., Keith, G., Dumas, P. and Westhof, E. In: Söll, D and Rajbhandary, RA (eds). 
tRNA: Structure, Biosynthesis, and Function. American Society for Microbiology Press, 
Washington DC, pp. 93–126 (1995). 
28. Sprinzl, M., Horn, C., Brown, M., Ioudovitch, A. and Steinberg, S. Compilation of tRNA 
sequences and sequences of tRNA genes. Nucleic Acids Res., 26, 148–153 (1998). 
29. Ambrogelly, A., Gundllapalli, S., Herring, S., Polycarpo, C., Frauer, C. and Söll, D. Pyrrolysine 
is not hardwired for cotranslational insertion at UAG codons. Proc. Natl. Acad. Sci. U.S.A., 104, 
3141–3146 (2007). 
30. Suzuki, T. and Nagao, A. Human mitochondrial tRNAs: biogenesis, function, structural aspects, 
and diseases. Annu. Rev. Genet., 45, 299–329 (2011). 
31. Christian, B.E. and Spremulli, L.L. Mechanism of protein biosynthesis in mammalian 
mitochondria. Biochim. Biophys. Acta, 1819, 1035–1054 (2012). 
32. Yanagisawa, T., Ishii, R., Fukunaga, R., Kobayashi, T., Sakamoto, K. and Yokoyama, S. 
Multistep engineering of pyrrolysyl-tRNA synthetase to genetically encode N(epsilon)-(o-
azidobenzyloxycarbonyl) lysine for site-specific protein modification. Chem. Biol., 15, 1187–
1197 (2008). 
33. Chatterjee, A., Xiao, H., Bollong, M., Ai, H.W. and Schultz, P.G. Efficient viral delivery system 
for unnatural amino acid mutagenesis in mammalian cells. Proc. Natl. Acad. Sci. U.S.A., 110, 
11803–11808 (2013). 
34. Guo, J., Melancon, C.E. 3rd, Lee, H.S., Groff, D. and Schultz, P.G. Evolution of amber 
suppressor tRNAs for efficient bacterial production of proteins containing nonnatural amino 
acids. Angew. Chem. Int. Ed. Engl., 48, 9148–9151 (2009). 
35. Plass, T., Milles, S., Koehler, C., Szymanski, J., Mueller, R., Wiessler, M., Schultz, C. and 
Lemke, E.A. Amino acids for Diels-Alder reactions in living cells. Angew. Chem. Int. Ed. Engl., 
51, 4166–4170 (2012). 
36. Lang, K., Davis, L., Torres-Kolbus, J., Chou, C., Deiters, A. and Chin, J.W. Genetically encoded 
norbornene directs site-specific cellular protein labelling via a rapid bioorthogonal reaction. 
Nat. Chem., 4, 298–304 (2012). 
37. Lang, K., Davis, L., Wallace, S., Mahesh, M., Cox, D.J., Blackman, M.L., Fox, J.M. and Chin, 
J.W. Genetic Encoding of bicyclononynes and trans-cyclooctenes for site-specific protein 
labeling in vitro and in live mammalian cells via rapid fluorogenic Diels-Alder reactions. J. Am. 
Chem. Soc., 134, 10317–10320 (2012). 
38. Nikic, I., Plass, T., Schraidt, O., Szymanski, J., Briggs, J.A., Schultz, C. and Lemke, E.A. 
Minimal tags for rapid dual-color live-cell labeling and super-resolution microscopy. Angew. 
Chem. Int. Ed. Engl., 53, 2245–2249 (2014). 
CHAPTER 2 2.7 References 
79 
 
39. Varshney, U., Lee, C.P. and RajBhandary, U.L. Direct analysis of aminoacylation levels of 
tRNAs in vivo. Application to studying recognition of Escherichia coli initiator tRNA mutants 
by glutaminyl-tRNA synthetase. J. Biol. Chem., 266, 24712–24718 (1991). 
40. Soukup, G.A. and Breaker, R.R. Relationship between internucleotide linkage geometry and 
the stability of RNA. RNA, 5, 1308–1325 (1999). 
41. Davis, D.R. and Poulter, C.D. 1H-15N NMR studies of Escherichia coli tRNA(Phe) from hisT 
mutants: a structural role for pseudouridine. Biochemistry, 30, 4223–4231 (1991). 
42. Charette, M. and Gray, M.W. Pseudouridine in RNA: what, where, how, and why. IUBMB Life, 
49, 341–351 (2000). 
43. Coin, I., Perrin, M.H., Vale, W.W. and Wang, L. (2011) Photo-Cross-Linkers Incorporated into 
G-Protein-Coupled Receptors in Mammalian Cells: A Ligand Comparison. Angew. Chem. Int. 
Ed. Engl., 50, 8077–8081. 
44. Odoi, K.A., Huang, Y., Rezenom, Y.H. and Liu, W.R. Nonsense and sense suppression abilities 
of original and derivative Methanosarcina mazei pyrrolysyl-tRNA synthetase-tRNA(Pyl) pairs 
in the Escherichia coli BL21(DE3) cell strain. PLoS One, 8, e57035 (2013). 
45. Xiao, H., Chatterjee, A., Choi, S.H., Bajjuri, K.M., Sinha, S.C. and Schultz, P.G. Genetic 
incorporation of multiple unnatural amino acids into proteins in mammalian cells. Angew. 
Chem. Int. Ed. Engl., 52, 14080–14083 (2013). 
46. Wan, W., Huang, Y., Wang, Z., Russell, W.K., Pai, P.J., Russell, D.H. and Liu, W.R. A facile 
system for genetic incorporation of two different noncanonical amino acids into one protein in 
Escherichia coli. Angew. Chem. Int. Ed. Engl., 49, 3211–3214 (2010). 
47. Niu, W., Schultz, P.G. and Guo, J. An expanded genetic code in mammalian cells with a 
functional quadruplet codon. ACS Chem. Biol., 8, 1640–1645 (2013). 
48. O’Donoghue, P., Prat, L., Heinemann, I.U., Ling, J., Odoi, K., Liu, W.R. and Söll, D. Near-
cognate suppression of amber, opal and quadruplet codons competes with aminoacyl-tRNAPyl 
for genetic code expansion. FEBS Lett., 586, 3931–3937 (2012). 
49. Nikic, I., Estrada Girona, G., Kang, J.H., Paci, G., Mikhaleva, S., Koehler, C., Shymanska, N.V., 
Ventura Santos, C., Spitz, D. and Lemke, E.A. Debugging eukaryotic genetic code expansion 
for site-specific click-PAINT super-resolution microscopy. Angew. Chem. Int. Ed. Engl., 55, 
16172–16176 (2016). 
50. Sakamoto, K., Hayashi, A., Sakamoto, A., Kiga, D., Nakayama, H., Soma, A., Kobayashi, T., 
Kitabatake, M., Takio, K., Saito, K. et al. Site-specific incorporation of an unnatural amino acid 
into proteins in mammalian cells. Nucleic Acids Res., 30, 4692–4699 (2002). 
51. Borrel, G., Gaci, N., Peyret, P., O’Toole, P.W., Gribaldo, S. and Brugere, J.F. Unique 
characteristics of the pyrrolysine system in the 7th order of methanogens: implications for the 
evolution of a genetic code expansion cassette. Archaea, 2014, 374146 (2014). 
52. Guan, Y., Haroon, M.F., Alam, I., Ferry, J.G. and Stingl, U. Single-cell genomics reveals 
pyrrolysine-encoding potential in members of uncultivated archaeal candidate division MSBL1. 
Environ. Microbiol Rep., 9, 404–410 (2017). 
CHAPTER 2 2.7 References 
80 
 
53. Kuhn, C.D., Wilusz, J.E., Zheng, Y., Beal, P.A. and Joshua-Tor, L. On-enzyme refolding permits 
small RNA and tRNA surveillance by the CCA-adding enzyme. Cell, 160, 644–658 (2015). 
54. Hopper, A.K. Transfer RNA post-transcriptional processing, turnover, and subcellular 
dynamics in the yeast Saccharomyces cerevisiae. Genetics, 194, 43–67 (2013). 
55. LaRiviere, F.J., Wolfson, A.D. and Uhlenbeck, O.C. Uniform binding of aminoacyl-tRNAs to 
elongation factor Tu by thermodynamic compensation. Science, 294, 165–168 (2001). 
56. Dale, T., Sanderson, L.E. and Uhlenbeck, O.C. The affinity of elongation factor Tu for an 
aminoacyl-tRNA is modulated by the esterified amino acid. Biochemistry, 43, 6159–6166 (2004). 
57. Tian, H., Furstenberg, A. and Huber, T. Labeling and single-molecule methods to monitor G 
protein-coupled receptor dynamics. Chem. Rev., 117, 186–245 (2017). 
  
CHAPTER 2 2.8 Supplementary Material 
81 
 
2.8. Supplementary Material 
2.8.1. Supplementary Tables 
Table S2.1: Coding-strand sequences of all tRNAs used in this study. Sequences of reference tRNAs are written in 
bold. Nucleotides that differ from reference are marked either in green for M. mazei and D. hafniense tRNAPyl variants or 
in yellow for B. taurus mt-tRNASer chimeric tRNAs. ▼Chimera 1 and Chimera 2 have been described in the literature 1. 
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Table S2.2: Suppression efficiency and orthogonality of tRNA variants paired with MbPylRSF, determined via 
the fluorescence assay in the presence and absence of Lys(Boc). Orthogonal tRNAs are not recognized by endogenous 
synthetases and should give no amber suppression (i.e. no fluorescence) when no ncAA is present. ▼data acquired using the 
codon optimized MbPylRSF. 
tRNA Relative fluorescence intensity in % [to wild type EGFP] 
(1x copy) + ncAA SD n - ncAA SD n 
non transfected HEK293 0.06 0.04 4 0.07 0.00 2 
tRNAPyl* 9.04 0.77 5 0.06 0.00 2 
M1 3.97 0.48 3 0.07 0.01 2 
M2 3.73 0.41 3 0.06 0.01 2 
M3 1.87 0.32 3 0.03 0.04 2 
M4 0.90 0.32 3 0.02 0.04 2 
M5 9.10 1.16 3 0.04 0.02 2 
M6 11.20 0.93 3 0.03 0.03 2 
M7 6.73 0.52 3 0.04 0.03 2 
M8 12.97 1.08 3 0.04 0.02 2 
M9 12.50 0.67 3 0.05 0.03 2 
M10 2.13 1.08 3 0.05 0.02 2 
M11 15.10 2.13 4 0.04 0.02 2 
M12▼ 17.10 2.62 4 0.05 0.01 2 
M13▼ 18.76 2.88 4 0.06 0.01 2 
M14▼ 15.52 1.66 4 0.06 0.01 2 
M15▼ 19.26 1.53 4 0.03 0.04 2 
M16▼ 13.58 2.05 3 0.32 0.01 2 
M17▼ 16.28 2.37 3 0.23 0.00 2 
M18▼ 15.82 1.70 4 0.21 0.03 2 
M19▼ 19.44 2.13 4 0.15 0.00 2 
M20▼ 21.50 2.29 4 0.09 0.00 2 
M21▼ 17.18 2.77 3 0.31 0.05 2 
C1 10.60 2.35 3 0.05 0.01 2 
C2 1.50 1.10 3 0.04 0.02 2 
C3 0.73 0.38 3 0.04 0.02 2 
C4 7.07 2.27 3 0.04 0.02 2 
C5 4.50 2.76 3 0.06 0.03 2 
C6 12.47 2.03 3 0.07 0.03 2 
C7 11.73 3.11 3 0.04 0.02 2 
C8 0.40 0.20 3 0.04 0.02 2 
C9 0.67 0.33 3 0.04 0.02 2 
C10 2.57 0.32 3 0.03 0.02 2 
C11 25.35 4.15 2 0.03 0.02 2 
C12▼ 24.83 3.22 3 0.04 0.02 2 
C13▼ 18.16 2.41 4 0.03 0.03 2 
C14▼ 20.69 3.08 4 0.04 0.03 2 
C15▼ 30.57 2.74 4 0.04 0.02 2 
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Table S2.3: Aminoacylation of tRNAPyl*, tRNAM15 and tRNAC15 with Lys(Boc) and Lys(Z). Data were obtained from 
densitometric analysis of Northern Blots and represent the percentage of AA-tRNA compared to total tRNA present in the 
sample, as follows: 
Aminoacylation rate in % =
amount of AA-tRNA
amount of AA-tRNA + amount of tRNA
∗ 100% 
 Lys(Boc) Lys(Z) 
 Aminoacylation rate ± SD n Aminoacylation rate ± SD n 
tRNAPyl* (1x) 50.1 5.8 3 49.8 3.4 3 
tRNAPyl* (4x) 44.4 1.9 3 47.2 1.5 3 
M15 (1x) 45.8 4.5 3 46.7 3.1 3 
M15 (4x) 44.8 6.4 3 45.8 4.9 3 
C15 (1x) 46.3 5.3 3 50.6 6.7 3 
C15 (4x) 47.7 4.3 3 51.6 5.0 3 
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2.8.2. Supplementary Figures 
 
Figure S2.1: Plasmids used in this study. A) pNEU. The backbone of pNEU is essentially the same as pcDNA3.1 with 
some variations in the restriction sites. Most important, SalI and XbaI restriction sites were introduced upstream the CMV 
promoter and removed from other regions of the vector. B) Reporter plasmid for the fluorescence assay. EGFP was cloned 
into the multi cloning site of pcDNA3.0 between EcoRI and XhoI sites. Amber (TAG), opal (TGA) and ochre (TAA) stop codon 
were introduced at the permissive site Y183. mCherry replaces the original neomycin resistance gene of pcDNA3.0 between 
XmaI and BstBI sites. C) pIRE4. The backbone of pIRE4 is based on pEGFP-N1 (Clontech, Mountain View, CA), with major 
modifications. The CMV-EGFP sequence of pEGFP-N1 was substituted for the AARS cassette, followed by four copies of the 
tRNA cassette right downstream the polyadenylation sequence, similar to pShax 2. The tRNA gene is under control of the 
U6 promoter 3. D) pUC19. In vitro tRNA transcription cassettes were cloned into a pUC19 vector between EcoRI and PstI 
restriction sites. To produce tRNA standards for Northern Blot analysis, the tRNA gene was 3’-flanked by a self-cleaving 
hepatitis delta virus (HDV) ribozyme to guarantee homogeneity of the 3’-end 4. To produce tRNA samples for structural 
probing, an additional hammerhead (HH) ribozyme was added at the 5'-site, which obviates the need for dephosphorylating 
the 5'-end prior to radiolabeling 4. HDV-cleavage leaves a 2',3'-cyclic phosphate product at the 3’, so that tRNAs need to be 
3’-dephosphorylated. Both constructs were driven by a T7 promoter. 
 
Figure S2.2: Comparing amber-suppression efficiency of tRNAPyl from M. mazei and D. hafniense. A) Cloverleaf 
structures of wild type MmtRNAPyl and DhtRNAPyl. Nucleotides that do not form Watson-Crick base-pairs are highlighted 
in red. B) Amber codon suppression in EGFP183TAG by different tRNAPyl variants (1x copy) combined with MbPylRSF for 
incorporation of Lys(Boc). Data represent the average ± SD of biological triplicates. DhtRNAPyl* indicates the GC stabilized 
variant of the DhtRNAPyl (U40C, U65C, U68C). Note that the U29aC mutation is more efficient that the G41bA mutation 
to stabilize the MmtRNAPyl. 




Figure S2.3: Densitometry analysis of tRNA amounts on Northern Blots. Bars represent intensity of bands relative 
to the corresponding in vitro transcripts (average ± SD of biological triplicates). Experiments were performed in the presence 
and absence of either A) Lys(Boc) or B) Lys(Z). Total tRNA per sample is given as sum of the amount of non-acylated tRNA 
plus the amount of AA-tRNA. 
 
Figure S2.4: Migration of tRNAPyl variants in PAGE analysis. Samples were resolved on 10.0% urea-PAA gels under 
semi-denaturing conditions (top) and denaturing conditions (bottom). Hybridization with biotin-labeled tRNAPyl*/tRNAM15 
and tRNAC15 probes together with 100x excess of unlabeled unfolder-primers. For each in vitro (iv) tRNA a total of 25 ng 
was loaded. Ribosomal 5.8S RNA was used as loading control. # indicates RNA probes extracted from non-transfected cells. 




Figure S2.5: In-line structure probing of different tRNA variants. A) Secondary structure model and B) in-line 
structure probing of tRNAPyl*, M15 and C15. RNA differentially degrades according to its secondary structure upon 
incubation in a mildly alkaline buffer (probing buffer, pH 8.5) 5. When the 2' oxygen of the ribose, the phosphorus, and the 
adjacent 5' oxygen enter an “in-line” conformation, the 2' oxygen acts as a nucleophile and displaces the 5’ oxygen in the 
neighboring phosphorus center, which cleaves the RNA linkage. Single-stranded RNA regions are highly susceptible to 
spontaneous cleavage while structured regions of folded RNA (e.g. base paired helical regions) have a reduced cleavage 
chance 6. B) Lane 1 (NR, no-reaction): radio-labeled 5’-32P-tRNA incubated in water; lane 2 (R, reaction): radio-labeled 5’-
32P-tRNA incubated with in-line probing buffer for 40 h; lane 3 (-OH): sequencing ladder from alkali treatment; lane 4 (T1): 
sample digested with RNase T1. Black arrows indicate guanine positions and clamps indicate cleavage regions within the 
RNA. Corresponding regions are highlighted in blue in the secondary structure model. All tRNAs gave similar cleavage 
patterns at the four single stranded loop regions (D-loop, anticodon-loop, variable-loop and TΨC-loop) and at N8-N9 linking 
the acceptor-stem and D-stem. The T-loop of all tRNAs displayed reduced cleavage, most likely due to reduced flexibility of 
the structurally conserved T-loop motif, which is stabilized by a reverse Hoogsteen base-pair between U54 and A58, a base-
stack between a pyrimidine at position U55 and U54, and additional hydrogen bonds with a D-loop guanosine, which in 
turn is inserted between A58 and G57 forming a three-nucleotide continuous base-stack 7.  




Figure S2.6: Detection of post-transcriptional modifications. A) Each panel represents reverse transcription (RT) 
profiles of the indicated tRNA. Extension reactions were performed using 32P-labeled primers and RT-products were resolved 
on 15% denaturing urea-PAA gels. Lanes 1-4: sequencing ladder indicating A, C, G and U positions; Lane 5: in vitro (iv) 
transcript; Lanes 6-8: RNA sample extracted from HEK293 cells expressing the desired tRNA; Lane 6 (+): no pre-treatment; 
Lane 7 (C): pre-treatment with Na2CO3 solution; Lane 8 (Ψ): pre-treatment with CMCT followed by Na2CO3 solution. The 
method relies on the occurrence of RT-pauses during a primer extension reaction on a tRNA template 8. RT-pauses occur at 
modified nucleotides due to impaired Watson-Crick pairing with dNTPs during the elongation reaction, which yield cDNA 
segments truncated one base before the mutated position. To enhance this effect, tRNA samples are treated with selective 
chemical reagents targeting a given type of modified nucleotide before the RT-reaction. However, RT-pauses can happen 
also because of unpredictable effects of the RNA primary and secondary structure 8. In general, the RT-profile of any tRNA 
shows a ladder of DNA products interrupted at different sites. To distinguish RT-pauses caused by the intrinsic structure 
of the tRNA from pauses caused by post-transcriptional modifications, RT-profiles of tRNAs produced in vivo are compared 
to profiles of the corresponding non-modified in vitro transcripts. To detect pseudouridine (Ψ) via RT, the tRNA is pre-
treated with CMCT, which reacts with G, U and Ψ residues and forms bulky G-CMC, U-CMC and Ψ-CMC adducts. Then, 
G-CMC and U-CMC sites are hydrolyzed back to G and U, respectively, upon extended incubation at alkaline pH, which 
does not affect the more stable Ψ-CMC adduct. RT of this sample gives truncated products caused both by tRNA hydrolysis 
during the alkaline treatment and RT-pauses at Ψ-CMC sites. At pseudouridine sites, samples treated with CMCT and 
Na2CO3 (lane 8, Ψ) will give a stronger band in respect to samples treated only with Na2CO3 (lane 7, C). B) Densitometric 
analysis of radioactive bands generated by RT-pauses. Signals acquired for samples pre-treated with CMCT followed by 
Na2CO3 (lane 8, Ψ) were compared to signals obtained for the control sample treated only with Na2CO3 solution (lane 7, C). 
The graph illustrates the average ± SD of the ratios between the band intensity of pseudouridine induced RT-stops divided 
by the band intensity of corresponding RT-stops observed in the alkaline treated control. At least four biological replicates 
were performed for each tRNA. T-tests were performed to check whether ratios are significantly larger than 1 and to 
estimate differences between tRNAPyl* and M15.  




Figure S2.7: Comparing the expression of full-length CRF1R95TCO*K-EGFP mediated by either tRNAPyl* or M15. 
A) Detection of EGFP (green) with a 20x objective, using automatic exposure time. Scale bar: 50 μm. B) Detection of EGFP 
(green) with a 63x objective. Scale bar: 20 μm. All pictures in the green channel were taken using an identical exposure time 
of 220 ms. Panel 1 and 2 represent the same picture, but the signal intensity in panel 2 was amplified using Zen 2 lite (Zeiss) 
software. A-B) Hoechst 33342 staining (blue) of all samples was performed directly prior to microscopy. 




Figure S2.8: Comparing amber-suppression efficiency of MbPylRS and NES-MbPylRS variants. Incorporation of 
Lys(Boc) is mediated by either MbPylRSF or NES-MbPylRSF paired with one or four copies of tRNA expression cassettes, 
while charging tRNAPyl with Lys(Z) and TCO*K is performed by MbPylRSAF or NES-MbPylRSAF. Data represent the average 
± SD of biological triplicates. 
  
CHAPTER 2 2.8 Supplementary Material 
90 
 
2.8.3. Sequences of humanized genes 






















Codon optimized MbPylRSF added of NES: 
The sequence of the nuclear export signal (lowercase letters) was appended to the N-terminal of 
codon optimized MbPylRS (excerpt written in capital letters): 
atggcctgccccgtgcccctgcagctgccacccctggagcgcctgaccctggacATGGACAAGAAACCCCTGGACGTGCTG
ATC… 
tRNA expression cassette (Example: tRNAPyl*): 
Restriction sites are underlined. The U6 promoter sequence is written in capital letters. The 
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Improving the tRNALeuCUA for amber suppression in mammalian cells 
2.9.1. Introduction 
The site-specific introduction of small fluorescent ncAAs into proteins is a powerful tool to gain 
information about their localization and molecular interactions, as well as to monitor their 
structural features in a dynamic environment. While large organic fluorophores exceed the size 
tolerance of the ribosome, ncAAs bearing small fluorescent probes on their side chain have been 
genetically encoded. Different variants of the E. coli LeuRS were engineered that allow for 
incorporation of fluorescent and photo-caged ncAAs in yeast and mammalian cells when combined 
with an amber suppressor variant of E. coli leucine isoacceptor tRNA5 (Ec-Lam5) 1–5. Fluorescent 
ncAAs like 2-amino-3-(5-(dimethylamino)-naphthalene-1-sulfonamide)propanoic acid (Dansyl-
alanine) and 3-(6-acetylnaphthalen-2-ylamino)-2-aminopropanoic acid (Anap) feature a small size, 
large Stokes shifts and high sensitivity of their emission wavelength and quantum yield to 
environmental effects 3. These characteristics are useful for studying local changes in structure or 
polarity with high precision and minimal perturbation of the target protein’s structure. Hence the 
leucine system was used for various studies including visualization of subcellular-localization 1 or 
induced conformational changes of soluble and membrane bound proteins 2,4,6,7. 
Leucine tRNAs have more than five nucleotides in the variable loop and therefore belong to type II 
of tRNAs 8. These additional nucleotides form an extra stem-loop structure in the variable region 
(Figure A2.1) and affect the overall tertiary fold of the tRNALeu. In order to maintain the high degree 
of amino acid specificity, which is essential for correct protein synthesis, aminoacyl-tRNA 
synthetases have evolved recognition systems with positive elements that facilitate recognition of 
the cognate tRNA and negative elements that prevent interactions with non-cognate synthetases 9. 
While subtle differences among tRNA folds have minimal effects on the interaction between the 
tRNA and the components of the translational machinery, they were shown to be important for 
specificity of a class II tRNA towards its cognate aminoacyl-tRNA synthetase 10,11. E.g. Crystal 
structure of class II tRNASer from T. thermophilius showed that SerRS specifically interacts with 
this additional stem-loop 12. For E. coli tRNALeu, it was shown that the tertiary interaction between 
the D- and T-loops greatly affect binding to LeuRS as well as the synthetases ability to correct mis-
acylation. Important identity elements of tRNALeu towards LeuRS include the discriminator base 
A73, the invariant A14, the Levitt base-pair A15:U48, the configuration of the D-loop with four 
nucleotides preceding and 3 nucleotides following the conserved G18 and G19 dinucleotide motif 
(α4/β3-configuration), and an unpaired N47 in the 3’-region of the extra stem-loop 11,13. 
Interestingly, it was shown that the extra stem-loop of tRNALeu is not essential for aminoacylation 
specificity and that truncation or exchange with a consensus type I variable loop has little to no 
effect on aminoacylation efficiency 13,14. 
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An engineered amber suppressor variant of the E. coli leucine tRNALeuUAA forms the tRNA part of 
the leucine orthogonal system for incorporation of ncAAs in eukaryotes (Figure A2.1). Unlike most 
aminoacyl-tRNA synthetases, LeuRS does not rely on recognition of the anticodon to retain its 
amino acid fidelity 15. However, mutational studies revealed that LeuRS is highly depends on a 
conserved A35 in the anticodon for efficient aminoacylation. Despite the natural occurrence of 
tRNALeu amber suppressors, replacement of the anticodon to CUA will result in an 11-fold decrease 
in aminoacylation efficiency 11. In addition, to express the tRNALeu gene in mammalian cells, 
external promoters have to be used because the tRNALeu lacks the intragenic A-box promoter 
consensus 16. In our experience with different systems for ncAA incorporation in mammalian cells, 
we have observed that the efficiency of the leucyl system is generally inferior to that of the tyrosyl 
system. Inspired by the positive results obtained with the pyrrolysine system, as described in 
Chapter 2, we attempted to improve the efficiency of the Ec-LeuRS/tRNA pair by manipulating the 
tRNA. We describe below our attempts to generate a better tRNA to pair to LeuRS. 
 
Figure A2.1: Cloverleaf and L-shape structures of suppressor tRNALeuCUA (Ec-Lam5) based on E. coli tRNALEUUAA. 
Positions highlighted in grey were subject to mutation in this study. Dashed lines present tertiary interactions inferred 
from the leucine isoacceptor tRNA designated to the CUC codon 10. A black dot indicates a G:U pair. 
2.9.2. Results and discussion 
The specificity of E. coli tRNALeu towards its cognate LeuRS is highly dependent on the delicate 
network of tertiary interactions between nucleotides of the tRNA’s elbow region as well as the 
orientation of the variable stem-loop, thereby limiting the number of mutation sites. Hence, we 
introduced mutations that aimed at stabilizing the overall tRNA structure or possibly increase the 
tRNA compatibility in the eukaryotic translational context. To exclude low expression of the LeuRS 
as a limiting factor of the system, we optimized the codon usage of the gene encoding E. coli LeuRS 
for a mammalian context. Further, we intentionally used wild type LeuRS, instead of an engineered 
variant for ncAA incorporation to guarantee optimal interaction of the aminoacylated leucyl-
tRNALeu with the translational machinery, while screening for efficiency of the tRNA mutants. 
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At first, we stabilized the tRNA by exchanging the wobble G:U pair between position 1 and 72 for 
either a G1:C72 or an A1:U72 pair. Both stabilized variants incorporated leucine in response to an 
amber codon with a 2.6-fold increase in suppression efficiency compared to wild type Ec-Lam5 
(Figure A2.2). Because the G1:C72 pair is also featured in other E. coli leucine tRNA, this stabilized 
variant was selected as starting point for the design of more tRNA mutants. 
Single site or base-pair mutations were introduced (summarized in Table A2.1) into the 
Ec-Lam5-U72C. We exchanged the C17 for a G in Mutants 1, because an additional G preceding 
the almost universally conserved G18-G19 motif helped increase efficiency of the pyrrolysine 
system (as described in chapter 2). The second mutant featured an A21, which is conserved in the 
consensus of human tRNAs. Mutants 3-7 were designed to test the influence of changes in the 
tRNAs core structure on in vivo suppression efficiency. Mutants 3-5 featured nucleotides for 
potential base pairing (G:C, C:G or A:U) between the terminal nucleotides of the D-loop at position 
13 and 22 in order to strengthen secondary folding by formation of a typical 4 base-pair long D-
stem. Mutants 6 and 7 had single nucleotide changes in the linker between D-arm and acceptor-
arm or at the beginning of the variable extra arm. Finally, the G59 was changed to C in Mutant 8. 
This position located in the elbow region of the tRNA should not interfere with the consensus of 
internal promoter sequences (B-box: GGTTCGANTCC) present in the T-arm of most tRNAs and it 
was previously shown to enhance the efficiency of aminoacylation of tRNALeu transcripts by LeuRS 
in vitro 10. 
Table A2.1: Coding-strand sequences of suppressor tRNALeu variants. Sequence of reference Ec-lam5 tRNA is written 
in bold. Nucleotides that differ from reference are highlighted in red. 
 
The fluorescence screening revealed that Mutant 1 is the only suppressor tRNALeu that was able to 
outperform the G:C or A:U stabilized Ec-Lam5 variants (Figure A2.2). Overall, Mutant 1 yields a 
3.6-fold improvement compared to wild type Ec-Lam5. Similar positive effects were observed for 
the corresponding mutation in the previously improved tRNAPyl. These findings suggest that a G17 
in the D-loop may improve the biocompatibility in eukaryotic hosts in general. However, previous 
works demonstrated that the L-shape interaction between G18:Ψ55 and G19:C56 tertiary base-
pairs is an important identity element towards LeuRS and especially the α4/β3 conformation of the 
D-loop was shown to be essential for discrimination of tRNALeu from E. coli SerRS 11,14. Since the 
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G17 present in Mutant 1 could in theory guide formation of an alternative L-shape conformation, 
further study regarding the identity of the amino acid loaded onto this tRNA variant is advisable. 
Both mutations C17G and G59C featured in Mutant 1 and Mutant 8, respectively, were 
investigated before through in vitro transcribed leucine tRNAs 10. Kinetic analysis of these variants 
revealed that they are better substrates for LeuRS in vitro. Together, LeuRS binds them with 
increased affinity and exhibits an increased aminoacylation activity towards these two tRNA 
variants. Interestingly, while Mutant 1 (C17G) allows for the most efficient in vivo suppression in 
mammalian cells, Mutant 8 (G59C) was less competent than the Ec-Lam5 U72C reference. These 
findings suggest that in vivo efficiency of an orthogonal system is not only a matter of 
aminoacylation capability. The mutation of G21 to an A, which is conserved in the consensus of 
human tRNAs, also caused decrease in protein yields from amber suppression. Further, allowing 
the terminal nucleotides of the D-loop to base-pair led to a significant decrease of tRNA efficiency 
(Mutants 3-5). This is very likely the result of disturbances in the delicate tertiary folding due to 
changes in distance between the D-loop and T-loop nucleotides in the L-shape structure. Similar 
negative effects, but less severe than for Mutants 3-5, were observed for Mutants 6 and 7, which 
allow for Watson-Crick base-pairing between position 26 and 44 in the three-dimensional tRNA 
fold. Interestingly, several Leucine isoacceptors feature a G:U pair at these positions. Since the 
observed reduction in suppression efficiency was less striking than for the D-stem variants, this 
could be the result of partial interference with tertiary folding due to the orientation of the Watson-
Crick base pair on top of the anticodon stem and its effect on positioning the variable arm. This 
hypothesis should be further investigated via structural analysis, e.g. in-line probing, in the future. 
 
Figure A2.2: Evaluation of leucine suppressor tRNA variants. Amber codon suppression in EGFPY183TAG by E. coli 
Lam5 and engineered tRNA variants. Bars represent the fluorescence of the probe relative to the fluorescence intensity of 
wild type EGFP expression. All values were normalized to mCherry fluorescence. The dotted line represents the value of 
the G-C stabilized Ec-Lam5-U72C tRNA. The data represent the average ± SEM of biological triplicates. Samples marked 
with * (P<0.05) or *** (P<0.001) are significantly different from the Ec-Lam5 reference, verified by one-way ANOVA with 
Dunnett’s test. 




In summary, by rationally designing and screening a small set of only ten different Ec-Lam5 
variants, we were able to improve the incorporation efficiency of ncAAs by the leucine orthogonal 
system in mammalian cells more than 3-fold. The findings presented here, together with the data 
for the pyrrolysine system, demonstrate that rational design of novel suppressor tRNAs is a very 
useful approach for optimization of an orthogonal system for a group of host organisms. The most 
efficient tRNA variant (Mutant 1) offers a reasonable foundation for further improvements of the 
system. For instance, the use of multiple tRNA cassettes was shown to improve overall performance 
of the leucine system previously 2.  
In addition to the general improvement of the leucyl system, the novel tRNA presented here could 
be highly beneficial, especially for the incorporation of fluorescent amino acids. These ncAAs often 
have to be applied at high intracellular concentrations to guarantee their efficient incorporation, 
which in turn requires intensive washing steps before imaging to remove the free amino acid 
present in the cytosol 17. An improved leucine system employing our novel tRNA could give good 
ncAA incorporation at lower ncAA concentration, thus reducing the background and allow in vivo 
studies of less abundant proteins. 
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High-end microscopy studies of G protein-coupled receptors (GPCRs) require installing onto the 
receptors bright and photostable dyes. Labeling must occur in quantitative yields, to allow 
stoichiometric data analysis, and in a minimally invasive fashion, to avoid perturbing GPCR 
function. We demonstrate here that the genetic incorporation of trans-cyclooct-2-ene lysine (TCO*) 
allows achieving on the surface of live cells quantitative single-residue labeling of the extracellular 
loops of the β2-adrenergic and the muscarinic M2 class A GPCRs, as well as of the corticotropin 
releasing factor class B GPCR, by reaction with dye-tetrazine conjugates. We show that labeled 
receptors are functional. To precisely quantify the labeling yields, we devise a method based on 
fluorescence fluctuation microscopy that extracts the number of labeling sites at the single-cell 
level. We demonstrate that a receptor labeled on a single residue diffuses faster than the same 
GPCR fused to EGFP, which is likely more representative of a physiological condition. Finally, by 
performing dual-color competitive labeling on a single TCO* site, we devise a method to estimate 
the oligomerization state of a GPCR without the need of a biological monomeric reference, which 
facilitates the application of fluorescence methods to oligomerization studies. As TCO* and the dye-
tetrazines used in this study are commercially available, and the described microscopy techniques 
can be performed on a commercial microscope, we expect our approach to be widely applicable to 
fluorescence microscopy studies of membrane proteins in general. 
3.2. Introduction 
G protein-coupled receptors (GPCRs) are the largest family of receptors on the eukaryotic cell 
membrane. They participate in the regulation of almost all pathophysiological processes and form 
the most important class of drug targets. Fluorescence microscopy is a powerful technique to 
investigate signaling dynamics and GPCR trafficking directly in intact cells. Modern high-end 
microscopy techniques are best applied to bright and photostable organic fluorophores, which 
feature a superior performance compared to classic fluorescent proteins. Such probes are commonly 
installed onto the GPCR post-translationally, by applying suitable fluorophore substrates on fused 
self-labeling enzymes (e.g. SNAP, CLIP and Halo), as well as on shorter peptide tags amenable of 
either chemical or enzymatic labeling (e.g. the tetracysteine and the ACP tags), all thoroughly 
reviewed in Tian et al 1. Although such tags have been successfully implemented to study aspects 
of GPCR oligomerization 2–4, GPCR activation 5-8 and GPCR-G protein interactions 9 in live cells, 
they are considerably large (e.g. SNAP, 20kDa; ACP17, 2 kDa) and can compromise the function of 
the GPCR when inserted at internal positions like the loops 5. Moreover, bulky tags are not suitable 
to build sensitive sensor for monitoring small changes in the GPCR conformation, which are at the 
base of the complexity of GPCR signaling.  
Organic fluorophores can be installed in a minimally invasive fashion onto a GPCR by genetically 
incorporating a non-canonical amino acid (ncAA) bearing an anchor for bioorthogonal chemistry, 
which is selectively modified by a suitable fluorophore-substrate in a second step 10–12. GPCR 
labeling on ncAA anchors has been first achieved on genetically incorporated p-azido-Phe in vitro 1. 
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However, the slow rates of catalyst-free reactions on azides (several hours to days) are not 
compatible with live-cell experiments 12. Recent ncAAs for bioorthogonal chemistry bear strained 
alkene of alkyne anchors for strain-promoted-inverse-electron demand Diels-Alder cycloaddition 
(SPIEDAC) with tetrazines, which proceeds rapidly within a few minutes 12–17. The reaction has 
been first demonstrated in live cells on the insulin 14,18,19 and the epidermal grow factor 
receptor 15,16. We and others have demonstrated proof of principle SPIEDAC labeling of GPCRs 
(GLP-1, glucagon and CRF Class B GPCRs), with measured labeling yields up to 70% 20,21. 
The labeling yield is a crucial aspect of all labeling techniques. A high to quantitative yield is 
necessary for applications requiring stoichiometric analysis, such as single molecule tracking and 
oligomerization studies, which would be biased by the presence of dark receptors 22. The efficiency 
of labeling is not trivial to quantify. In some cases, labeling of SNAP or tetracysteine tags is 
assumed to be complete when the fluorescence observed upon labeling with increasing 
concentrations of dyes reaches a plateau 2,5. In other cases, the fluorescence signal of the label is 
compared to the signal obtained with the same fluorophore via immunostaining 23, or normalized 
to the number of receptors estimated by using radio-ligands 3. Labeling of SNAP is sometimes taken 
as reference for 100% labeling to evaluate labeling efficiency of other labeling methods 20. 
However, in most cases these measurements are extracted from population averages, based on 
whole cell readouts without any selectivity for the plasma membrane. Furthermore, fluorescence 
intensity alone is not a direct nor reliable indicator of the number of molecules: quenching, 
bleaching and fluctuations of the optical focus are the most prominent factors affecting such an 
estimate 24. More advanced approaches are needed to reliably ‘count’ molecules in a fluorescence 
microscope. Thanks to the use of fluorescence correlation spectroscopy (FCS) 25 and the broad 
family of derived techniques, fluorescence fluctuation spectroscopy (FFS) allows precisely 
estimating the concentration of even a few (sub nM) fluorescent molecules using a commercial 
confocal microscope. By analyzing the fluctuations of the fluorescent signal in a single pixel of a 
confocal image over time, image-based FFS methods allow determining the average number of 
fluorescent entities diffusing in and out of the pixel and quantifying their brightness 26–28. In 
particular, fluorescence spectroscopy tools based on the so-called molecular brightness, both in time 
(i.e. temporal brightness, TB) and in space (i.e. spatial intensity distribution analysis, SpIDA), have 
been extensively employed in the membrane receptors field 26, and specifically in the GPCR 
community 29,30. 
Here, by using trans-cyclooct-2-ene lysine (TCO*) 18 ncAA and tetrazine reagents, we demonstrate 
that single-residue SPIEDAC labeling is generally applicable to both Class A and Class B GPCRs. 
By developing a novel accurate quantification method of the labeling efficiency based on molecular 
brightness measurements, we demonstrate that yields of TCO* labeling are up to quantitative. 
Furthermore, we show that a GPCR labeled on a single residue diffuses in the cell membrane faster 
than a receptor C-terminally tagged with a fluorescent protein. Finally, by performing competitive 
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TCO* labeling with two distinct fluorophores, we devise a novel method to evaluate the 
oligomerization state of a GPCR that does not need a monomeric protein reference. 
3.3. Results 
3.3.1. Incorporation of TCO* into Class A and Class B GPCRs 
We selected two prototypical class A GPCRs, the 2-adrenergic and the muscarinic M2 receptor (2-
AR, M2R), and a class B GPCR, the corticotropin releasing factor receptor type 1 (CRF1R). The 
receptors were fused to a HA epitope at the N-terminus and to EGFP at the C-terminus. We first 
aimed at identifying a pool of positions in each GPCR that would give good rates of ncAA 
incorporation and labeling. Based on existing crystal structures, we choose solvent exposed 
positions both in the extracellular (ECLs) and intracellular loops (ICLs), as detailed in 
Supplementary Figures S3.1, S3.2 and S3.3. TCO* was incorporated at the designated sites in 
response to the amber stop codon using the Y271A, Y349F double mutant of the pyrrolysine tRNA 
synthetase (MbPylRSAF) paired to our enhanced tRNAM15, which guarantees the best performance 
of the ncAA incorporation system 21 (Figure 3.1A).  
All GPCR variants were expressed in 293T cells and cell-surface expression was determined using 
a whole-cell ELISA detecting the N-terminal HA epitope 31 (Figure 3.1B). The incorporation rates 
of TCO* differed between the three receptors and were position dependent. TCO* was incorporated 
with the highest efficiency into the M2R, with TCO*-M2R mutants featuring in average 75% the 
expression level of the wild type (wt) receptor. TCO* was well incorporated also into the CRF1R. 
Amounts of TCO*-CRF1R variants averaged about 50% the amount of the wt-CRF1R, with a few 
exceptions toward the CRF1R C-terminus (e.g. 299TCO*-CRF1R). Instead, the levels of TCO*-2-
AR mutants at the cell-surface were less than 5% compared to wt, and averaged about 60% of the 
wt-2-AR level obtained by transfecting one-tenth of the DNA amount used for the mutants. These 
results, together with the variable incorporation rates of ncAA into GPCRs reported in the 
literature, suggest that some GPCRs are better amenable to ncAA mutagenesis than others 20,31–35. 
In parallel, all TCO*-GPCR variants were expressed in HEK293AD cells and treated with either 
cyanine-based membrane-impermeable dyes (Cy3-tetrazine, Cy5-tetrazine) or rhodamine-based 
membrane-permeable dyes (SiR-tetrazine or TAMRA-tetrazine), in order to label extracellular or 
intracellular positions, respectively. Labeled cells were inspected by wide-field fluorescence 
microscopy both in the green and red/far-red channels to separately visualize EGFP and the label. 
The surface expression of the GPCRs inferred from the EGFP fluorescence was in line with the 
ELISA results. As expected, none of the wild type receptors underwent visible labeling 
(Figure 3.1C-E, upper panels). Neat membrane labeling was observed, albeit with different 
intensities, for all M2R and CRF1R mutants bearing TCO* in the ECLs, whereas only a few 
positions of the 2-AR showed clear labeling (Figure 3.1C-E, middle panels and Supplementary 
Figures S3.1B, S3.2B and S3.3B). On the other hand, epifluorescence imaging of intracellular 
labeling was biased by a high fluorescence background in the cytosol and was clearly visible only 
in a few cases (Supplementary Figures S3.1C, S3.2C and S3.3C). The labeling efficiency of each 
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mutant was qualitatively estimated either as “good”, or “fair” or “poor” (Supplementary Table S3.1). 
In general, we did not observe a correlation between the expression level and the labeling efficiency 
of the single TCO*-mutants. For instance, 186TCO*-2-AR was well expressed but appeared to be 
poorly labeled. 
 
Figure 3.1: Bioorthogonal labeling of TCO*-GPCR-EGFP variants. A) Schematic representation of the ncAA 
incorporation and labeling protocol. B) Surface-ELISA of 293T cells expressing β2-AR, M2R and CRF1R variants containing 
TCO* at the position indicated under each bar. Data represent the mean ± SD of biological triplicates. Wild type receptor 
constructs were transfected using either the same DNA amounts as the mutants (M2R and CRF1R) or 1/10 of it (β2-AR). 
C-E) Wide-field images of HEK293AD cells. The top and middle panels show wild-type and TCO*-GPCR variants after 
SPIEDAC-labeling with Cy3-tetrazine. The bottom panel shows the same samples reported in the middle panel upon 
treatment with isoproterenol (10 µM), acetylcholine (200 µM) and CRF (500 nM), respectively. Red: Cy3; Green: EGFP. 
Scale bar 20m. Image were taken at automatic exposure time.  
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3.3.2. Quantification of the labeling efficiency 
In order to establish a procedure for precisely quantifying the labeling efficiency, we selected a 
subset of representative TCO*-GPCRs showing variable labeling ratios: 98TCO*-, 100TCO*-, 
183TCO*-2-AR; 94TCO*-, 186TCO*-M2R; 185TCO*-, 263TCO*-, 266TCO*-CRF1R. In general, the 
TCO* mutation did not impair the functionality of the receptors. All examined 2-AR and CRF1R 
mutants gave EC50 values of agonist stimulation comparable to the corresponding wild-type in 
cAMP accumulation assays (Supplementary Table S3.2). As assessed using a FRET sensor for Gi3 
activation 36, both TCO*-M2R mutants were able to activate Gi proteins (Supplementary 
Figure S3.4). 
HEK293AD cells expressing each TCO*-GPCR-EGFP construct were labeled with Cy3-tetrazine. 
Fluorescence movies of the basolateral membrane of single cells were recorded in the green (EGFP) 
and red (Cy3) channels. According to the TB method of FFS (Figure 3.2A), the number of Cy3 and 
EGFP emitters contained in the excitation beam of the microscope was extracted from the analysis 
of a temporal series of timeframes. For each cell, the number of Cy3 counts was plotted vs the 
number of EGFP and the labeling efficiency was derived from the slope of the linear regression 
(Figure 3.2B). Each receptor could be labeled in high (90%) or close-to-quantitative yields (95%) 
on at least one position (Figure 3.2C). Interestingly, while position 98 in ECL1 of the 2-AR was 
quantitatively labeled, the labeling ratio of the adjacent position 100 was only 20%. This finding 
suggests that the accessibility of the bioorthogonal anchors depends only partially on controllable 
factors, and it remains unclear whether optimal labeling positions can be identified in silico. 
Importantly, the labeled receptors internalized upon agonist stimulation (Figure 3.1C-E, lower 
panels), showing that they retained their functionality. 
To assess whether the measure is biased by background fluctuations of fluorescence or non-
specifically bound dye, we attempted Cy3 labeling of a CRF1R-EGFP variant bearing the inert ncAA 
LysZ instead of TCO* at position 263, which was quantitatively labeled in the previous experiment. 
In this case, the number of recorded Cy3 labeling sites was of the order of only 6% of the EGFP 
labeling sites (Supplementary Figure S3.5A-B), which can be ascribed to Cy3 photoblinking 
(Supplementary Figure S3.5C). To test the reliability of the TB measurements, the quantifications 
were repeated using the SpIDA method 28–30 (Supplementary Figure S3.6A), which yielded 
compatible results (Supplementary Figure S3.6B-D). As a further validation, a dual-color 
competitive labeling experiment was performed on 263TCO*-CRF1R-EGFP. HEK293AD cells 
expressing the receptor were labeled with a Cy5-tetrazine solution containing increasing amounts 
of Cy3-tetrazine, and the fluctuation of fluorescence was recorded in the green (EGFP), red (Cy3) 
and far-red (Cy5) channels (Figure 3.3A). Within the errors, the extracted sum of Cy3 and Cy5 
labeling sites is consistent with a full labeling of the receptor, i.e. (#Cy3 + #Cy5) = #EGFP sites 
(Figure 3.3B), both when applying TB and SpIDA (Figure 3.3C). 
 




Figure 3.2: Estimation of GPCR labeling efficiency via fluorescence fluctuation microscopy. A) Principle of 
temporal brightness (TB) measurements. PSF: Point Spread Function, excitation beam. The number of molecules in a pixel 
fluctuates over time because of molecular diffusion. Experimentally, we measure the emitted fluorescence signal (average 
photon count per pixel, k) in a series of confocal images of the same spot. From the photon count k and the variance 2 of the 
fluctuating signal, we derive the apparent brightness B, the molecular brightness   and the number N of fluorescent entities 
per pixel. B) Quantification of the labeling rate of TCO*-GPCRs. The average number of Cy3-labeled sites (ordinate axis) 
on the membrane of an individual cell is plotted in log-log scale vs the number of C-terminally fused EGFP observed in the 
same area of the membrane. TB measurements were conducted on at least 8 cells in three distinct experiments for each 
case. Each point on the plot represent the results obtained for one cell. Colored lines represent linear regression. C) Labeling 
rates derived from B). The slope of the linear regression gives the labeling efficiency. A slope of 1 correspond to 100% labeling 
efficiency (relative to EGFP), whereas a slope of 0.1 means 10% labeling efficiency. Data are reported  SD of the slope of 
the fit. 




Figure 3.3: Dual-color competitive labeling at a TCO* site. A) Representative examples of the plasma membrane of 
HEK293AD cells expressing 263TCO*-CRF1R-EGFP labeled with two different Cy3 to Cy5 ratios. Green: EGFP; Red: Cy3; 
Magenta Cy5; Scale bar 10 µM; B) Plot of the number of Cy3 and Cy5 labeling sites over EGFP sites (Cy3/EGFP, Cy5/EGFP) 
and of the sum of Cy3 to Cy5 sites over EGFP ((Cy3+Cy5)/EGFP) as a function %Cy3 extracted using TB. Each data point 
is the average calculated from at least 12 individual cells. C) Comparison of results obtained from temporal and spatial 
brightness analysis.  Error Bars represent standard error of the mean (s.e.m.). 
Once the reliability of the method to quantify extracellular labeling was assessed, we explored the 
possibility of quantifying intracellular labeling. We selected 149TCO*- and 224TCO*-CRF1R-
EGFP, both of which yielded EC50 comparable to wt-CRF1R in cAMP accumulation assays 
(Supplementary Table S3.1). The two mutants were expressed in HEK293AD cells along with a wt 
control, which served to estimate the background of the measure, and 263*TCO*-CRF1R-EGFP, 
which should give a reference for quantitative labeling. All samples were treated with membrane 
permeable TAMRA-tetrazine. The accurate focusing of the confocal microscope on portions of the 
basolateral membrane allowed applying TB to determine the number of TAMRA sites (Figure 3.4). 
The average TAMRA counts obtained in the wt samples were subtracted from the other 
measurements, and data plotted as described above for Cy3 labeling (Figure 3.4B). Gratifyingly, 
the labeling rate calculated for position 263 was identical to that obtained using Cy3 (compare 
Figure 3.2C). The labeling rates at the intracellular sites averaged about 50%. 




Figure 3.4: Intracellular labeling of TCO*-CRF1R-EGFP mutants. A) Confocal images of portions of the basolateral 
membrane of HEK293AD cells expressing the indicated receptors, labeled with TAMRA-tetrazine (green: EGFP; red: 
TAMRA). All cells were transfected with the plasmid encoding the PylRSAF/tRNAM15 pair in the presence of TCO*. For wt-
CRF1R sample, the amount of plasmid encoding for the receptor half the amount used for the mutants. White arrows 
highlight intracellular aggregates of TAMRA-TCO-tRNA (see Supplementary Figure S3.7). B) Number of TAMRA counts 
vs EGFP counts plotted as in Figure 3.2B. The slopes of the linear regression are summarized in the adjacent table. For 
149TCO*-CRF1R-EGFP we imaged 9 cells in two independent experiments and for 224TCO*-CRF1R-EGFP 12 cells in three 
independent experiments.   
Intracellular labeling of ncAA anchors has been demonstrated in the literature on highly abundant 
proteins such as vimentin 37 or a membrane-targeted variant of EGFP 38. Although GPCRs feature 
a lower expression level, our results show that ncAA labeling of intracellular GPCR loops is in 
principle possible. However, imaging requires a very precise membrane focusing, as the high 
intracellular background limits wide-field microscopy (Supplementary Figures S3.1, S3.2, and 
S3.3). This background is only partially due to the free dye itself. Instead, it arises from the TCO* 
trapped in the cytosol despite intensive washing 39 and from tRNA-TCO* conjugates 40 that react 
with the dye-tetrazine (Supplementary Figure S3.7). Indeed, while the use of a fluorogenic dye was 
not advantageous, the background could be reduced by working at lower concentrations of TCO*, 
although this approach affects the expression level of the receptor (Supplementary Figure S3.8). 
We did not observe a significant improvement of the signal to background ratio by reducing the 
amount of the tRNA in the system (data not shown). It is likely that the cytosolic TCO* also affects 
the achievable yields of intracellular labeling. 
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3.3.3. Assessing the diffusion of a GPCR labeled on a single residue 
To demonstrate the advantage of single-residue labeling, we investigated the rapidity of motion of 
a receptor exclusively labeled with an organic dye at a TCO* site. HEK293AD cells expressing 
263TCO*-CRF1R constructs with and without a C-terminal EGFP were labeled with Cy3. Rapid 
line-scanning confocal microscopy in the Cy3 spectral channel was applied to extract diffusion 
coefficients at short timescales, based on a line-FCS approach 41–43. The molecular Mean Squared 
Displacement (MSD) of the two receptors was extracted in the time-lag range between 125 s and 
1 s from the broadening of the spatial-temporal correlation function 44. As depicted in Figure 3.5, 
the MSD of the EGFP-tagged CRF1R grew at a slower pace than that of the EGFP-free receptor. 
Notably, the diffusion coefficient of the EGFP-free CRF1R (47 kDa) calculated from the linear fit of 
the MSD (0.096  0.033 m2/s), was about double that of the EGFP tagged variant (0.05  0.03 
m2/s). Considering that the increase in size due to the C-terminal EGFP tag (27 kDa) is about 1.6 
times and, based on purely hydrodynamic considerations, a 1.6 increase of the volume/mass of a 
spherical diffusing particle should lead only in a 31.6  1.2 decrease of the diffusion coefficient, our 
results point out to a small, but sizable “anchor-like” effect of the C-terminal EGFP on the dynamics 
of the CRF1R, which may be explained by molecular crowding considerations 45,46. 
 
Figure 3.5: Molecular diffusion of CRF1R with and without EGFP-tag. Average Mean Squared Displacement (MSD) 
of 263TCO*-CRF1R-EGFP (circles) and 263TCO*-CRF1R (crosses) calculated from three independent experiments. Dashed 
lines represent fits performed in the 125  s to 0.1 s range. Points along the time axis are logarithmically binned. The inset 
shows the MSD plotted against a logarithmic time axis in the 125  s to 0.1 s range. The y-axis intercept of the MSD plot 
was 0.049  0.002 for CRF1R-EGFP and 0.046  0.002 for CRF1R, which is consistent with the typical waist of the PSF in a 
confocal microscope (about 250 nm) and shows that there is no bias in each of the two datasets. 
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3.3.4. Assessing the oligomerization state of the CRF1R 
Finally, we combined our labeling method and the TB microscopy method to address the 
oligomerization state of a GPCR. In general, a quantitatively-labeled biological GPCR dimer 
behaves as a single fluorescent object bearing two fluorophores, thus featuring a molecular 
brightness (ɛ) double that of a monomer. Thus, the molecular brightness can be directly used as a 
reporter of the oligomerization state of a GPCR. However, a cumbersome issue affecting molecular 
brightness studies of oligomerization is the identification of a proper monomeric reference 26. We 
reasoned that dual-color competitive labeling of an ncAA would offer a novel approach to this 
problem. Indeed, even an oligomeric receptor, if sparsely labeled in a selected imaging channel, will 
appear as a ‘fluorescence’ monomer (Figure 3.6A), thus providing an internal control for the 
monomeric reference of fluorescence. 
 
Figure 3.6: Characterization of the oligomerization state of 263TCO*-CRF1R-EGFP. A) Schematic representation 
of a mixed monomeric and dimeric GPCR population labeled with different ratios of two dyes (e.g. red=Cy3; purple=Cy5). 
Since a monomer cannot bear more than one label, the brightness of the fluorescent entities in a monomeric receptor sample 
is independent from the labeling ratio. Instead, the fluorescent entities in a dimeric receptor sample can bear either one or 
two labels of a given color (e.g. Cy3), so that their brightness in one channel increases with increasing amounts of the 
corresponding dye in the labeling mixture. When the fraction of a given color (e.g. Cy5) is very low, dimers will bear, if any, 
only one Cy5 label (species highlighted with black circles), thus yielding in the Cy5 channel the brightness of a monomer. 
B) Plot of the temporal brightness of Cy3, Cy5 and EGFP for an increasing Cy3 to Cy5 ratio used for labeling 263TCO*-
CRF1R-EGFP. Each data point is the average of at least 12 single cell measurements in three independent experiments. 
Errors are std. error of the mean. C) Molecular brightness (ε) (relative to EGFP) measured for the 100% Cy3 labeled samples 
and the 1:1 Cy3 to Cy5 labeled sample. Each value comes from a set of 10 cells in two independent experiments. Errors are 
std. error of the mean D) Mathematical relation between  values for a completely monomeric population (top) and a 
completely dimeric population (middle) at 100% Cy3 labeling (100%) and 50/50 Cy3/Cy5 labeling (B50%). M and D represent 
the molecular brightens of the monomer and the dimer, respectively.  
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263TCO*-CRF1R-EGFP was labeled with a variable ratio of Cy3- and Cy5-tetrazine. The apparent 
molecular brightness (B) was measured using TB in the three spectral channels (Cy3, Cy5 and 
EGFP) and plotted as a function of the percentage of Cy3 in the labeling solution (Figure 3.6B). As 
expected, B of EGFP resulted to be overall independent of the labeling ratio. Instead, by increasing 
the Cy3 fraction, the molecular brightness in the Cy3 channel increased progressively, which was 
mirrored by a decrease of the brightness in the Cy5 channel, indicating that the receptor forms 
oligomers. As the oligomerization rate depends on the concentration of the receptor 2 
(Supplementary Figure S3.9A), the quite large variance on the brightness values are due the 
sampling of a cell population with a heterogeneous expression profile. The same trends were 
confirmed using SpIDA (Supplementary Figure 9B). Taking the apparent brightness value BM=1.34 
± 0.05 obtained at 10% Cy3 labeling as a reference for the Cy3 monomer, the molecular brightness 
for a constitutive fluorescent dimer equals BD=1.68 ± 0.1 [=1+(0.34*2)], which is very close to the 
brightness experimentally measured in our sample at full Cy3 labeling (B=1.65 ± 0.05). 
An indication on the oligomerization state can also be obtained from the relative Cy3/EGFP 
brightness (for ease of calculation, now =B-1) at full Cy3 labeling and at equimolar Cy3 to Cy5 
labeling (Figure 3.6C). As schematically illustrated in Figure 3.6D, the brightness  for 50% Cy3 
labeling (50%) of a dimeric population is equal to 1.33 times that of a monomeric population, and 
about two-thirds of that measured at 100% Cy3 labeling (100%).The experimental ratio between the 
two  values equals 1.26 ± 0.08 and lies in between what is expected for a monomer (=1) and a dimer 
(=1.5) (Supplementary Figure S3.9C).  
In both cases, our results are indicative of a species displaying an oligomeric fingerprint: either a 
monomer-dimer equilibrium or a mixture of monomers, dimers and higher order oligomers. The 
finding is in line with previous estimates that employed either FRET (70% estimated dimers) 47 or 
FCS/smTIRF/FRET (20% estimated dimers) 48. While these data demonstrate the applicability of 
the approach to oligomerization studies, a precise quantification of CRF1R oligomerization at 
physiological concentration clearly awaits a wider range of experiments.  
In conclusion, we have demonstrated that GPCRs can be quantitatively labeled on the extracellular 
loops using SPIEDAC chemistry on genetically-encoded TCO* ncAA. It is worth mentioning that 
TCO* bears the double bond in position 2 of the cyclooctene ring, which compared to the trans-
cyclooct-4-ene (TCO) anchor used in other works 20 is ten times more stable in physiological 
milieu 18. The approach is in principle applicable for intracellular labeling, although a major effort 
still has to be invested to solve the background issue. We have designed a rapid method, based on 
non-perturbing fluorescence fluctuation spectroscopy, to precisely quantify the labeling rate of 
functional receptors laterally diffusing in the plasma membrane using a commercial confocal 
microscope. When combined with dual-color competitive labeling on a single ncAA, the approach 
allows estimating the oligomerization state of a GPCR without the need of a biological monomeric 
reference. Finally, we have shown that a GPCR labeled in a minimally-invasive fashion at a TCO* 
site diffuses more rapidly, and likely more physiologically, than the same GPCR fused to EGFP. 
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Importantly, both the ncAA and the dye-tetrazine substrates used in this study are commercially 
available. Therefore, the approach is generally applicable to equip GPCRs with bright and 
photostable dyes for high-end microscopy studies of GPCR function and dynamics in live cells. 
3.4. Materials and Methods 
3.4.1. General Molecular Biology 
Plasmid pNEU-MbPylRSAF/4xtRNAM15 was used for genetic encoding TCO* 21. The genes of HA-
GPCR-EGFP constructs were cloned into pcDNA3.1 between EcoRI and NotI restriction sites. 
Receptors bear an N-terminal HA-tag and are connected to EGFP by a polyglycine linker containing 
an AgeI restriction site. The CRF1R gene features its native signal peptide. To aid membrane 
localization, the β2-AR and M2R genes bear a cleavable signal peptide at the N-terminus 49. TAG-
codons were introduced via site-directed mutagenesis PCR. 
3.4.2. Cell Culture 
HEK293AD and HEK293T cells were maintained in Dulbecco’s Modified Eagle’s Medium (DMEM; 
high glucose 4.5 g/L, 4 mM glutamine, pyruvate; Thermo Fisher Scientific, Rockford, USA) 
supplemented with 10% FBS (v/v; Thermo Fisher Scientific) and 100 U/mL penicillin and 100 μg/mL 
streptomycin (Thermo Fisher Scientific) at 37°C under 5% CO2 and 95% humidity. Cells were 
passaged at 80-90% confluence every 2–4 days. 
3.4.3. Whole cell surface-ELISA 
15,000 293T cells per well were seeded in poly-D-lysine-coated 96-well plates. The following day, 
TCO* was added to 250 µM. Cells were co-transfected with 5 ng of plasmid encoding for the stop 
codon variants of the desired GPCR and 5 ng of the MbPylRSAF/4xtRNAM15 plasmid. Wild type 
controls for M2R and CRF1R were transfected as the TCO*-mutants, while the β2-AR wt control was 
transfected with 0.5 ng of receptor plasmid. The total DNA amount was filled to 100 ng per well 
with mock DNA. After 24 h, cells were fixed with 4 % formaldehyde in PBS, blocked in DMEM 
containing 10 % FBS and incubated with a HRP-conjugated rat-anti-HA-antibodies (Roche, clone 
3F10) diluted 1:200 in DMEM containing 10 % FBS for 1 h at 37 °C. The read-out was generated 
using an o-phenylenediamine dihydrochloride (OPD) substrate. The raw data were collected as 
mean ± s.e.m. from three independent experiments, each performed in triplicate, corrected for the 
absorption obtained from mock-transfected cells. 
3.4.4. Transfection for GPCR imaging 
Approximately 20 h prior to transfection, cells were plated in 6-well plates on circular high precision 
cover glasses (25 mm, 1.5H; Marienfeld, Lauda-Koenigshofen, Germany) pre-treated with poly-D-
lysine hydrobromide (MW 500-550 kDa, 25 µg/mL; BD Biosciences, Heidelberg, Germany). TCO* 
(SiChem, Bremen, Germany) was added 1 h before transfection to a concentration of 250 µM for 
extracellular labeling and 50 µM for intracellular labeling experiments. Cells were co-transfected 
with MbPylRSAF/4xtRNAM15 and receptor constructs in a 1:1 ratio for a total amount of 1.5 µg DNA 
using Lipofectamine 2000 (Thermo Fisher Scientific) as described in ref. 50. 
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3.4.5. Labelling procedure 
16-20 h post-transfection, the glass covers were transferred to new 6-well plates containing 
complete dye-free FluoroBrite® medium (Thermo Fisher Scientific) and cells were incubated at 
least 2h without ncAA at 37°C under CO2 (5%) atmosphere. Fluorophore-tetrazine conjugates were 
dissolved in complete FluoroBrite® medium from 500 µM stock solutions in DMSO to 
0.15 µM – 1.5 µM, and the solution applied to the cells for 5 min at 37°C. Cy3-H-tet or Cy5-H-tet 
(Jena Biosciences, Jena, Germany) were used for labelling of extracellular sites and SiR-H-tet 
(Spirochrome, Stein am Rhein, Switzerland) and TAMRA-H-tet (Jena Biosciences, Jena, Germany) 
for intracellular positions. Cells were rinsed once (extracellular labeling) or washed once for 2 h 
(intracellular labeling) with complete Fluorobrite® medium before imaging. For the initial wide-
field screening, cells were fixed with PFA (2% w/v in PBS) for 30 min at room temperature and 
stored in PBS until imaged.  
3.4.6. Wide-field microscopy 
Labeled cells were placed into cell chambers (Thermo Fisher Scientific) and added complete 
Fluorobrite® growth medium or PBS for live cell studies or screening of fixed cells, respectively. 
For internalization studies, cells expressing β2-AR, M2R or CRF1R were treated with Acetylcholine 
(200 µM), Isoproterenol (10 µM) and CRF (500 nM) in complete Fluorobrite®, respectively. Vesicle 
formation was imaged after 30 minutes of incubation for β2-AR and CRF1R expressing cells and 
after 1 hour for M2R. Cells were visualized at 63x magnification on an inverted Observer.Z1 
microscope (Zeiss, Oberkochen, Germany) equipped with an AxioCam MRm camera and HXP120 
fluorescence light source. Fluorescence was detected using the following filters: EGFP - Ex: 
470/40 nm and Em: 525/50 nm; Cy3 - Ex: 565/30 nm and Em: 620/60 nm; SiR – Ex: 640/30 nm 
and Em: 690/50 nm. Images were analyzed and prepared with Zen 2 blue edition software (Zeiss).  
3.4.7. TB microscopy 
Labeled cells were placed into cell chambers and added of complete Fluorobrite® medium. Images 
were taken with a Leica SP8 DMi8 inverse confocal laser scanning microscope and Leica LAS X 
software. Cells were imaged with a 40x/1.10 water immersion objective. Sets of 50 or 100 frames 
were taken with a scanner speed of 400 Hz at 256x256 pixels resolution and a zoom-factor of 22.8 
yielding a pixel size of 50 nm. Fluorescence was detected with a Hybrid detector in photon counting 
mode (gain 10%). For EGFP detection, the argon-ion laser was set to 20% and the 488 nm laser line 
was used at 2-4% power and emission was measured at 500-550 nm. Cy3 emission was measured 
at 570-650 nm upon excitation with a solid state diode DPSS 561 nm laser at 2-3% power. Cy5 and 
SiR were excited with a HeNe 633 nm laser set between 0.4% and 3% power and detected at 638-
750 nm. The Regions of Interest (ROIs) were drawn in free area selection mode to avoid areas in 
the membrane with inhomogeneous distributed fluorescence. Data were analyzed as described 
previously utilizing a custom-written Igor Pro (Wavemetrics) routine 51. The brightness values were 
calculated based on the average of the brightness values from each pixel within the region of 
interest using a custom written routine as previously described 52.  
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3.4.8. Receptor diffusion measurements 
The same microscope setup was used as for TB analysis. Image sets were taken in xt mode. Line 
scans were performed at a scanner speed of 8000 Hz with a resonant scanner at a 256x1 resolution 
and a pixel size of 50 nm. Approximately 2 million lines were collected per set. Cy3 was excited at 
561 nm with a laser power of 25%. Analysis of image sets was performed using a custom written 
Igor Pro routine to calculate the spatial temporal correlation function of the line scan and extract 
the Mean Squared Displacement (MSD) from the spatial increase over time of the autocorrelation 
function as previously described 41. 
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3.7. Supplementary Material 
3.7.1. Supplementary Methods 
SpIDA microscopy: Spatial Intensity Distribution Analysis (SpIDA) was performed using the 
same microscope setup used for TB. Each SpIDA measurement comprised a set of three frames 
with a resolution of 512x512, a zoom factor of 22.8 and a pixel size of 25 nm. The detector scan rate 
was set to 100 Hz. Depending on the GPCR expression level of individual cells, EGFP, Cy3 and Cy5 
were excited at laser powers between 10-15% to prevent detector overload and significant 
photobleaching of the probes. Analysis of image sets was performed using the SpIDA function on 
MATLAB routine as described previously 1. The higher laser power used in SpIDA experiments as 
opposed to temporal brightness led to a limited (of the order of 10%) photobleaching of the EGFP, 
resulting in the observed slight overestimation of the #Cy3/#EGFP and #Cy5/#EGFP ratios. 
cAMP Accumulation assay via luciferase reporter: 1.4*106 HEK293 cells were seeded in 6 cm 
culture plates. The following day, TCO* was added to the cell culture medium to a final 
concentration of 250 µM and cells were co-transfected with a plasmid encoding for the desired 
receptor under control of the CMV promoter (200 ng), the pNEU-MbPylRSAF/4xtRNAM15 plasmid 
(200 ng), the reporter construct bearing the firefly luciferase gene driven by a cAMP-responsive 
element (2 µg), and a plasmid encoding for Renilla luciferase (200 ng). For wild type receptor 
controls (CRF1Rwt-EGFP or β2-AR wt-EGFP), 100 ng of wt receptor plasmid and 100 ng of mock 
plasmid DNA were used. The transfection was performed using PEI as described above. 24 h post-
transfection, cells were transferred into 96-well plates at a density of 180,000 cells per well and 
were cultured in complete DMEM containing TCO* (250 µM) for other 24 h. Cells were stimulated 
for 3 h at 37 °C by adding serial dilutions of either CRF or isoproterenol. Cells were lysed and the 
luminescence of firefly and Renilla luciferase was measured upon adding the corresponding 
substrates luciferin (0.3 mM; Carl Roth, Karlsruhe, Germany) and coelenterazine (1.67 µM; Sigma-
Aldrich, Munich, Germany). Firefly luminescence was normalized for the Renilla luminescence, 
plotted and analysed using Prism 5.03 (Graphpad Software Inc., San Diego, USA). EC50 values 
were obtained as mean ± s.e.m from at least three independent experiments, each performed in 
triplicate. 
Single-cell G protein activation assays: 1.8 x 105 HEK293AD cells were plated onto 24mm glass 
coverslips one day before transfection. One hour before transfection, a TCO* solution was added to 
give a final concentration of 250 µM. Per coverslip, cells were transfected with 750 ng of pcDNA3.1-
SigPep-HA-M2R-94(or 186)TAG-EGFP, 750 ng of a plasmid encoding the MBPylRSAF/tRNAPyl 
pair 2, and 500 ng of a Gi3-FRET sensor plasmid co-expressing G i3-mTq2, G1, and cp173Venus 
G2 subunits 3, using Lipofectamine 2000 according to the manufacturer’s instructions. 24 h after 
transfection, coverslips were mounted in a round imaging chamber and cells were washed once with 
FRET buffer (140 mM NaCl, 5.4 mM KCl, 2 mM CaCl2, 1 mM MgCl2, 10 mM HEPES, pH=7.4). 
Cells were kept in FRET buffer at room temperature throughout the experiment. FRET imaging 
was performed on a Leica DMi8 inverted microscope (Leica Microsystems, Wetzlar, Germany) 
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equipped with an oil-immersion objective (HC PL APO 40x/1.30), a T505lpxr beam splitter (Visitron 
Systems; Puchheim, Germany), a high-speed polychromator (Visitron Systems) and a Photometrics 
Prime 95B CMOS camera (Visitron systems) with Optosplit II dual emission image splitter (Cairn). 
Regions of interest were drawn around single cells using the Visiview 4.0 imaging software 
(Visitron Systems). A time series of images was recorded every 5 seconds upon 100 ms exposure to 
436 nm light. Inverted FRET was calculated as the ratio between mTq2 emission at 480 nm and 
cp173Venus emission at 535 nm with correction for bleedthrough of mTq2 signal into the 
cp173Venus channel. Absolute FRET of each cell under basal conditions was set 0 % and ΔFRET 
upon stimulation with ACh (100 µM) was expressed as a percentage of increase over baseline. 
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3.7.2. Supplementary Figures 
 
Figure S3.1: Screening of β2-AR variants in HEK293AD cells. A) Schematic representation of the β2-AR. Positions 
selected for TCO*K incorporation are represented by white circles. B, C) Fluorescence microscopy of HEK293AD cells 
expressing TCO*-β2-AR variants. Cells were imaged in the green channel to visualize EGFP fluorescence and in the red/far 
red channel to visualize the label. The white number in each EGFP panel indicates the site of incorporation of position of 
TCO*. B) Mutants bearing TCO* in the extracellular loops were labeled with 1.5 µM tetrazine-Cy3 for 5 minutes. Green: 
EGFP; Red: Cy3. C) Mutants bearing TCO* in the intracellular loops were labeled with 1.5 µM tetrazine-SiR for 5 minutes. 
Images were taken 2 hours after labeling to allow dye washout. Green: EGFP; Magenta SiR. Scale bar: 20 µm. Shown are 
representative images of a total of 10 cells analyzed in 2 independent experiments. 




Figure S3.2: Screening of M2R variants in HEK293AD cells. A) Schematic representation of the M2R. Positions selected 
for TCO* incorporation are represented by white circles. B, C) Fluorescence microscopy of HEK293AD cells expressing 
TCO*-M2R variants. Cells were imaged in the green channel to visualize EGFP fluorescence and in the red/far red channel 
to visualize the label. The white number in each EGFP panel indicates the site of incorporation of position of TCO*. B) 
Mutants bearing TCO* in the extracellular loops were labeled with 1.5 µM tetrazine-Cy3 for 5 minutes. Green: EGFP; Red: 
Cy3. C) Mutants bearing TCO* in the intracellular loops were labeled with 1.5 µM tetrazine-SiR for 5 minutes. Images were 
taken 2 hours after labeling to allow dye washout. Green: EGFP; Magenta SiR. Scale bar: 20 µm. Shown are representative 
images of a total of at least 8 cells analyzed.  




Figure S3.3: Screening of CRF1R variants in HEK293AD cells. A) Schematic representation of the CRF1R. Positions 
selected for TCO* incorporation are represented by white circles. B, C) Fluorescence microscopy of HEK293AD cells 
expressing TCO*-CRF1R variants. Cells were imaged in the green channel to visualize EGFP fluorescence and in the red/far 
red channel to visualize the label. The white number in each EGFP panel indicates the site of incorporation of position of 
TCO*. B) Mutants bearing TCO* in the extracellular loops were labeled with 1.5 µM tetrazine-Cy3 for 5 minutes. Green: 
EGFP; Red: Cy3. C) Mutants bearing TCO* in the intracellular loops were labeled with 1.5 µM tetrazine-SiR for 5 minutes. 
Images were taken 2 hours after labeling to allow dye washout. Green: EGFP; Magenta SiR. Scale bar: 20 µm. Shown are 
representative images of a total of at least 10 cells analyzed in 2 independent experiments. 




Figure S3.4: Activation of Gai3 proteins by muscarinic M2R mutants. (A-C) Shown are representative traces of M2 
receptor-mediated Gi3 activation in single HEK293AD cells expressing either the wild-type M2 receptor A) or the 186TCO* 
B) or 94TCO* C) mutants. The inverted FRET ratio (mTurqouise2/cp173Venus) of the Gi3 sensor was monitored over time 
before and after G protein-activation was stimulated by bath application of ACh (100 µM) at indicated time points. D) 
Summary of maximum delta FRET ratios (%) of all cells analyzed. The results show that both TCO*-M2R mutants are able 
to activate Gi proteins when stimulated with acetylcholine (ACh), although 94TCO*-M2R is slightly less efficient than wild-
type M2R. Data are means  s.e.m. from 2-3 independent transfections. The number of cells analyzed was 14, 35, and 23 of 
the M2 wild-type, 186TCO*-, and 94TCO*-M2R-EGFP mutants, respectively. ** (P<0.01) significantly different from wild-
type according to a one-way ANOVA with Bonferroni’s multiple comparisons test; ns: not significantly different from wild-
type. 




Figure S3.5: Temporal Brightness analysis of LysZ negative control. A) Cells expressing 263LysZ-CRF1R-EGFP 
were labeled with tetrazine-Cy3 and imaged using TB in the green and red channel in the same way as samples in Figure 2 
were analyzed. Note that LysZ does not react with tetrazines. The figure depicts a snapshot of a portion of membrane of one 
cell. The white dashed line in the Cy3 channel marks the border of the cell. The thin vertical lane and the arrow indicates 
sections further investigated in panel C (see below). The EGFP channel shows that the receptor is well expressed at the cell 
membrane. In the Cy3 channel, sparse single Cy3 molecules are visible, homogeneously distributed both where the cell is 
present and in the background region. We associate this signal to unwashed Cy3 molecules that stick to the glass coverslip. 
B) Molecular number (#) and brightness (B) values extracted from a TB movie of the 263LysZ-CRF1R-EGFP labeled with 
Cy3. The apparent brightness (B) of Cy3 is very close to the background value of 1, although not entirely negligible. This 
effects results in a number count for Cy3; in the pixels where background molecules are present, molecular counts in the 
Cy3 channel are 6% of those counted in the EGFP channel. C) Kymograph taken from the vertical white line highlighted in 
panel A. The kymograph shows how the fluorescent signals of the emitters present in the section is intermittent over the 
time of 10 seconds. A continuous line characterizes an active molecule, a dashed line a blinking molecule. A blinking-off 
molecule is conceptually equivalent to a molecule diffusing out of the pixel, a blinking-on molecule to a molecule diffusing 
in the pixel. In this case, the dashed lines indicate Cy3 photoblinking. This explains why we observe a residual molecular 
brightness, although the Cy3 fluorophores in the background (see panel A) do not move. The residual brightness does not 
arise from molecular diffusion (for an immobile, steadily emitting molecule,  =0), but from photoblinking. 




Figure S3.6: Evaluation of labeling efficiency via SpIDA. A) Principle of SpIDA measurements. SpIDA extracts the 
number of molecules per pixel and their brightness from the variance of the photon counts between adjacent pixels, whereas 
TB (Figure 3.2A, main text) extract these values from the fluorescence fluctuation of the same pixel over time. B) Labeling 
efficiency measured using SpIDA on one TCO* mutant for each of the investigated GPCRs. Measurements were conducted 
on at least 8 cells in three distinct experiments for each case. Each point on the plot represents the results from one cell. 
The average number of Cy3 labeling sites on the membrane of an individual cell is plotted in log-log scale vs the number of 
C-terminally fused EGFP observed in the same area of the membrane. Color lines represent linear regression, which is used 
to extract the labeling efficiency. A slope of 1 correspond to 100% labeling efficiency (relative to EGFP), whereas a slope of 
0.1 means 10% labeling efficiency. C) Labeling efficiency calculated for each of the mutants investigated in panel B. With 
respect to TB, SpIDA yields a slight overestimation of the labeling efficiency due to a minor bleaching of EGFP during the 
measurements. 




Figure S3.7: Intracellular background of TAMRA and SiR labeling. Wide-field images of HEK293AD cells. Non 
transfected cells (left and middle panel) were treated with either TAMRA-tetrazine or SiR-tetrazine (1.5 µM, 5 min). Free 
Dyes were allowed to wash out for two hours in fresh Fluorobrite® medium before imaging. TAMRA-fluorescence is visible 
both in presence and absence of TCO*. Instead, SiR-fluorescence was visible only when TCO* was present in the cytosol. As 
SiR-tetrazine is fluorogenic, this results shows that the background fluorescence observed in our labeling experiments is 
due only partially to the free dye, but rather by TCO-dye conjugates. The right panels represent cells that have been 
transfected with the tRNA and ncAARS encoding for TCO*. We used a variant of the PylRSAF that bears a nuclear export 
sequence (NES) at the N-terminus and has been reported to reduce nuclear background 4. With both dyes, we observed a 
similar background as observed for the non-transfected cells containing TCO*. However, in the presence of the orthogonal 
pair, bright fluorescent points were observed, in large part accumulating in the nucleus, which can be attributable to 
aggregates of dye-TCO-tRNA species. Red: TAMRA; magenta: SiR; blue: Hoechst 33342. Scale bar: 20 µm. All images in 
each channel were taken at the same exposure time. 
 
Figure S3.8: Intracellular background of TAMRA and SiR labeling at different TCO* concentration. Wide-field 
images of HEK293AD cells. Red: TAMRA, magenta: SiR, green: EGFP and blue: Hoechst 33342. All images were taken at 
fixed exposure times, which have been adjusted for each dyes prior to the individual experiments. 263TCO*-CRF1R-EGFP 
(extracellular labeling, quantitative yield) was expressed in HEK293AD cells in the presence of different concentrations of 
TCO*, as indicated on the top. Scale bar: 20 µm. Shown are representative images of a total of 8 cells analyzed. 




Figure S3.9: Assessing the oligomerization state 263TCO*-CRF1R-EGFP. A) Molecular Brightness of 263TCO*-
CRF1R-EGFP measured in the EGFP channel, as a function of the expression level of the receptor. Each circle represents 
the brightness measures in a single cell. As the molecular brightness is a property of the average diffusing entity, an increase 
of brightness indicates that the number of diffusing entities bearing more than one fluorophore increases, which is a 
symptom of oligomerization. B) Both the spatial and temporal brightness calculated in the EGFP channel (B EGFP, grey 
dots) and in the Cy3 channel (B Cy3, red diamonds) are plotted, in order to validate the results using two methods. The 
sample is labeled by variable relative concentration of Cy3 and Cy5 that compete for the same labeling site. The Brightness 
of EGFP appears well clustered (independent of Cy3 to Cy5 ratio), whereas the brightness of Cy3 increases with the Cy3 to 
Cy5 ratio. C) Theoretical molecular brightness (ℇ) expected for a monomeric or dimeric receptor for the three cases: (i) 100% 
Cy3 labeling, (ii) 1:1 Cy3 to Cy5 and (iii) 100% Cy5 labeling. We assume here that the brightness of the monomer ℇM=1. 
Based on elementary statistical considerations, for a protein which is strictly a monomer the molecular brightness Cy3 and 
Cy5 are both independent of the labeling ratio (left). If the receptor is a constitutive dimer (right), the brightness for 
100%Cy3 and 100%Cy5 (cases (i) and (iii)) will be twice that of the monomer (ℇD=2), and 1.5 times that of 1:1 equimolar 
labeling (as illustrated in Figure 5D). Red bars: Cy3. Purple bars: Cy5. 
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3.7.3. Supplementary Tables  
Table S3.1: Summary of receptor screening. Based on a series of fluorescence microscopy images we compared 
membrane localization of the different GPCR variants harboring TCO* Further we compared the Cy3 intensity relative to 
the EGFP intensity for the different variants of each receptor and prepared a rough estimate of labeling efficiency. When 
there was no visually detectable labeling positions were marked with “-“. 
 β2-AR   CRF1R   M2R  
position membrane 
localization 
labeling position membrane 
localization 




97 good - 179 good good 21 good good 
98 good fair 182 good good 94 good fair 
100 good poor 183 good fair 186 good good 
177 fair good 185 good fair 412 good good 
179 good fair 256 fair good 420 good good 
183 good good 257 fair fair    
186 good poor 263 good good    
188 fair poor 266 good poor    
300 good - 335 fair good    
301 good - 336 good good    
302 good poor 337 fair fair    
intracellular 
62 good poor 145 - - 50 good - 
63 good good 149 good fair 127 good good 
139 good good 222 poor good 380 good - 
140 good fair 223 good fair 453 good - 
142 fair fair 224 good fair    
143 good good 225 good fair    
144 good good 298 good fair    
   299 - -    
   302 good fair    
   303 fair fair    
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Table S3.2: EC50 values of TCO*-β2-AR -EGFP receptor and TCO*-CRF1R-EGFP mutants. Receptor activation was 
derived from the function of cAMP level in transiently transfected HEK293 cells stimulated by increasing concentrations of 
agonist isoproterenol for β2-AR variants and CRF for CRF1R receptor mutants. EC50 values were elicited from the 
concentration-effect curves of at least three independent experiments, each performed in triplicate and are shown as 
mean ± SD. 
Residue substituted with TCO* EC50 [nM] 
CRF1R 
wild type 0.53 ± 0.18 
185 0.78 ± 0.47 
263 0.31 ± 0.12 
266 0.30 ± 0.11 
149 0.54 ± 0.07 
224 0.36 ± 0.06 
β2-AR 
wild type 6.90 ± 5.91 
98 2.19 ± 1.04 
100 2.21 ± 1.26 
183 2.76 ± 0.58 
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4.1.1. Short abstract 
We describe a facile fluorescence-based method to evaluate the efficiency of orthogonal amino-acyl-
tRNA-synthetase/tRNA pairs for the incorporation of non-canonical amino acids (ncAAs) into 
proteins expressed in mammalian cells. Further, we describe application of ncAAs to study 
G protein-coupled receptors (GPCRs), including photo-crosslinking mapping of binding sites and 
bioorthogonal GPCR labelling on live cells.  
4.1.2. Long abstract 
The genetic incorporation of non-canonical amino acids (ncAAs) via amber stop codon suppression 
is a powerful technique to install artificial probes and reactive moieties onto proteins directly in 
the live cell. Each ncAA is incorporated by a dedicated orthogonal suppressor tRNA/amino-acyl-
tRNA-synthetase (AARS) pair that is imported into the host organism. The incorporation efficiency 
of different ncAAs can greatly differ and be unsatisfactory in some cases. Orthogonal pairs can be 
improved by manipulating either the AARS or the tRNA. However, directed evolution of tRNA or 
AARS using large libraries and dead/alive selection methods is not feasible in mammalian cells. 
We present here a facile and robust fluorescence-based assay to evaluate the efficiency of orthogonal 
pairs in mammalian cells. The assay allows screening tens to hundreds of AARS/tRNA variants 
with a moderate effort and within a reasonable time. We used this assay to generate new tRNAs 
that significantly improve the efficiency of the pyrrolysine orthogonal system. We then show 
application of ncAAs to the study of G protein-coupled receptors (GPCRs), which are challenging 
objects for ncAA mutagenesis. First, by systematically incorporating a photo-crosslinking ncAA 
throughout the extracellular surface of a receptor, we map binding sites of different ligands on the 
intact receptor directly in the live cell. Second, by incorporating last-generation ncAAs into a GPCR, 
we demonstrate ultrafast catalyst-free receptor labelling with a fluorescent dye using bioorthogonal 
strain-promoted inverse Diels Alder cycloaddition (SPIEDAC) on the live cell. As ncAAs can be 
generally applied to any protein independently on its size, the method is of general interest for a 
number of applications. In addition, ncAA incorporation does not require any special equipment 
and is easily performed in standard biochemistry labs. 
4.2. Introduction 
The genetic incorporation of chemical probes into proteins is a powerful method to facilitate 
investigation of structural and dynamic aspects of protein function directly in the native context of 
the live cell. Nowadays, hundreds of non-canonical amino acids (ncAAs) equipped with the most 
disparate chemical groups can be site-specifically incorporated into proteins by biosynthesis 1–4. 
Between them, we find photo-sensitive ncAAs such as photo-crosslinkers 5, photo-caged 6–9 and 
photo-switchable amino acids 10,11, amino acids bearing strained alkenes and alkynes for catalyst-
free bioorthogonal chemistry 1,12–17, amino acids carrying dansyl 18, coumarin 8,19, and prodan 20,21 
fluorophores, and amino acids equipped with other biophysical probes as well as with post 
translational modifications 1–4,22–25. 
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The genetic encoding of an ncAA is enabled by a dedicated amino-acyl-tRNA-synthetase (AARS) 
paired to a cognate suppressor tRNA, which incorporates the ncAA in response to an amber stop 
codon during the regular ribosomal synthesis. ncAARS/tRNA pairs are engineered so as to be 
orthogonal in the host organism, i.e. not cross-talk with the endogenous pairs. The technique is well 
established both in prokaryotic and eukaryotic hosts and easily applicable to mammalian cells. 
Pairs for ncAA incorporation in mammalian cells are based on three main orthogonal systems: the 
tyrosyl system, that combines the TyrRS from E. coli 26 with a tyrosyl amber suppressor from 
B. stearothermophilus 27 (EcTyrRS/BstYam pair), the E. coli leucyl system (EcLeuRS/tRNALeuCUA 
pair) 9,18,28 and the archaeal pyrrolysyl system (PylRS/tRNAPyl pair) 3, whereby the tRNAPyl is a 
natural amber suppressor. In general, each ncAA is recognized by a specialized ncAARS. Depending 
on the structure of the ncAA, the ncAARS is obtained via directed evolution of either TyrRS, LeuRS 
or PylRS, although some synthetases can accept more than one ncAA. 
The orthogonal pair is imported into the cells by simply using a plasmid vector. Most common and 
efficient plasmids are bicistronic and encode both for the synthetase and the tRNA forming the 
orthogonal pair 29. A second plasmid encoding for the protein of interest bearing an amber codon at 
the site designated for modification is co-transfected. The ncAA is simply added to the cell growth 
medium. However, there exist several variants of constructs for the incorporation of the same ncAA, 
differing in arrangement of the genes in the vector, codon usage in the synthetase gene, promoter 
usage, variant of the tRNA employed and number of tRNA expression cassettes. Moreover, the 
incorporation efficiency of different ncAAs can vary drastically due to different catalytic efficiency 
of the different synthetases, the quality of the tRNA, and other factors 30. Therefore, it is important 
to have at hand a fast and reliable method to evaluate the efficiency of an orthogonal pair, both to 
choose the most suitable system for a desired application and to perform some optimization steps 
that improve overall protein expression yields.  
We have established a simple and robust fluorescence-based assay to evaluate the efficiency of 
orthogonal pairs (Figure 4.1) 29. In the assay, cells are co-transfected with the plasmid encoding for 
the orthogonal pair, together with a bicistronic reporter plasmid encoding both for the green 
fluorescent protein bearing an amber stop codon at a permissive position (EGFPTAG) and the 
mCherry gene. Red and green fluorescence of whole cell lysates are read in separate channels on a 
plate reader in a 96-well plate. The intensity of the green fluorescence directly correlates with the 
efficiency of amber suppression, whereas the intensity of red fluorescence gives a direct estimate of 
the size of the measured sample and the transfection efficiency. In respect to similar assays based 
on fluorescence assisted cell sorting (FACS) read out 31,32, the assay gives an immediate and 
comprehensive assessment of protein expression in the whole cell population, which is more 
representative of usual experimental conditions, and offers an easier data acquisition and 
processing with standard Office software. Overall, the main advantage of the assay is that a 
medium to large number of samples can be analysed in parallel. Using this assay, we have screened 
a rationally designed library of suppressor tRNAs to improve the efficiency of the Pyl orthogonal 
system 30. We describe here the experimental protocol to perform this assay and show examples of 
CHAPTER 4 4.2 Introduction 
132 
 
its application, including the optimization of the orthogonal pair for the incorporation of the photo-
crosslinking ncAA p-azido-L-phenylalanine (Azi) and the comparison of incorporation efficiencies 
of different amino acids (Figure 4.2C).  
 
Figure 4.1: Fluorescence-based assay to evaluate the efficiency of stop codon suppression. HEK293 cells are co-
transfected with two plasmids in the presence of the ncAA. One plasmid encodes for the desired ncAARS and suppressor 
tRNA. When screening different tRNAs, in order to facilitate cloning procedures, only one tRNA cassette is embedded in the 
plasmid. When screening either different ncAARS, or the incorporation efficiency of different ncAAs by the same orthogonal 
pair, four tandem repeats of the tRNA cassette are preferred to achieve the highest yields of ncAA incorporation. The second 
plasmid encodes for the EGFP gene bearing a TAG stop codon at a permissive site together with a mCherry control. Two 
days after transfection, cells are harvested and lysed. Green and red fluorescence of whole-cell lysates are measured in a 
plate reader. As the EGFP N-segment upstream the stop codon (grey) is not fluorescent, the yield of full-length EGFP (green) 
directly correlates to the efficiency of ncAA incorporation, while mCherry (red) provides an independent reference for 
normalization. The efficiency of the orthogonal system is given by the ratio between the amount of EGFP obtained via stop 
codon suppression and the amount of wild type EGFP obtained by regular translation (no amber suppression) (modified 
from Serfling and Coin, 2016) 29. 
Over the last years, ncAA tools have been proved very powerful to investigate structural and 
functional aspects of G protein-coupled receptors (GPCRs) 33–38. In humans, GPCRs form a large 
family of membrane receptors (800 members) and represent main targets for therapeutic drugs. 
Direct structural characterization of GPCRs is still challenging and complementary biochemical 
methods are highly needed for their investigation. We have pioneered the use of photo-crosslinking 
ncAAs to map GPCR surfaces and discover ligand binding pockets 33. Using our optimized system 
for Azi incorporation, we systematically incorporate Azi throughout the whole juxtamembrane 
domain of a GPCR directly in live mammalian cells. Upon UV irradiation, Azi forms a highly 
reactive nitrene species that covalently captures neighbouring molecules. When the ligand is added 
to the system, Azi serves as a proximity probe to reveal which positions of the receptor come close 
to the bound ligand. In this way, we have first unveiled the binding mode of the neuropeptide 
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hormone Urocortin I (Ucn1) on the class B GPCR corticotropin-releasing-factor receptor type 1 
(CRF1R) 34. Lately, we have disclosed distinct binding patterns of agonists and antagonists on the 
same receptor 36. A similar approach has been applied by others to reveal orthosteric and allosteric 
binding sites of other peptides and small molecules ligands on other GPCRs 39–42. We describe here 
the experimental protocol applied in our lab for photo-crosslinking mapping of GPCR surfaces. The 
method is relatively fast, straightforward and does not require any special equipment, so that it is 
applicable in standard biochemistry labs. Importantly, the approach provides a valuable tool not 
only to identify ligand binding sites where 3D structural data are scarce, but also to supplement 
existing in vitro data with information from fully post-translationally modified receptors in the 
physiological environment of the live cell. 
The recent development of novel ncAAs bearing on the side chain chemical groups suitable for 
ultrafast catalyst-free bioorthogonal chemistry has opened up the possibility to install last-
generation fluorophores for super-resolution imaging into proteins directly on the live cells 1,43. 
Such chemical anchors include strained cyclooctyne in SCOK 16, bicyclo[6.1.0]nonyne in BCNK 12,13, 
and trans-cyclooctenes in TCO*K 13,15,17 among other ncAAs harbouring a norbornene 13,14,44 or 
cyclopropane 45,46 moiety. Bulky ncAAs for bioorthogonal chemistry are incorporated by a variant 
of the PylRS usually denoted as PylRSAF (indicating mutation Y271A and Y349F in M. barkeri 
PylRS), as well as by other ad hoc evolved ncAARSs 13,44. The bioorthogonal anchors react with 
tetrazine reagents 47 via inverse-electron demand Diels–Alder cycloaddition to give high labelling 
yields within a few minutes 43,48. However, application of this powerful approach to label GPCRs 
has been challenging due to low overall efficiency of the orthogonal ncAA incorporation system. 
Using our enhanced Pyl system, we have recently demonstrated high yield incorporation of such 
amino acids into GPCRs and ultrafast GPCR labelling on the surface of live mammalian cells 30. 
Labelled receptors were still functional, as they physiologically internalized upon activating the 
receptor with an agonist. We describe here the experimental protocol for the incorporation of 
bioorthogonal anchors into GPCRs and the following labelling steps. Equipping GPCRs with small 
bright fluorophores is the first fundamental step toward the study of GPCR structural dynamics in 
the live cell via advanced microscopy techniques.  
4.3. Protocol 
4.3.1. Fluorescence-based screening of incorporation efficiencies 
1. Maintain HEK293 cells in Dulbecco’s Modified Eagle’s Medium (DMEM; high glucose, 4mM 
glutamine, pyruvate) supplemented with 10 % (v/v) fetal bovine serum (FBS), 100 units/ 
penicillin and 100 µg/mL streptomycin at 37 °C, 95 % humidity and 5 % CO2. 
2. Seed cells the day before transfection. 
3. Detach the cells for 5 min at 37 °C in 0.05 % Trypsin/PBS supplemented with 0.5 mM EDTA. 
Use 1 mL Trypsin/EDTA for a 10 cm dish. Quench with 10 volumes of complete medium and 
resuspend the cells by pipetting. Count the number of cells in the suspension using a 
hemocytometer 49. 
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4. Seed 6.0 x 105 HEK293 cells per well of 6-well plates in 2 mL complete growth medium. Prepare 
as many well as the number of samples, and two additional wells for the wild type EGFP 
positive control and a mock-transfected negative control. 
5. Control confluence (area occupied by the cells) under a microscope. Transfect cells at ~70 % 
confluence using Polyethyleneimine (PEI) reagent. 
6. One hour prior to transfection, add the appropriate amount of freshly prepared ncAA stock 
solution to all wells for a final ncAA concentration of 0.25-0.5 mM. It is recommended to add 
the ncAA to all wells, including wild type positive control and mock transfected cells, to prevent 
differences in fluorescence signals that may be caused by effects of the ncAA on cellular growth. 
Note: To prepare stock solutions, dissolve the ncAA to 0.1-0.5 M using 0.2-0.5 M NaOH. However, 
some ncAAs may require initial solubilisation in DMSO and/or neutralization by four volumes of 
1 M HEPES (pH 7.4) before use. Commonly, the manufacturer recommends a protocol to prepare a 
stock solution. 
7. Mix 1 µg of plasmid DNA encoding for the ncAARS/tRNA pair with 1 µg of reporter plasmid 
DNA (pcDNA3.0-EGFP183TAG-mCherry). In separate tubes, prepare an identical transfection 
using the EGFP wild type variant to serve as reference, and a mock transfection. 
Note: How many copies of the tRNA cassette should be embedded in the plasmid encoding for the 
ncAARS/tRNA pair depends on the application. To facilitate cloning, one tRNA copy is 
recommended when screening different tRNAs, whereas 4 copies are recommended (albeit not 
strictly necessary) when either testing different ncAARS or the incorporation of different ncAAs by 
the same orthogonal pair. 
8. Add 100 µL lactate buffered saline (LBS) containing 20 mM sodium lactate at pH 4.0 and 
150 mM NaCl to the tube containing the plasmid DNA. Mix the solution briefly. 
9. Add 6 µL of 1µg/µL PEI in LBS (ratio PEI/DNA = 3/1 w/w) to the DNA-LBS mix and vortex 
immediately. Incubate at RT for 10-15 min. 
10. Take 400 µL cell medium from the well and add it to the DNA-PEI mixture in LBS (pH 4.0) to 
neutralize the pH. DMEM usually contains phenol red as pH indicator. During the 
neutralization step the colour of the mixture added in the tube will change from yellow (acid) 
to red (neutral). Dribble the DNA mixture onto the cells. 
Note: Although forming the DNA complexes at acidic pH gives the highest transfection yields 50, 
DNA-PEI complexes can alternatively be formed directly at pH 7.4 (for instance in serum free 
DMEM). If using DMEM to form DNA complexes, skip the neutralization step 1.3.5. In any case, it 
is essential that no serum is present in the mixture when forming the complexes.  
11. Harvest cells 48 h post-transfection. 
12. Aspirate the medium and rinse the cells once with 2 mL pre-warmed PBS (37C). Add 800 µl 
PBS supplemented with 0.5 mM EDTA and incubate for 20 min at 37 °C. Detach and suspend 
the cells by pipetting up and down. 
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13. Transfer the cell suspension into 1.5 mL tubes containing 200 µL PBS supplemented with 5 
mM MgCl2. 
14. Centrifuge for 2 min at 800 x g and discard the supernatant.  
Note: The protocol can be paused here. In this case, flash-freeze the pellets in liquid N2 and store 
at -80 °C for up to one month. CAUTION: Wear eye protection goggles.  
15. Add 100 μL Tris lysis buffer containing 50 mM Tris-HCl pH 8.0, 150 mM NaCl, 1% Triton X-
100, 1 mM EDTA and freshly added PMSF to the cell pellets and incubate on ice for 30 min. To 
facilitate lysis, vortex every 5 min. 
16. Spin down cell debris for 10 min at 4 °C and 14000 x g and transfer 90 μL of the supernatant 
into black 96-well plates. Measure EGFP and mCherry fluorescence using a plate reader 
equipped with a fluorescence module. 
Note: Use appropriate excitation and emission filters for EGFP (λabs: 488 nm; λem: 509 nm) and 
mCherry (λabs: 588 nm; λem: 611 nm). Measured EGFP values will span a range between the 
minimum value obtained from mock transfected cells and a maximum value, which is usually 
obtained from wild type EGFP. Take care of setting up the correct measurement window in your 
instrument. 
17. The efficiency of ncAA incorporation is calculated as the ratio between the fluorescence of the 
sample and the fluorescence obtained from expression of wild type EGFP. All values are 
normalized to mCherry fluorescence. 







4.3.2. Genetic incorporation of ncAAs into GPCRs for photo-crosslinking mapping 
of ligand-GPCR interactions 
1. Maintain HEK293T cells in DMEM supplemented with 10 % (v/v) FBS, 100 units/mL penicillin 
and 100 µg/mL streptomycin at 37 °C, 95 % humidity and 5 % CO2. 
2. Seed cells the day before transfection. 
3. Detach the cells for 5 min at 37 °C in 0.05 % Trypsin/PBS supplemented with 0.5 mM EDTA. 
Use 1 mL Trypsin/EDTA for a 10 cm dish. Quench with 10 volumes of complete medium and 
resuspend the cells by pipetting up and down. Count the number of cells in the suspension 
using a hemocytometer 49. 
4. Seed 5.0 x 105 293T cells per well in 2 mL complete growth medium in 6-well plates. For each 
position to be screened, prepare one well per ligand, plus two additional wells for the expression 
and binding controls. 
5. Control confluence (area occupied by the cells) under a microscope. Transfect cells at ~70% 
confluence using PEI. 
6. One hour prior to transfection, add Azi to the cell medium to a final concentration of 0.5 mM. 
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7. Prepare a 0.5 M stock solution of Azi. Per 6-well plate, weigh 1.2 mg Azi into a tube and dissolve 
it in 15 µL 0.5 M NaOH. Dilute the stock solution in 1.2 mL complete medium and add 200 µL 
of the mixture to each well.  
Note: Prepare a fresh stock solution of Azi for every experiment. The azide moiety has a short half-
life in aqueous solutions, especially at basic pH, and the AziRS incorporates the intact but also the 
degraded form. 
8. Prepare a total amount of 2 µg DNA per well. Use 1 µg of plasmid encoding the FLAG-tagged 
GPCR bearing a TAG codon at the desired position in pcDNA3.1. Add 1 µg of the optimized 
plasmid construct encoding the Azi-tRNA synthetase (E2AziRS) 51 and four copies of the 
cognate suppressor tRNA (BstYam). 
9. Proceed as described in 1.3.3-1.3.5. 
10. 48 h post-transfection proceed either with step 2.4 for photo-crosslinking of the ligands or go to 
step 2.5 for direct harvesting and analysis for verifying receptor expression.  
11. Photo-crosslinking of the ligand. 
12. Prepare a 1000 x ligand stock solution. Dissolve the peptide ligand at a concentration of 100 
µM in DMSO. 
Note: The ligand concentration depends on the dissociation constant KD of the ligand-GPCR 
interaction. A final concentration of 100 x KD is recommendable. If the peptide ligand is a salt of 
trifluoroacetic acid (TFA), consider the weight of TFA when calculating the molecular weight (1 x 
TFA per basic amino acid in the peptide). Also consider that peptides are in general hygroscopic. 
Avoid repeated freezing of peptide powder and never open a peptide container until it has not 
reached room temperature.  
13. Dilute the ligand stock solution 1:1000 in binding buffer consisting of 0.1% BSA, 0.01% Triton-
X 100, 5 mM MgCl2 in HEPES dissociation buffer (HDB) containing 12.5 mM 4-(2-
hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES)-HCl pH 7.4, 140 mM NaCl and 5 mM 
KCl. Prepare 1 mL per Azi-GPCR mutant. Replace the cell medium with 1 mL of the ligand 
solution. Incubate for 10 min at RT. 
Note: Adjust the incubation time to the specific GPCR, accounting for ligand kinetics and receptor 
internalization. In our experience, prolonging the incubation time does not improve crosslinking 
yields. 
14. Irradiate the samples for 20 min in a UV crosslinker at 365 nm with 5 x 8 Watt tubes and ~ 5 
cm distance to the cells. Detach the cells by pipetting and transfer them into a 1.5 mL reaction 
tube. Pellet the cells for 3 min at 800 x g and discard the supernatant. 
15. Dissolve a tablet of protease inhibitor (PI) cocktail in 1 mL 25 mM EDTA/H2O to make a 50 x 
stock solution. Aliquot the PI stock solution and store it at -20 °C. Dilute the 50 x stock 1:25 in 
HDB and resuspend the cell pellets in 50 µL of 2 x PI in HDB. Flash-freeze the cells in liquid 
N2. CAUTION: Wear eye protection goggles. 
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Note: At this point, the samples can be stored at -80 °C for up to one month. Proceed with step 2.6. 
16. Direct cell harvest. 
17. Aspirate the medium. Add 800 µL of 0.5 mM EDTA HDB. Incubate for 10 min at RT or on ice. 
18. Detach the cells by pipetting up and down and transfer them into a 1.5 mL reaction tube. Add 
200 µL of 5 mM MgCl2 in HDB. Pellet the cells for 3 min at 800 x g and discard the supernatant. 
19. Resuspend the cell pellets in 50 µL of 2 x PI in HDB and flash freeze in liquid N2. CAUTION: 
Wear eye protection goggles.  
Note: At this point, the samples can be stored at -80 °C for up to 1 month.  
20. Cell lysis. 
21. Thaw the cells in a water bath at 37 °C for 30-45 s. Vortex the samples and keep them on ice 
from now on. Centrifuge for 10 min at 2500 x g and 4 °C. Discard the supernatant. 
22. Resuspend the cell pellets in 50 µL HEPES lysis buffer containing 50 mM HEPES-HCl pH 7.5, 
150 mM NaCl, 10 % glycerol, 1 % Triton X-100, 1.5 mM MgCl2, 1 mM EGTA, 1 mM DTT and 
freshly added 2 x PI cocktail. Mix thoroughly. Lyse the cells 30 min on ice and vortex every 
5 min. 
23. Spin down cell debris for 10 min at 14000 x g and 4 °C. Transfer the supernatant into a fresh 
reaction tube. 
Note: Proceed with the analysis right away. The lysates can be stored at -20 °C, however, every 
freeze-thaw cycle impairs the quality of the results.   
24. Western Blot analysis. 
25. Prepare samples: Take 3-5 µL lysate and fill it up to 7 µL with H2O. Add 2 µL 1 M DTT and 3 
µL 4 x sample buffer containing 63 mM Tris-HCl pH 6.8, 2 % SDS, 10 % glycerol and 0.04 % 
bromphenolblue. Incubate for 30 min at 37 °C. 
26. When the GPCR is glycosylated and faint or smeared bands are a problem, use PNGase F to 
deglycosylate the samples. This can increase the intensity of the signals and sharpen the bands. 
Use 3-5 µL lysate and deglycosylate in a total volume of 10 µL following the supplier’s protocol. 
Add 3 µL 4 x sample buffer. 
Note: Membrane proteins are often glycosylated in multiple sites and states, which impairs the 
quality of resolution in SDS-PAGE analysis. However, do not deglycosylate the samples for analysis 
of the expression level of the Azi-GPCR mutants using anti-FLAG antibodies because it is relevant 
to evaluate the portion of the fully glycosylated, mature receptor at the cell surface. 
27.  Resolve samples on standard SDS-PAGE and blot transfer proteins to a PVDF membrane. 
CAUTION: Acrylamide is neurotoxic. Wear gloves and eye protection. 
28.  Block the membrane for 1 h at RT or overnight at 4 °C in 5 % skim milk in TBS-T containing 
20 mM Tris-HCl pH 7.4, 0.15 M NaCl and 0.1 % Tween 20. 
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29.  Probe the membrane with an anti-ligand antibody followed by the HRP-conjugated secondary 
antibody. Wash in between with TBS-T. To detect the expression level of the Azi-GPCR, probe 
the membrane with anti-FLAG-HRP. 
30.  Perform enhanced chemiluminescence reaction and detect signals for 5 min in the dark. 
4.3.3. Ultrafast bioorthogonal labelling of GPCRs on live mammalian cells 
Note: The protocol is optimized for microscopy slides equipped with 4 x wells (well area = 2.2 cm²). 
For different well sizes, the protocol has to be scaled accordingly. 
1. Coating of microscopy slides. Carry out the whole procedure under a sterile hood. 
2. Prepare a poly-D-lysine hydrobromide (MW=500-550 kDa) (PDL) stock solution at a 
concentration of 1 mg/mL in 50 mM borate buffer (pH 8.5). Store at 4 °C for up to 6 months. Do 
not freeze. 
3. Dilute the PDL stock solution 1:40 in sterile milliQ water to a final concentration of 25 µg/mL 
(working solution), then filter the solution through a 0.22µm sterile filter. The working solution 
can be stored at 4 °C for up to 3 months. 
4.  Fully cover the bottom of each well of the microscopy slide with 500 µL of PDL working 
solution. Incubate for 20 min at RT and aspirate the PDL working solution. 
Note: The PDL working solution can be used up to three times. If you wish to reuse the solution, 
transfer the used solution from the coated slides to a fresh sterile tube and label the tube 
accordingly. Never mix recycled solution with fresh solution.  
5.  Rinse each well 3 x with ~ 700 µl sterile milliQ water and let dry for at least 1 h. 
Note: It is very important to rinse the wells accurately, as residues of the PDL solution are toxic to 
the cells. The coated microscopy slides can be used straight away or stored for up to one week at 
4 °C. 
6. Maintain HEK293T cells in DMEM supplemented with 10 % (v/v) FBS, 100 units/mL penicillin 
and 100 µg/mL streptomycin at 37 °C, 95 % humidity and 5 % CO2. 
7. Seed cells the day before transfection 
8. Detach the cells for 5 min at 37 °C in 0.05 % Trypsin/PBS supplemented with 0.5 mM EDTA. 
Use 1 mL Trypsin/EDTA for a 10 cm dish. Quench with 10 volumes of complete medium and 
resuspend the cells by pipetting. Count the number of cells in the suspension using a 
hemocytometer 49.  
9. Seed 1.0 x 105 HEK293T cells per well in 600 µL dye free complete DMEM.  
Note: For imaging purposes, it is very convenient to work from the beginning in a medium that 
does not contain any dye. Dye free DMEM formulations are commercially available.  
10. Control confluence (area occupied by the cells) under a microscope and transfect the cells at 
~70 % confluence using Lipofectamine 2000 according to the manufacture’s protocol. 
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11. One hour prior to transfection, prepare a fresh 100 mM stock solution of TCO*K in 0.2 M 
NaOH.  
12. Mix 3 µl of the TCO*K stock solution with 12 µL of 1 M HEPES pH 7.4. Gently add the 
solution to the well for a final TCO*K concentration of 0.5 mM. 
13. Prepare a total amount of 500 ng DNA per well. In a microcentrifuge tube, dilute 200 ng of 
pcDNA3.1_CRF1R-95TAG-EGFP, 200 ng of the plasmid encoding for the MbPylRSAF/tRNAPyl 
orthogonal pair (four cassettes of tRNAM15) and 100 ng of pcDNA3.1_Arrestin3 plasmid in 50 
µL medium (dye free, serum free, antibiotic free). 
Note: In general, co-transfection of Arrestin is not necessary to observe GPCR internalization. 
However, we have observed that co-transfecting Arrestin3 speeds up internalization of CRF1R, 
which is very convenient when analysing internalization of many mutants. 
14. Dilute 2 µL of Lipofectamine 2000 commercial solution (4 µL per 1 µg of DNA) in 50 µL medium 
(dye free, serum free, antibiotic free). Add the Lipofectamine solution to the DNA solution. 
Vortex the mixture immediately and incubate 5-10 min at RT. Add DNA-lipid complexes to the 
cells.    
Note: In our experience, the morphology of cells transfected using Lipofectamine 2000 looks more 
physiologic compared to that of cells transfected with PEI. As PEI gives higher transfection 
efficiency, PEI should be preferred for downstream applications like Western Blot, whereas 
Lipofectamine 2000 is a better reagent to transfect cells for imaging experiments.  
15. 24 h post-transfection, label the receptor with fluorescent dyes. 
16. Prepare a 0.5 mM tetrazine-Cy3 stock solution in DMSO and a 10 mg/mL Hoechst 33342 stock 
solution in milliQ H2O. Hoechst 33342 is a stain for genomic DNA. 
17. Transfer 100 µL medium from each well into a 1.5 mL reaction tube. Add 1.8 µL of the Cy3-
tetrazine stock solution and 0.3 µL of the Hoechst 33342 stock solution. 
18. Transfer the medium containing the dyes back to the well and incubate for 5 min at 37 °C. 
Tetrazine-Cy3 has a final concentration of 1.5 µM. 
19. Aspirate the medium and gently rinse the cells twice with PBS to remove excess of dye. 
20. Add 600 µl of complete dye free growth medium preheated to 37 °C. 
21. Fluorescence microscopy and receptor internalization. 
22. Visualize the labelled receptors under 63x (or similar) magnification using filters appropriate 
for EGFP (λabs: 488 nm; λem: 509 nm), Cy3 (λabs: 550 nm; λem: 570 nm) and Hoechst 33342 (λabs: 
350 nm; λem: 461 nm). Take a picture with each filter before activating the receptor. 
23. Promote receptor internalization using 200 nM of Ucn1. 
24. Prepare an Ucn1 stock solution of 200 µM in DMSO. 
Note: Depending on the solubility of the peptide, you may be able to prepare the stock in pure water 
or buffer. 
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25. Transfer 100 µL medium from a well into a 1.5 mL reaction tube and add 0.6 µL of the peptide 
agonist stock solution. Transfer the medium back into the well. 
26. Observe the internalization under the microscope. Take pictures after clearly detectable 
occurrence of internalization (10-15 min to hours, depending on the receptor and on the 
overexpression of Arrestins) using the Cy3, GFP and Hoechst filter. 
4.4. Representative Results 
The outline of the fluorescence assay is depicted in Figure 4.1. We employed the assay in three 
applications. In first place, we screened a number of tRNA variants for incorporation of Lys(Boc) 
by the Pyl orthogonal pair. Lys(Boc) is an amino acid sterically similar to Pyl. As Pyl is not 
commercially available, Lys(Boc) is commonly used as a standard substrate for the PylRS. The 
screened tRNAs are based on the tRNAPyl and include mutations of single bases or base-pairs 
rationally designed to improve tRNA stability and compatibility in eukaryotic hosts, as described 
in our recent work 30. 
Typical results are described in Figure 4.2A: different tRNAs give different suppression efficiency, 
which is clearly reflected in the amount of measured fluorescence. The small error bars of biological 
triplicates show that the values are highly reproducible. In second place, we evaluated two gene 
variants of the E2AziRS 26,51, which incorporates the photo-crosslinker p-azido-Phe (Azi). E2AziRS 
is derived from the E. coli TyrRS. One gene variant employed native E. coli codon usage, whereas 
the second was codon-optimized for the use in H. sapiens. The fluorescence assay shows that the 
codon-optimized variant gives higher protein yields (Figure 4.2B). Finally, we compared the 
incorporation rate of different amino acids for bioorthogonal click chemistry (Figure 4.2C). All the 
ncAAs presented here (BCNK, TCO*K and SCOK) are incorporated by the same orthogonal 
MbPylRSAF and tRNAPyl. Lys(Z) is also incorporated by this pair and was used as a positive control. 
To illustrate the reliability of the fluorescence assay, we have also made parallel ncAA 
incorporation experiments on a GPCR, the CRF1R, and carried out Western Blot analysis to 
estimate GPCR expression (Figure 4.2B, C). We observed in the CRF1R the same trends observed 
with EGFP in the fluorescence assay. Notably, we saw that Azi incorporation into CRF1R is highly 
enhanced when using the codon optimized E2AziRS gene compared to the native gene, showing 
that even a moderate improvement of 1.5-2 fold for a soluble protein (EGFP) according to the 
fluorescence assay can have a greater impact on the expression level of more challenging membrane 
proteins (Figure 4.2B). 




Figure 4.2: Representative applications of the fluorescence assay. For screening the optimal tRNA variant (A), only 
one copy of the tRNA cassette is used. Once the optimal tRNA is selected, highest ncAA incorporation is achieved using four 
tandem repeats of the tRNA cassette embedded in the same plasmid (B, C). A) Screening of rationally designed variants of 
tRNAPyl for incorporation of Lys(Boc). HEK293 cells were co-transfected with the reporter plasmid and plasmids encoding 
for MbPylRS and one copy of a tRNAPyl variant. Each tRNA variant bears single or multiple mutations in the loops and 
stems, which are expected to affect tRNA stability and/or compatibility with the eukaryotic translational machinery. All 
details are reported in Ref.°30. Bars represent the relative fluorescence of EGFP obtained from incorporation of Lys(Boc) 
compared to wild type EGFP and directly correlate to the efficiency of stop codon suppression. B) Evaluating the influence 
of codon-usage for ncAARS genes on target protein yields. (left panel) Fluorescence assay of cells transfected with two 
different gene variants of the E2AziRS. (1) codon usage from E. coli and (2) codon-optimized gene for use in H. sapiens. 
(right panel) Western Blot analysis of CRF1R95Azi. The receptor is labelled with a FLAG-tag at the C-terminus. Full-length 
receptor obtained from incorporation of Azi in response to the TAG stop codon is detected by an anti-FLAG antibody. Actin 
β was used as loading control. C) Evaluating the incorporation efficiency of three ncAAs designed for bioorthogonal 
chemistry. (left panel) Structures of ncAAs used in this experiment. (1) LysZ, which was used as positive control, (2) BCNK, 
(3) TCO*K and (4) SCOK. (central panel) Fluorescence assay of HEK293 cells transfected with a plasmid encoding for 
MbPylRSAF and four copies of tRNA15 from (A) to incorporate (1), (2), (3) and (4). (right panel) Western Blot analysis of a 
CRF1R mutant bearing one of the four ncAAs at position 95. The receptor is equipped with a FLAG-tag at the C-terminus. 
Actin β was used as loading control. Panel A was adapted from Serfling, R. et al. Designer tRNAs for efficient incorporation 
of non-canonical amino acids by the pyrrolysine system in mammalian cells Nucleic Acid Research, in press (Oxford 
University Press) and are reproduced according to the Creative Commons Attribution license. 
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The optimized system for Azi incorporation was deployed to map the binding pocket of the CRF1R 
and define binding paths of 5 different ligands: the two peptide agonists Ucn1 and CRF, and the 
three peptide antagonists Ucn1(8-40), CRF(9-41) and dFXCRF(12-41) (Figure 4.3). 
While the efficiency of Azi incorporation was previously shown to decrease when approaching the 
GPCR C-terminus 33,34, our optimized system for Azi incorporation enables comparable expression 
levels of Azi-mutants with TAG-sites in different parts of the GPCR gene (Figure 4.4A). The results 
in Figure 4.4B show the screening of the extracellular loop 2 (ECL2) and helix V of CRF1R as a 
representative part of the ligand binding pocket. A band at the correct size of the crosslinking 
product reveals that the position lies in proximity of the ligand within the ligand-receptor complex, 
i.e. it is part of the binding pocket. We found multiple crosslinking hits with all ligands tested. 
 
Figure 4.3: Schematic representation of the Azi-mediated photo-crosslinking mapping. A photo-activatable azido 
function (yellow star) is placed into a defined position within the receptor (grey). When the azido group is located proximal 
to the bound ligand (red), a covalent crosslinking product is formed upon UV irradiation (yellow circle indicates crosslinking 
site). The incorporation of the azido group into different positions of the receptor reveals the binding surface (purple) of the 
ligand, which represents the binding pocket. 




Figure 4.4: Incorporation of Azi throughout CRF1R for photo-crosslinking mapping of the binding pocket. 
A) Comparison of expression levels of Azi-receptor mutants towards wild type receptor. The receptor is equipped with a 
FLAG-tag at the C-terminus. The humanized gene of E2AziRS was used. The incorporation sites were spread between the 
N- and the C-terminus of the receptor gene as indicated in the top row. Anti-FLAG Western Blots of whole-cell lysates are 
shown. Actin β was used as loading control. Further controls about expression level and binding properties of mutant 
receptors are reported in previous publications 34,36. B) Western Blots probed with either anti-CRF or anti-Ucn1 antibodies 
are shown. The residues replaced by Azi are indicated in the upper row. The cells were incubated with the ligands listed on 
the right, followed by UV irradiation at 365 nm and lysis. The samples were resolved on 10 % SDS-PAGE and analyzed by 
Western Blotting. To obtain sharper bands, samples were deglycosylated using PNGase F. The deglycosylated ligand-
CRF1R complex runs at an apparent MW of ~40 kDa 34. The non-crosslinked ligand is not detected (MW ~3-4 kDa). Both 
panels of this figure have been modified from Seidel, L. et al. Structural insight into the activation of a class B G protein-
coupled receptor by peptide hormones in live human cells. Elife. 6 10.7554/eLife.27711 and are reproduced according to the 
Creative Commons Attribution license. 
We identified distinct binding patterns for the peptide agonists and the antagonists. Notably, the 
pattern of crosslinking hits provides information about structural elements of the receptor. A 
number of successive hits, as observed in the ECL2 (positions F260-R263 in combination with 
antagonists) suggests a flexible loop region. A pattern of hits every three to four residues as found 
in helix V (D269/Y270, Y272/Q273, I277) hints towards a helical structure. The screen can be 
extended to all relevant domains of the GPCR. If a 3D structure or a molecular model of the receptor 
exists, ligand footprints can be visualized by highlighting the crosslinking hits for each ligand 
(Figure 4.5). 
 




Figure 4.5: Footprints of peptide agonists and antagonists on the class B GPCR CRF1R. Surface representation 
of the CRF1R transmembrane domain. Positions of CRF1R that crosslinked the ligand when substituted by Azi are 
highlighted. Footprints of the peptide agonists CRF and Ucn1 are highlighted in magenta, footprints of the antagonists 
CRF(9-41) and Ucn1(8-40) in blue. The footprint of the antagonist dFXCRF(12-41) is highlighted in orange. The seven 
transmembrane helices I-VII are indicated by roman numbers. A-B) Side views of the binding pocket from the membrane 
plane. C) Top view into the binding pocket from the extracellular side. Reprinted from Seidel, L. et al. Structural insight 
into the activation of a class B G protein-coupled receptor by peptide hormones in live human cells. Elife. 6 
10.7554/eLife.27711 and are reproduced according to the Creative Commons Attribution license. 
Both fluorescence and Western Blot data (Figure 4.2C) suggest that TCO*K is the ncAA for 
bioorthogonal chemistry that gets incorporated with the highest efficiency by the MbPylRSAF. 
Different PylRS mutants might give higher incorporation yields of other click ncAAs 13, but we did 
not test them in this study. TCO*K was incorporated into a CRF1R-EGFP fusion and enabled 
installing via SPIEDAC chemistry (Figure 4.6A) a small bright fluorophore on the receptor (Figure 
4.6B). As a proof of specific labelling, the fluorescence of the label should be visible only in cells 
expressing the receptor (green cells in Figure 4.6B) and not in dark cells, which thus provide an 
internal negative control in each experiment. Receptors labelled using ultrafast SPIEDAC 
chemistry are still functional. After adding a peptide agonist, fluorescent compartments were 
observed throughout the cytosol, revealing the physiological process of GPCR internalization 
(Figure 4.6C). The signals of the fused EGFP co-localized with the fluorescent dye at all times, 
confirming the selective biorthogonal labelling of the GPCR.  




Figure 4.6: SPIEDAC labelling of CRF1R on live cells. A) Reaction scheme of the strain-promoted inverse electron-
demand Diels-Alder cycloaddition (SPIEDAC): the trans-cyclo-2-octene group of the ncAA TCO*K reacts with the tetrazine 
group linked to the fluorophore Cy3. B-C) HEK293T cells expressing CRF1R95TCO*K-EGFP. Representative images of the 
green, red and blue channel. The size of the scale bar is 10 µm. B) Cells were treated with tetrazine-Cy3 (1.5 µM) for 5 min. 
Only cells expressing the receptor (green) show occurrence of labelling (red). C) Cells were treated with 200 nM Ucn1 and 
imaged after 15 min. Intracellular vesicles correspond to the internalized receptor. Panels B and C are modified from 
Serfling, R. et al. Designer tRNAs for efficient incorporation of non-canonical amino acids by the pyrrolysine system in 
mammalian cells Nucleic Acid Research, in press (Oxford University Press) and are reproduced according to the Creative 
Commons Attribution license. 
4.5. Discussion 
We describe here a simple and reliable assay to assess the efficiency of orthogonal pairs for the 
incorporation of ncAAs into proteins expressed in mammalian cells. The main advantage of this 
method in respect to widely used assays based on FACS is that it allows the simultaneous 
preparation and measurement of larger numbers of samples and provides data that are easily 
analysed using ordinary Office software. The availability of a medium-throughput method to 
analyse orthogonal pairs in mammalian cells is very important for the development of new 
orthogonal pairs and the improvement of existing ones. Indeed, it is not possible to perform directed 
evolution of orthogonal pairs via the generation of large random libraries and dead/alive selection 
in mammalian systems. The assay allows screening small sized libraries (hundreds of members) by 
investing a reasonable experimental effort within a relatively short time. By screening rationally 
designed tRNA sets via this assay, we could generate novel tRNAs that significantly boost the 
efficiency of the pyrrolysine system 30. We rely on the classic combination EFGP/mCherry for the 
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fluorescent read-out, whereby EGFP serves as reporter of incorporation efficiency and mCherry as 
internal control. The EGFP reporter and the mCherry control are harboured in the same plasmid, 
but are embedded in two separate expression cassettes bearing two independent promoters. In this 
way, mCherry expression relates to the transfection efficiency and cell count, but is independent 
from EGFP expression, so that the measured green fluorescence can be normalized to the red 
fluorescence. This is not exactly the case of other reporters built as a tandem of the two proteins 
such as EGFP-TAG-mCherry 7 and iRFP-GFPY39TAG (with iRFP denoting the infrared fluorescent 
protein) 52. In such constructs both proteins are on the same mRNA transcript. In eukaryotes, 
mRNAs bearing premature stop codons undergo surveillance and degradation by the nonsense 
mediated decay (NMD) mechanism 53. Therefore, both the sequence of the reporter and the control 
are simultaneously degraded and expression of the two genes is not strictly independent. Similar 
assays based on a luciferase reporter instead of a fluorescence reporter have been described by 
others 54,55. While enzymatic luminescence offers higher sensitivity than fluorescence 
measurements, the latter showed in our hands higher reproducibility between different cell 
batches.  
Robust systems for ncAA incorporation in mammalian cells are absolutely needed when working 
with demanding protein targets like membrane proteins and low abundant proteins. We have 
shown here an optimized orthogonal pair for robust incorporation of the photo-activatable ncAA 
Azi into GPCRs. We achieve homogeneous Azi incorporation rates throughout the whole receptor 
that allow for systematic photo-crosslinking mapping of entire GPCR surfaces and identification of 
ligand binding sites. The two major points of strength of the method are that different ligands can 
be analysed on the same receptor in parallel and that the data are derived from the receptor in the 
live cell, which complements information obtained from in vitro approaches. The method is in 
principle applicable to any protein target and is suitable also to map topologies of protein-protein 
interactions. Moreover, the identified subset of crosslinked positions can further be analysed with 
2D crosslinking to pin-point intermolecular pairs of proximal amino acids in the associated 
complex 34,36. Such amino acid pairs provide spatial constraints that are applied to in silico 
experiments to build accurate molecular models of the interaction 34,36. From the methodical point 
of view, it is worth remarking that only positive results from crosslinking experiments should be 
considered. A position that did not crosslink can still be within the critical radius from the ligand. 
False negatives can occur when the mutation introduced by the crosslinker hampers the native 
interaction, but can also occur when the crosslinking moiety either points away from the ligand, or 
is quenched by the solvent, or undergoes intramolecular crosslinking. A crucial part of the method 
is how to detect the occurrence of crosslinking. In first place, whole cell lysates are resolved on SDS-
PAGE, to separate any ligand that is not covalently bound to the receptor. Second, the covalent 
ligand-receptor complex is detected via Western Blotting using an anti-ligand antibody. For peptide 
ligands, high affine polyclonal antibodies raised against the ligand are the optimal choice. We also 
have good experience with the detection of peptide ligands equipped with a FLAG-tag at a 
permissive position, provided the tag is made accessible to the anti-FLAG antibody through a 
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suitable spacer. Biotin tags can also be used, although results may be difficult to interpret due to 
the background by endogenous biotinylated proteins. Small molecule ligands are usually 
radiolabelled, although tag-labelling may also be possible 56,57. Protocols for Azi incorporation into 
GPCRs have been published also by others 57–59. However, these protocols involve the use of three 
plasmids for Azi incorporation, whereas we use a simpler two-plasmid system. In addition, we use 
a humanized gene for E2AziRS, which we show to be superior to the non-optimized one (Figure 
4.2B). 
Modern microscopy techniques require installing very bright and efficient fluorophores into the 
protein of interest, as genetically encoded protein fluorophores such as the classic EGFP are not 
suitable for high-end applications. Therefore, there is a continuous search of methods that enable 
installing organic fluorophores onto proteins, which has led to the development of the popular 
SNAP 60 and Halo 61 tags, between others. However, such tags still have a size of several kDa, which 
may perturb the function of the target protein and leave quite a large uncertainty about the exact 
position of the fluorophore. With a minimal size of a few amino acids, the tetracysteine motif 
represents a smaller alternative for more precise labelling using fluorescein or resorufin arsenical 
compounds (FlAsH, ReAsH) 62,63. Although this approach has been applied very successfully also to 
GPCR studies 64–66 , it requires extensive washing steps with thiols, it suffers often from high 
background, and in any case does not allow positioning the label with single-residue resolution. 
Instead, ncAAs equipped with bioorthogonal anchors offer the possibility of installing fluorescent 
labels at a single amino acid position, thus minimizing the risk of interfering with the native 
conformation and functionality of the target protein. Last-generation ncAAs for bioorthogonal 
chemistry, like the TCO*K 15 we have employed here, have enabled protein labelling directly on 
live cells 13,43. The method is applicable to protein targets on the cell surface, but also on 
intracellular targets, provided that suitable cell-permeable dyes are available 13,67,68. SPIEDAC 
chemistry is several orders of magnitude faster in respect to strain promoted azido-alkyne 
cycloaddition (SPAAC) and Staudinger Bertozzi ligations on azide anchors 1,15. In fact, several 
protocols have been published for GPCR labelling on genetically incorporated Azi, but they are 
applicable only to isolated GPCRs in vitro 37,58,69. Instead, we have demonstrated here smooth 
bioorthogonal labelling of functional GPCRs on the live cell. Our protocol is similar to existing 
protocols using the same chemistry 43,48,70, but our optimized ncAA incorporation system expands 
the scope of the method to GPCR studies. A critical step in the experimental procedure is the choice 
of the position to be exchanged with TCO*K, as not all positions within the receptor are either 
permissive for a replacement or accessible to the fluorescent dye. Therefore, several positions 
should be tested in a preliminary screen to find the most suitable one.  
In conclusion, we have presented here tools for general application of ncAAs, including application 
to challenging protein targets such as GPCRs. We anticipate that photo-crosslinking mapping and 
bioorthogonal labelling, nowadays the main applications of ncAAs to GPCR studies, will find many 
future applications both to unveil topologies of GPCR interactions with ligands or other proteins 
and to study GPCR structural dynamics in the live cell. 
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CONCLUSION AND PERSPECTIVES 
The pyrrolysyl-tRNA synthetase/tRNAPyl pair is undoubtedly the most commonly used system for 
the biosynthetic incorporation of ncAAs into proteins. The exceptional orthogonality of this archaeal 
AARS/tRNA pair both in bacteria and eukaryotes and the malleability of the substrate pocket of 
the PylRS make it the most powerful tool to genetically encode an unchallenged spectrum of ncAAs 
for studying protein structure, function and dynamics in the live cell. Nonetheless, at the beginning 
of this PhD work, the applicability of the pyrrolysine system in mammalian expression hosts was 
limited by suboptimal yields of ncAA incorporation, which hampered ncAA studies of low abundant 
biological targets. While most efforts to improve the pyrrolysine system had been focused on 
increasing the expression of the tRNAPyl, the approach used here aimed at improving the quality of 
the tRNA rather than its quantity.  
As a result, novel high-quality tRNAs that significantly boost the efficiency of the pyrrolysine 
system in mammalian cells have been developed. Such tRNAs can be paired to any engineered 
ncAARS derived from the PylRS and are beneficial for the incorporation of a large number of ncAAs. 
Moreover, as the PylRS does not select for the anticodon of its tRNA, the novel tRNAs can be 
effectively used not only as amber, but also as ochre and opal suppressors, thus facilitating the 
simultaneous incorporation of two distinct ncAAs in the same protein. It is well known that the 
expression rate of proteins obtained by suppression of multiple stop codons is very low. The new 
tRNAs enabled the incorporation of two different ncAAs even into GPCRs, which are notoriously 
challenging targets for ncAA mutagenesis. Recently, mutually orthogonal PylRS/tRNAPyl pairs 
from Methanosacina mazei and Methanomethylophilus alvus for simultaneous incorporation of 
different ncAAs in bacteria have been reported. Upon further engineering, the pyrrolysine system 
described in this work, together with the M. alvus Pyl pair, could yield by far the most versatile 
and efficient combination for incorporating multiple ncAAs in mammalian cells in the future.  
Furthermore, the results presented here confirm the notion that adapting a suppressor tRNA to 
the host organism is a rewarding approach to improve the general efficiency of an orthogonal 
system. It is interesting that the enhanced tRNAs, besides featuring higher intracellular 
concentrations compared to wild type tRNA, are also distinctly post-transcriptionally modified in 
human cells. Intriguingly, the processed positions bear the same nucleotide both in the enhanced 
and wild type tRNA. This means that small changes of the nucleotide sequence of a tRNA can have 
profound effects on the way the whole tRNA is processed, which is probably due to different 
interactions of the tRNA molecule with the processing machinery of the host organism. 
Post-transcriptional modifications play an important role for stabilizing the tRNA structure and 
facilitating the unambiguous recognition by the AARS, among other functions. However, such 
effects on suppressor tRNAs haave not been considered so far. Further research aimed at 
understanding the exact mechanism regulating heterologous expression of suppressor tRNAs may 
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provide new points of intervention for an overall improvement of genetic code expansion techniques 
in general.  
As a further major achievement of this work, single-residue labeling of functional GPCRs in live 
cells was demonstrated. GPCRs translate extracellular stimuli into intracellular signals by means 
of subtle changes in their structure that lead to specific recruitment of different effectors. One major 
challenge of the current GPCR research is to understand how such structural rearrangements take 
place in the live cell in real time. The most powerful technique to investigate this kind of biological 
question in live cells is fluorescence microscopy. Indeed, many groups seek the development of 
sensible FRET sensors revealing structural changes, which can only be built by using small 
fluorophores incorporated into very precise regions of the receptors, such as the loops. While 
common methods of protein labeling are based on the introduction of relatively bulky tags, the 
enhanced Pyl system developed in this work enabled the smooth incorporation of last-generation 
ncAAs for bioorthogonal chemistry into the loops of three different GPCRs. Ultrafast and highly 
selective SPIEDAC-chemistry yielded quantitative labeling of all three receptors directly on the 
live mammalian cell. Importantly, the incorporation of single ncAAs into most positions throughout 
the whole GPCR sequence was very well tolerated, thus giving the possibility of labeling very 
precisely almost any receptor domain. 
The possibility of quantitatively labeling a functional GPCR on a single-residue with small organic 
fluorophore opens new avenues for the application of high-end microscopy techniques to GPCR 
studies in live cells. In the first place, receptors labeled with small fluorophores on a single site are 
more likely to behave as the wild type receptors than receptors labeled with bulkier tags. Indeed, 
it was shown here that a GPCR labeled on an ncAA diffuses faster compared to a GPCR 
C-terminally labeled with a fluorescent protein. The application of ncAA labeling will therefore be 
an optimal choice for future studies of GPCR distribution and oligomerization including the use of 
super-resolution microscopy and single-molecule tracking techniques. Secondly, given the 
possibility of incorporating two ncAAs into the same receptor, it can well be expected that the 
development of sensitive FRET sensors revealing the relative movements of single GPCR helices 
or rearrangements between helices and loops should be possible. Moreover, the simultaneous 
incorporation of distinct ncAAs into the interaction interfaces of protein complexes has a great 
application potential for studies of protein-protein interactions.  
From the methodological point of view, this work contributed to the ncAA field a simple, rapid and 
straightforward assay to evaluate the efficiency of an orthogonal system in mammalian cells based 
on a bicistronic plasmid bearing two fluorescent reporters. The assay is a very handy tool to quickly 
explore and optimize experimental conditions of ncAA incorporation before working with expensive 
ncAAs or challenging protein targets. Furthermore, the assay is ideally suited for the screening of 
small sets of tRNAs and AARSs for the improvement of orthogonal pairs in mammalian cells. 
Additionally, this work has described a method of fluorescence microscopy to precisely quantify the 
labeling rate of proteins diffusing in the plasma membrane of live cells. The method is based on 
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fluorescence fluctuation spectroscopy and takes a genetically fused fluorescent protein as an 
internal reference. A strategy based on dual-color competitive labeling at a single ncAA has been 
presented, which allows estimating the oligomerization state of GPCRs in the live cell, by obviating 
the cumbersome need of a biological reference. The imaging experiments can be performed on a 
commercial confocal microscope, so that the methods are not restricted to specialized labs, since the 
approach can be applied to any type of membrane protein and any labeling strategy.  
In conclusion, this work fundamentally contributes to the general applicability of ncAAs to live cell 
studies of proteins in mammalian cells. Indeed, as soon as this work was published, the engineered 
tRNAs have been requested by several colleagues from many labs in a number of European 
countries, the UK, Israel and the USA, with very positive feedback. Therefore, this work is likely 
to have an important impact in the field of ncAA mutagenesis, which is not limited to the specific 
applications investigated here. 
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